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Abstract 
THE IMPACT OF OBJECTIVE QUALITY RATINGS ON PATIENT SELECTION OF COMMUNITY 
PHARMACIES: A DISCRETE CHOICE EXPERIMENT AND LATENT CLASS ANALYSIS 
 
By Julie A. Patterson, BS, PharmD/PhD Candidate 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor 
of Philosophy at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2017 
Advisor: David A. Holdford, R.Ph., M.S., Ph.D., FAPhA 
Professor, Department of Pharmacotherapy and Outcomes Science 
 
 
Background: Pharmacy-related performance measures have gained significant attention 
in the transition to value-based healthcare. Pharmacy-level quality measures, including 
those developed by the Pharmacy Quality Alliance, are not yet publicly accessible. 
However, the publication of report cards for individual pharmacies has been discussed as a 
way to help direct patients towards high-quality pharmacies. This study aimed to measure 
the relative strength of patient preferences for community pharmacy attributes, including 
pharmacy quality. Additionally, this study aimed to identify and describe community 
pharmacy market segments based on patient preferences for pharmacy attributes. 
 
Methods: This study elicited patient preferences for community pharmacy attributes using 
a discrete choice experiment (DCE) among a sample of 773 adults aged 18 years and older. 
Six attributes were selected based on published literature, expert opinion, and pilot testing 
feedback. The attributes included hours of operation, staff friendliness/courtesy, 
pharmacist communication, pharmacist willingness to establish a personal relationship, 
overall quality, and a drug-drug interaction specific quality metric. Participants responded 
 xiii 
to a block of ten random choice tasks assigned by Sawtooth v9.2 and two fixed tasks, 
including a dominant and a hold-out scenario. The data were analyzed using conditional 
logit and latent class regression models, and Hierarchical Bayes estimates of individual-
level utilities were used to compare preferences across demographic subgroups. 
Results:  Among the 773 respondents who began the survey, 741 (95.9%) completed the 
DCE and demographic questionnaire. Overall, study participants expressed the strongest 
preferences for quality-related pharmacy attributes.  The attribute importance values 
(AIVs) were highest for the specific, drug-drug interaction (DDI) quality measure, 
presented as, “The pharmacy ensured there were no patients who were dispensed two 
medications that can cause harm when taken together,” (40.3%) and the overall pharmacy 
quality measure (31.3%). The utility values for 5-star DDI and overall quality ratings were 
higher among women (83.0 and 103.8, respectively) than men (76.2 and 94.5, 
respectively), and patients with inadequate health literacy ascribed higher utility to 
pharmacist efforts to get to know their patients (26.0) than their higher literacy 
counterparts (16.3). The best model from the latent class analysis contained three classes, 
coined the Quality Class (67.6% of participants), the Relationship Class (28.3%), and the 
Convenience Class (4.2%).  
Conclusions:  The participants in this discrete choice experiment exhibited strong 
preferences for pharmacies with higher quality ratings.  This finding may reflect patient 
expectations of community pharmacists, namely that pharmacists ensure that patients are 
not harmed by the medications filled at their pharmacies. Latent class analysis revealed 
underlying heterogeneity in patient preferences for community pharmacy attributes. 
 1 
Chapter 1: Introduction 
1.1 Introduction  
The amount of publicly available healthcare quality data has proliferated in recent 
decades. Patients may now access a variety of quality information compiled through 
governmental (e.g. HEDIS), for-profit (e.g. HealthGrades), and not-for-profit (e.g. LeapFrog) 
outlets. A substantial body of literature has debated the impact of these metrics on patient 
selection of healthcare providers and facilities. While pharmacy-level quality metrics are 
not yet publicly accessible, the publication of report cards for individual pharmacies has 
been discussed as a way to help direct patients towards high-quality pharmacies.1   
 The effort to quantify and promote pharmacy quality has been led by the Pharmacy Quality 
Alliance (PQA), a non-profit, multi-stakeholder organization founded in 2006.2 PQA aims to 
collaboratively and strategically establish meaningful performance measures at the 
pharmacy and pharmacist-level.2 Furthermore, health-plan level PQA measures are 
included in the Health Insurance Marketplace plan rating system3 and Medicare Part D Plan 
star ratings, which impact payments from the Centers for Medicare and Medicaid (CMS).4  
Most studies examining how American patients choose pharmacies have focused on 
patient decisions to select mail order pharmacies5–7 or were conducted over twenty years 
ago. Older studies on patient selection of community pharmacies reported that patients 
consider location,8,9 pharmacist friendliness and professionalism,10,11  price,10 and 
pharmacist services10 to be important factors when selecting a pharmacy. More recently, a 
survey asked patients to indicate the importance, on a scale of one to five, of 26 attributes 
when choosing a pharmacy.  The survey also assessed the degree to which respondents 
perceived those attributes to differ between pharmacies.12 Survey participants expressed 
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strong preferences for pharmacies with competent, knowledgeable, and friendly 
pharmacists and staff. Furthermore, these attributes were perceived as the most 
differentiating factors between competing pharmacies.12 Location, prescription prices, and 
hours of operation were important to most patients but were not seen as differentiating.12 
In another study, participants commonly cited relationships with staff (43.6%), 
convenience (28.2%), and local pharmacy ownership (15.4%) as important factors when 
choosing a pharmacy.13  Themes surrounding relationships with staff and owners were also 
prevalent in a series of focus groups conducted by Shiyanbola and Mort.14 
A limited number of qualitative studies have explored the potential impact of quality 
metrics on the pharmacy selection process. While many participants in one series of focus 
groups indicated a willingness to use publicly available quality measures when choosing a 
pharmacy, rural patients often expressed a reluctance to use outside metrics given their 
relationships with their pharmacy’s owner(s).14  Others stated that the measures would be 
useful for pharmacy selection only in specific scenarios, including in the aftermath of a 
negative experience or error or if they were moving to a new area.15 The relative 
importance of pharmacy structures, processes, and quality-related outcomes of care has 
not yet been fully examined, particularly among modern patients with increasing access to 
quality and satisfaction information. This research study adds to body of knowledge on the 
potential impact of publicly available pharmacy quality metrics by quantitatively assessing 
the relative strengths of patient preferences when selecting a community pharmacy.  
A discrete choice experiment among a sample of 500 adults (≥18 years) was 
conducted for this study. An initial list of sixteen potential attributes for the DCE 
experiment was formed based on expert opinion and published literature on how patients 
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select healthcare providers. The attribute selection process was guided by the Donabedian 
Model for healthcare quality and the SERVQUAL framework for service quality. Pilot testing 
feedback was used to reduce the number of attributes to six: hours of operation, staff 
friendliness/courtesy, pharmacist communication, pharmacist willingness to establish a 
personal relationship, overall quality, and a specific quality metric related to drug-drug 
interactions. Participants responded to a block of ten random choice tasks and two fixed 
tasks, including a dominant and a hold-out scenario. A conditional logit analysis was used 
to quantified the importance of quality information to patients when choosing a 
community pharmacy relative to the importance placed on pharmacy characteristics 
reflecting structures and processes of care. Additionally, a latent class analysis was used to 
identify and describe segments in the community pharmacy market based on patient 
preferences.  
The study rationale, specific aims, and study significance are provided in the latter 
half of Chapter 1. Background information and a systematic review of the literature are 
provided in Chapter 2.  The methods and results for this study are presented in Chapters 3 
and 4, respectively.  In chapter 5, a discussion of the study results, study limitations, 
suggestions for future research, and study conclusions are presented.
 4 
1.2 Study Rationale and Specific Aims 
1.2.1 Study Rationale 
Patients select healthcare providers and facilities based on a complex array of 
factors. Insights into patient understanding and use of quality information are increasingly 
pertinent to community pharmacy given the recent development of pharmacy quality 
metrics16 and growing emphasis on pharmacy differentiation.2 Focus group participants 
have demonstrated varying degrees of comprehension of and willingness to use pharmacy 
quality measures.14,15 At the same time, pharmacy attributes like staff friendliness and 
convenience are well understood and consistently ascribed importance by pharmacy 
patrons.12–15 A clearer understanding of patients’ priorities during pharmacy selection and 
the relative perceived importance of quality metrics can inform pharmacy organizations of 
the extent to which publicly available pharmacy quality ratings may drive patients to high 
quality community pharmacies. The results may also help to ascertain future needs for 
marketing efforts promoting the impact of pharmacists on the quality of medication 
management. Additionally, the identification of market segments based on patient 
preferences for pharmacy attributes may help pharmacies to provide more effective 
patient-centered care by targeting and personalizing services. 
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1.2.2 Specific Aims 
This study aims to explore the relative importance of pharmacy attributes during 
the community pharmacy selection process and to identify market segments based on 
patient preferences for pharmacy characteristics. I propose the following specific aims: 
 
Specific Aim 1 
To measure the relative strength of patient preferences for community pharmacy 
attributes, including quality metrics, during pharmacy selection 
 
Specific Aim 2 
A) To describe the associations between patient sociodemographic characteristics 
and preferences for pharmacy attributes during pharmacy selection 
B) To describe the associations between patient health status, literacy, and 
confidence and preferences for pharmacy attributes during pharmacy selection 
 
Specific Aim 3 
A) To describe community pharmacy market segments based on patient preferences 
for pharmacy attributes 
B) To describe the sociodemographic and health characteristics of patients in each 
of the identified community pharmacy market segments 
C) To compare the sociodemographic and health characteristics of patients in each 
of the identified community pharmacy market segments to those of patients in other 
segments 
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Chapter 2: Background and Literature Review 
2.1 The History of Quality Metrics in American Healthcare 
The movement to improve healthcare quality in the United States encompasses 
diverse stakeholders and approaches. In the last twenty years, governmental agencies and 
initiatives, including the Agency for Healthcare Research and Quality (AHRQ) and the 
Institute of Medicine’s (IOM) Health Care Quality Initiative, were established to focus and 
prioritize research efforts on the evaluation and improvement of healthcare quality. AHRQ 
works within the U.S. Department of Health and Human Services to produce evidence that 
improves the safety, quality, and accessibility of health care.17 The Agency developed AHRQ 
Quality Indicators (QIs), standardized quality measures derived from hospital inpatient 
administrative data.  The QIs are used both by health systems for internal quality 
improvement initiatives and by external agencies for quality-based purchasing and 
coverage decisions. The IOM, established in 1996, has published a number of seminal 
reports on the quality of healthcare in America, including Crossing the Quality Chasm: A 
New Health System for the 21st Century, and To Err is Human: Building a Safer Health System. 
To Err is Human has been credited with increasing awareness of medical errors and 
establishing the goal of reducing errors by 50 percent over five years. The organization also 
published reports making recommendations for the measurement and reporting of 
performance data, stating, “public reporting is integral to improving performance.”18 
Non-profit organizations have also played a critical role in the rise of healthcare 
quality metrics in the United States. The Joint Commission on Accreditation of Healthcare 
Organizations (JCAHO), the National Committee for Quality Assurance (NCQA), and the 
National Quality Forum (NQF) emerged over the last 40 years to measure the performance 
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of healthcare facilities, practitioners, and health plans. In addition to offering accreditations 
and certifications, these multidisciplinary organizations have dedicated considerable 
resources to the development of standardized performance metrics for the risk-adjusted 
evaluation of healthcare organizations.19 
The Centers for Medicare and Medicaid Services (CMS) is increasingly utilizing 
healthcare quality metrics in reimbursement decisions and incentive programs. For 
example, the AHRQ QIs are used by CMS in its Hospital Value-Based Purchasing Initiative, 
the Accountable Care Organizations (ACO) program, and the Meaningful Use Incentive 
program.  Quality metrics are also commonly made publicly available to inform consumer 
decision-making. The Healthcare Effectiveness Data and Information Set (HEDIS), 
maintained by NCQA, contains over 80 measures of health plan quality relating to 
effectiveness of care, access/availability of care, experience of care, utilization, and relative 
resource use.20 The Consumer Assessment of Healthcare Providers and Systems (CAHPS) 
family of surveys, also maintained by NCQA, publicly report on patient experiences with a 
variety of healthcare facilities.  The NCQA combines HEDIS, CAHPS, and accreditation 
standards scores into a single rating, on a scale of 1-5, for public and private health 
insurance plans. Furthermore, the 2009 Affordable Care and Patient Protection Act 
enhanced federal funding for a number of quality-related initiatives, including the Center 
for Medicare and Medicaid Innovation, the Medicaid Incentives for Prevention for Chronic 
Diseases program, and the Testing Experience and Functional Assessment Tools (TEFT) 
grant program.21 
The Hospital Quality Alliance, a public-private collaboration established in 2002 to 
promote and inform hospital quality of care,22 publicly released hospital performance data 
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on ten process of care measures though the Hospital Compare website in 2005.19 Since that 
time, similarly formatted sites hosted by Medicare.gov have been generated to provide 
consumers with quality metrics for nursing homes, physicians, home health agencies, and 
dialysis facilities; an analogous site publicly reporting pharmacy quality has not yet been 
developed.  
 
2.2 The Development and Emergence of Pharmacy Quality Metrics 
2.2.1 Pharmacy Quality Alliance Quality Metrics 
A formal, concerted effort to develop pharmacy-related quality metrics began in 
2006 with the establishment of the non-profit, multi-stakeholder Pharmacy Quality 
Alliance (PQA). Through a consensus-based process, PQA defines and endorses 
performance measures that focus on the appropriate use of medications and pharmacy 
services.2 The process by which PQA performance measures are endorsed is lengthy and 
includes concept identification, evaluation and refinement. In the first step, PQA staff, 
members, and a Measure Advisement Group review national priorities and create lists of 
potential measure concepts to meet clinical needs and fill measure gaps.23 Based on a list of 
measure concepts prioritized by the Measure Advisement Group, Measure Development 
Teams (MDTs), which consist of experts in specific medication use systems or therapeutic 
areas, each focus on the development of a single draft measure.  
PQA member organizations are invited to comment on draft measures, and the 
feedback received is used to edit and refine the measures. Experts in quality and 
performance measures then test each draft measure for feasibility, usability, and validity. 
Based on the results of these tests, a Strategic Advisory Panel decides whether to 
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recommend the measure for endorsement. If a measure is recommended, member 
comments are elicited via the PQA website, mail, and a conference call for member 
organizations. Following these comments, member organizations vote on whether to 
endorse a measure.24 
PQA measures are defined by precise measure specifications and must be used 
according to specific criteria in order to allow for the evaluation of rates across 
comparators. As of February 20, 2017, PQA maintains 18 endorsed quality metrics, each of 
which are reviewed annually. Adherence features prominently in the quality metrics, which 
include the proportion of days covered (PDC) for each of ten chronic medications and non-
warfarin oral anticoagulants. A measure of primary medication non-adherence has also 
been endorsed. Other quality metrics reflect the therapeutic appropriateness of medication 
therapy. These metrics include diabetes medication dosing; statin use in persons with 
diabetes and coronary artery disease; medication therapy for persons with asthma; use of 
high risk medications in the elderly; and opioid and antipsychotic use in high risk 
populations. The prevalence of drug-drug interactions and the proportion of 
comprehensive medication reviews (CMRs) completed are also captured by PQA-endorsed 
pharmacy quality metrics. In December 2016, PQA endorsed two new measures reflecting 
the concurrent use of opioids and benzodiazepines and adherence to non-infused disease 
modifying agents to treat multiple sclerosis.25 
 PQA quality measures are used in a number of official capacities. Beginning in 2017, 
Qualified Health Plans (QHPs) in the Health Insurance Marketplace are required to report 
three PQA metrics to the Quality Rating System (QRS). These measures include the PDCs 
from the 2016 coverage year for renin angiotensin system antagonists (RASA), oral 
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diabetes medications, and statins.26 PQA quality metrics also play a role in Medicare Part D 
Plan Star Ratings. Specifically, five PQA measures are included in in the “Drug Pricing & 
Patient Safety” domain of the star ratings. These measures are the PDCs for renin 
angiotensin system antagonists (RASA), oral diabetes medications, and statins as well as 
the use of high-risk medications in the elderly and the CMR completion rate. The PQA 
adherence and high risk medication measures are heavily weighted in the calculation of the 
overall plan ratings and are weighted twice as highly as, for example, the criteria “getting 
needed prescription drugs”, “appeals upheld”, and “members choosing to leave the plan.” 
Furthermore, CMS publicly reports “display measures” for Part D plans on a patient safety 
website. The PQA measures for drug-drug interactions, oral diabetes medication dosing, 
and statin use in persons with diabetes are included as display measures. In conclusion, the 
Pharmacy Quality Alliance has pioneered the development and validation of pharmacy 
quality metrics that are now used in a number of governmental capacities related to health 
plan ratings.   
 
2.2.2 Patient Perceptions of Pharmacy Quality 
Although pharmacy quality experts have endorsed pharmacy quality metrics 
through a consensus-driven process, little consensus exists among patients regarding the 
components and definition of pharmacy quality. In a series of focus groups guided by the 
Donabedian Framework, British patients and pharmacists discussed attributes of a “good” 
community pharmacy.27 Patients felt that high quality pharmacies have structures in place 
to manage their workload and provide reliable and individualized care. They also 
maintained that high quality pharmacies educate their patients about their medications 
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and how to take them.27 Shiyanbola et al. also used the Donabedian Framework to inform 
their study on older adults’ perceptions of what constitutes a high-quality pharmacy. 28 The 
focus group participants in that study most commonly perceived a quality pharmacy to be 
one focused on the processes of care. That is, when asked to describe the “kinds of things 
that make a pharmacy good,” focus group participants often responded with attributes 
focused on the relational aspects of community pharmacy, including the friendliness and 
helpfulness of staff and pharmacist availability to communicate directly with patients.28 
Therefore, though the body of literature on patient perceptions of pharmacy quality is 
limited, patients have consistently opined that pharmacy quality primarily reflects 
processes, rather than outcomes, of care.    
 
2.3 The Impact of Publicly Reported Quality Metrics in the United States 
The impact of published quality metrics in the United States has been widely 
discussed by both proponents and opponents of public performance data. Advocates for 
publicly available quality measures assert that the data allow patients to make more 
informed decisions about their care and spurs providers to focus on quality improvement 
efforts.29 Concerns have been raised, however, that concentrating energy and resources on 
improving the public measures may come at the cost of innovation and improvements in 
other clinically important outcomes.29 In a 2015 survey of primary care physicians, half of 
those surveyed felt that the increased use of physician quality metrics is negatively 
impacting healthcare quality.30 A number of studies have specifically examined the impact 
of quality metrics on healthcare quality and market share, a proxy for patient choice, to 
more empirically assess the effect of public performance data. 
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2.3.1. The Impact of Quality Metrics on Healthcare Quality  
Conflicting evidence exists on the impact of publicly available healthcare quality 
metrics on the quality of healthcare systems, providers, and health plans. A 2012 evidence-
based practice report from AHRQ concluded that studies on this topic report inconsistent 
results, particularly regarding metrics’ impact on outcome measures.31 A Cochrane Review 
and a systematic review in the Annals of Internal Medicine echoed this finding, stating that 
there is an inconsistent association between publicly available metrics and the quality of 
healthcare precluding firm conclusions about the relationship.32,33 
The 2012 AHRQ report cited the potential for unintended negative effects in the 
wake of public quality reporting, but studies on these consequences report mixed 
findings.31 The reported reductions in mortality rates for coronary artery bypass graft 
surgery (CABG) following New York State’s public release of CABG report cards have raised 
questions about physician “cherry-picking” by turning away and referring the sickest 
patients.34–36 Healthcare providers and facilities may also focus their quality efforts on the 
specific outcomes published publicly to the detriment of others and on short-term metrics 
rather than long-term improvements.37 These changes in provider behavior on account of 
public reporting have complicated the pursuit of high quality evidence on the effect of 
publicly available quality metrics on overall healthcare quality. 
Though the impact of publicly reported metrics on the quality of healthcare is not 
clear, the impact on the structures and processes of healthcare is more evident.31 The 
results of a study in Wisconsin suggest that publicized quality ratings may increase the 
number of quality improvement efforts undertaken by hospitals, particularly those with 
low reported quality.38 Nursing homes were also shown to improve unreported measures 
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of care processes through quality improvement efforts following the implementation of 
public reporting.39 Both the Cochrane32 and Fung 33 reviews report positive associations 
between public reporting and hospital-initiated quality improvement activities. Overall, 
then, while the impact of quality metrics on healthcare outcomes is debated, publicly 
reported quality data has consistently been associated with improvements in the 
structures and processes of healthcare provision. 
 
2.3.2 The Impact of Publicly Reported Quality Metrics on Provider Market Share 
An assumption underlying many studies on the impact of metrics on healthcare 
quality asserts that public reporting will incentivize providers and facilities to improve 
quality in order to retain or attract patients. A number of studies have used administrative 
claims to test that assumption by assessing patient response – in the form of market share 
and patient volume – to publicly reported quality metrics.  
The evidence on the impact of hospital report cards on market share is conflicting. 
Hospital performance on one specific hospital-based procedure, coronary artery bypass 
graft (CABG), received significant attention in the 1990s as states began publicly reporting 
hospitals’ mortality rates for the procedure. Following the publication of New York state 
surgery mortality reports, one study reported that hospitals with higher mortality rates 
had small but significant decreases in the growth rate of market share (1.8 percentage 
points).40 However, another study reported that significant market share gains for high 
quality hospitals were short-lived, disappearing three months after report card 
publication.41 A study of Pennsylvania’s CABG mortality report cards reported non-
significant changes in the number of CABG surgeries per quarter at high- and low-mortality 
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hospitals 42 Significant changes were, however, seen in the surgeon-level analyses; high-
mortality surgeons and those without report cards performed 4.76 and 8.04 fewer 
surgeries per quarter after the release of the report cards.42  
Apart from CABG-specific report cards, overall hospital ratings and performance 
data for other hospital services have generally shown very limit impact on market share. A 
study of 30 hospitals in Cleveland, Ohio reported that hospital outlier status was not 
significantly associated with market share.43  Similarly, the publication of graft survival 
rates for kidney transplants had a limited impact on patient registration, with only 
registrations for young patients (aged 18-40 years) decreasing at low performing 
hospitals.44 A 2005 commentary published in the Journal of the American Medical 
Association summarized the body of literature on the impact of public report cards. The 
authors concluded that there is “limited evidence” that public report cards influence 
market share by allowing consumers to make more informed choices between providers.35  
The responsiveness of hospital markets to public quality information may be limited 
by the often-urgent nature of the hospital selection process as well as differences in 
insurance network status and location. Several studies have examined the effects of public 
report cards in markets where decision-making may be less impacted by urgency, cost, 
and/or location. One such study investigated the impact of Medicare’s Home Health 
Compare report cards on the market share of home health agencies among Medicare 
patients.45 Given that the home health care market uniquely demands no travel costs or 
copayments, the authors hypothesized that report cards may have a greater impact on the 
home health care market than the markets for other healthcare providers and services. 
Consistent with this hypothesis, the study results suggested that a one standard deviation 
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increase in quality scores for functional outcomes could be expected to increase an 
agency’s annual market share for hospital-discharged and community dwelling patients by 
0.6 and 0.9 percentage points, respectively.45 Similar results were reported in an analysis of 
the skilled nursing facility (SNF) market, though the impact of specific metrics for SNFs 
differed. 46 Specifically, an increase from the 25th to the 75th percentile on the performance 
metric reflecting patient pain control was associated with a 0.1-0.7-percentage point 
increase in market share, depending on market size. However, a performance metric 
reflecting rates of patient delirium was not found to be associated with market share.39  
Although they provide very different services than home health agencies and skilled 
nursing facilities, fertility clinics are similarly situated in that patients generally select 
clinics in the absence of significant time pressures and insurance network considerations. 
In a study on the impact of the introduction of online fertility clinic report cards in 1998, 
market share increased for fertility clinics with higher birth rates and decreased for clinics 
that treated primarily younger patient populations or did not report quality information.47 
Model simulations predicted that increasing the reported birth rate by 0.13 percentage 
points, equivalent to increasing from the 25th percentile of clinics to the 75th, would result 
in an increase in market share of 2.9 percentage points. 47 
The results of several market share studies suggest that patient demographics may 
play a role in the impact of public report cards. The authors in the fertility clinic study 
suggested that the demographics of patients undergoing fertility treatments, who are 
disproportionately wealthy, young, and highly educated, likely contributed to their finding 
that public quality information impacted market share.47 Similarly, patients with higher 
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education levels demonstrated a slightly larger response to report cards in an analysis of 
nursing home market share using Medicare claims data.39  
In conclusion, the impact of public report cards on provider market share is debated 
but is likely minimal. Statistically significant changes in market share following public 
release of quality data for skilled nursing facilities and home health care were limited in 
magnitude. The largest documented market share changes were seen in the fertility clinic 
market, which may reflect the disproportionately well educated, wealthy demographics of 
patients undergoing fertility treatments and the lack of insurance networks for the 
services.   
 
2.4 Patient Perceptions of Healthcare Quality Metrics 
The publication of two systematic reviews concluding that quality metrics have no 
or minimal impact on hospital market share48,49 has raised questions as to the factors 
underlying the negative findings. Several theories about these factors have been posited. 
Specifically, researchers have suggested that capacity constraints may limit referrals to 
high quality providers, that patients may be unable to change providers due to insurance 
networks, and that the stability of quality ratings of over time contributes to a lack of 
attention-grabbing “news” surrounding report cards.34,49 Furthermore, in order for publicly 
reported quality metrics to impact patient selection of health care providers, patients must 
use and act upon these metrics. For patients to act upon quality data, 1) report cards must 
exist; 2) patients must know about them and have access to them; 3) patients must 
understand and believe the rankings; and 4) patients must act on the rankings.35 A number 
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of studies have investigated each of these underlying processes involved in the use of 
report cards during patient selection of healthcare facilities and providers.  
 
2.4.1 Patient Awareness of Healthcare Quality Metrics 
The current body of literature suggests that patient awareness of healthcare report 
cards is limited. A study of nearly 12,000 adults with chronic illness in 2008 and 2012 
reported that awareness of hospital and physician quality measures was generally low and 
showed substantial regional variation.50 In 2008, approximately a quarter (25.5%) of 
patients were aware of publicly available hospital quality metrics, while half as many 
(12.8%) were aware of physician quality information. Awareness of physician quality 
metrics varied geographically, ranging from 6.9% (Maine) to 19.3% (Detroit). Similarly, 
patients in the Midwest more commonly reported awareness of hospital quality metrics 
than those on the West Coast. From 2008 to 2012, awareness of physician, but not hospital, 
comparative quality information increased, though the magnitude of that change, 3.7 
percentage points, was small.50,51  
Conflicting results have been reported on the impact of demographic characteristics 
on patient awareness of quality measures. In a nationally representative survey of patients 
with chronic illnesses, demographic factors had limited impact on patient awareness of 
quality metrics, which was generally low among individuals of all races, educational 
backgrounds, and income levels.51 Patients also report low awareness of quality metrics for 
other types of healthcare providers. Many focus group participants who had recently help 
loved ones select home health care agencies were not aware that ratings for these agencies 
existed.52 Notably, whether patients want to be aware of comparative quality information is 
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debated. When interviewed, many patients expressed perceptions that “ignorance [is] 
bliss” when it comes to hospital practices. 53 
Public awareness of commercial or employer-provided reports appears to be 
substantially higher than knowledge of government reports, including Hospital Compare. 
Huesch et al., who investigated Google search behavior, reported that searches for Health 
Grades, a physician rating and comparison database, occurred as many as 80 times more 
often than searches for Hospital Compare from 2012-2013.54 In a survey of nearly 1,000 (n 
= 927) individuals with employer-sponsored HMO health insurance, 63% reported having 
seen employer report cards.55 A similar proportion (65%) of a nationally representative 
sample (n = 2,137) was aware of online physician ratings.56 Ease of accessibility to quality 
information may not have a significant impact on patient awareness.  When an employer 
group mailed quality ratings on local hospitals directly to employees’ homes, only 61% 
reported being exposed to the ratings either by seeing the report or hearing about it from 
someone else.57 Awareness declined substantially over time; two years later, only 6% 
remembered seeing the report.57 While the awareness of these report cards exceeds that of 
non-profit and governmental report cards, it is still far lower than awareness of ratings for 
cars (87%), movies/books (82%), and restaurants (81%).56 In conclusion, low levels of 
patient awareness for objective quality information may present a considerable barrier to 
the widespread use of this data by patients in healthcare decision-making. 
 
2.4.2 Patient Understanding of Healthcare Quality Metrics 
The ability of patients to properly interpret and understand publicly available 
quality metrics has gained considerable attention among quality researchers. A number of 
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studies have investigated the degree to which patients are able to understand quality 
metrics and the influence of the quality data presentation on patients’ levels of 
understanding.   
Comprehension tests have been used to assess the degree to which participants are 
able to correctly interpret healthcare quality data. In these tests, participants are presented 
data and asked questions regarding the information contained in that data. For example, a 
participant may be presented with information about a quality metric presented in a bar 
chart with a benchmark bar representing the state average for that metric. A participant 
may then be asked, “Do bigger bars on the chart show better or worse quality?” and “Does 
Facility A have a better score on this measure than typical facilities in this state?”58 Two 
studies on nursing home quality data reported that, for each comprehension question 
asked, approximately 70-90% of participants answered correctly.59,60 However, the 
percentage of correct responses was much lower (47%) when information was presented 
only in a bar graph.60 In another study, participants answered, on average, about 5.4 of 8 
comprehension questions correctly, a finding interpreted by the authors as suggesting high 
levels of understanding.58 In qualitative interviews, however, many patients were confused 
about how to interpret various indicators related to hospital-acquired infections (HAI).53 
Additionally, some expressed confusion about the distinction between the number of cases 
and rates, whether longer length of stay reflected higher quality of care, and why a high 
score on a process measure did not necessarily result in a high score on a corresponding 
outcome measure.53  
Many, but not all, studies on the presentation of quality metrics report a significant 
association between presentation format and patient comprehension. Several studies have 
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identified simplification of data presentation as a key change to improving understanding. 
Simplification may include limiting the amount of information displayed. In a study by 
Peters et al., patients were best able to identify the hospital with the highest quality when 
hospital profiles were focused only on quality and non-quality hospital information was 
omitted from hospital profiles.61 Similarly, the likelihood that seniors selected the lowest 
cost Medicare Part D plan in a choice experiment increased when less non-cost related 
information about the plans was presented.62 Limiting the number of providers, facilities, 
or health plans, presented simultaneously to patients may also improve their 
comprehension of quality metrics.59,62,63 Furthermore, ratings presented in a star format 
with a scale of one star to three stars may be clearer to patients than those presented on a 
scale of one star to five stars.59 However, not all forms of simplification have been shown to 
improve comprehension. Presenting patients with a lesser number of quality metrics was 
not associated with comprehension in a study testing patient understanding of nursing 
home quality metrics.59 The number of quality metrics displayed was also a weak predictor 
of patient comprehension of hospital quality information.64  
Beyond simplification, the use of evaluative symbols in addition to or in place of 
numerical or graphical data has been shown to promote patient understanding of quality 
information. In focus groups and cognitive testing, many participants have qualitatively 
expressed preferences for star systems rather than percentages, letter grades, or numerical 
scales.14,60 Others, however, see symbols as more difficult to interpret or a way to “hide 
something” that would have been revealed if rates or percentages were displayed.53,65 
When comparing different forms of data presentation, colored dots59 and stars60,66 
outperform other symbols and numbers in promoting patient understanding of quality 
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metrics, and bar graphs are consistently,59,60 but not exclusively,67 associated with the 
lowest levels of comprehension. Bar charts were commonly misinterpreted in patient 
interviews; one patient remarked “the bar chart says nothing.”65  
The impact on comprehension of evaluative word labels (e.g. excellent, good, fair, 
poor) added to graphical or numerical information is debated in the literature. While the 
addition of word labels to bar graphs59 or evaluative tables60 has been shown to improve 
comprehension, this finding is not consistent.68 Word labels may have a greater impact on 
patient understanding of quality measures when the labels are used to clarify whether a 
high or low number is better for a specific indicator (e.g. mortality rate, infection rate).53 
Additionally, when the addition of general word labels that broadly define what quality 
metric stars represent, (e.g. “doctor quality,” rather than “quality rating” or “star rating”) 
may improve patients’ understanding of what quality stars actually measure.69 Similarly, in 
qualitative interviews on comparative information for health plans, patients expressed a 
desire for clear representations of the meaning of quality stars.65 In the absence of this 
information, patients may misunderstand what the stars actually represent; one patient in 
a qualitative study interpreted “quality indicators” as representing the extent to which a 
health care plan pays attention to patients.65 
Patient comprehension of benchmarking and risk-adjusted quality measure varies 
considerably based on the presentation of the information. Qualitative interviews have 
suggested that many patients struggle to understand the definition of risk adjustment.53 In 
one study that presented hypothetical physician quality information for coronary artery 
bypass grafts, fewer than a quarter of patients selected the physician with the lowest risk-
adjusted patient mortality rate when the that metric was presented alongside observed 
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patient mortality rates and number of operations completed.70 However, when only risk-
adjusted data was presented to participants, either in a bar graph (53%) or with 
benchmarked symbols (66%), the majority of patients selected physicians with the highest 
quality (i.e., lowest risk-adjusted mortality rate).70 These results are consistent with 
reports that the presentation of quality metrics in both absolute and relative 
(benchmarked) forms simultaneously may create confusion among patients.65 Despite the 
finding that benchmarking may improve patient comprehension of risk-adjusted quality 
measures, benchmarked quality data may still be confusing and/or undesirable to patients. 
Symbols based on benchmarks have confused patients in cognitive testing.65 Furthermore, 
patients in focus groups found little value in comparing a pharmacy’s quality to a state 
average, stating, “I don’t really care what the state average is,” and “what if I don’t know 
what the state average is necessarily? What if the whole state is doing poorly?”14 
In several focus groups, patients suggested that presenting an overall performance 
scale in addition to more specific quality metrics would aid in the identification of high-
quality pharmacies and hospitals. 14,53,71 These qualitative findings are consistent with 
experimental data demonstrating that survey participants were more consistently able to 
identify high quality nursing homes when an overall performance measure was included in 
addition to specific quality metrics.59 Another study examined patient choices when 
presented with three pieces of quality information for each of five hospitals, including an 
overall safe practices score and specific hospital acquired infection and mortality rates.67 
When one hospital had the best overall score but another hospital had the best infection 
and mortality rates, more patients (46%) indicated that they would choose the hospital 
with the best overall score than one with the best component scores (34%), suggesting a 
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reliance on general quality scores for decision-making.67 Many patients, however, do not 
want to be presented with only a single, overall performance metric. Participants in several 
focus groups expressed a desire to see more detailed quality information beyond just an 
aggregated, overall measure,14,71 suggesting that overall and specific scores may appeal to 
different subgroups of the population seeking comparative quality information.  
Demographic characteristics have consistently been associated with patient 
comprehension of healthcare quality data. Three studies on nursing home quality 
information reported that more educated participants more often correctly interpreted 
quality information when compared to less educated respondents.58,63 Participants with at 
least a college education were also more often able to identify the “best” hospital67 or 
surgeon70 when presented with quality information than their lower educated 
counterparts.  However, higher health literacy and numeracy, rather than education level, 
may more strongly predict comprehension of quality information.64,72 Age is also 
significantly associated with patient understanding of quality data, with younger patients 
consistently demonstrating higher levels of understanding than older patients.58,63,64   
Overall, patient understanding of quality metrics is relatively limited, though some 
presentations of quality data may promote higher degrees of comprehension. Simplifying 
the amount and type of information displayed, presenting information with symbols like 
stars or colored dots, and adding evaluative word labels (e.g. excellent, good, fair, poor) to 
charts and graphs may improve patient understanding of quality information. Finally, 
patient preferences for benchmarked data and overall performance scores vary 
considerably, and though risk-adjusted quality scores present a more accurate picture of 
provider quality, risk-adjustment may be difficult for patients to understand or interpret.  
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2.4.3 Patient Perceptions of Trustworthiness of Healthcare Quality Metrics 
Patients who access and understand quality metrics can only be expected to 
consider the quality information during provider selection if they believe both the source 
and the measurement of the metrics to be credible. Only a fraction of the quality 
information to which patients are exposed is disseminated by non-profit organizations 
that, like PQA and NCQA, are dedicated to measure development and validation. The quality 
metrics designed by these organizations – and others - may be published by governmental 
organizations. Employers and insurers regularly circulate quality information, and 
personal conversations with family and friends often yield informal provider assessments 
and recommendations. Furthermore, healthcare-specific (e.g. healthgrades.com, 
ratemds.com) and general ratings websites (e.g. yelp.com, google.com) provide patients 
with easy access to opinions on and experiences with healthcare providers and facilities. 
The relative credibility of and trust in these sources of information among patients will 
impact the degree to which validated quality metrics are used in patient decision-making. 
When surveyed, patients often express high degrees trust in the opinions of their 
family, friends, and existing physicians. One survey of a nationally representative sample of 
individuals with chronic diseases asked participants the extent to which they would trust 
the information about health care quality they received from each of seven sources of 
information on a scale of “a lot”, “a little” and “not at all.” The results indicated that patients 
very often placed “a lot” of trust in information received from their doctor (83.4%), their 
hospital (56.0%) and their friends and family (47.4%). In comparison, fewer than one 
quarter placed “a lot” of trust in information received from their employer (23.2%) or a 
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government agency (24.5%).73 In qualitative cognitive interviews exploring patient 
perspectives on comparative information on health plans, some patients especially valued 
the opinion of family doctors on the plans,65  while others felt that “family doctors do not 
know how their fellow clinicians do their work.”65 Similarly, participants in a focus group 
on comparative provider information for hospitals all agreed that the opinions of family 
and friends are highly trustworthy, with one participant remarking, “It's simple, you rely on 
the experiences of the people you know.”71 The group debated the merits of physicians’ 
recommendations, however, with some asserting that “you will tend to listen to your 
[primary care physician]” and others maintaining, “you can’t expect that the PCP knows 
everything about this.” 71  
In contrast to the high degree of trust placed in the opinions of family and friends, 
patients often express concerns over the trustworthiness of quality information provided 
by insurers, employers, and government agencies. Nearly a quarter of older adults 
surveyed felt that Medicare performance data would serve primarily to help save the 
government money rather than to help patients receive better care.74 When asked to rate 
the trustworthiness of CAHPS and HEDIS data, only 13.5% and 15.1% of patients perceived 
the data to be “very” trustworthy. However, most patients (69.6%, 70.2% respectively) felt 
that these sources were “somewhat” trustworthy, suggesting that patients may not 
consider agency quality information to be categorically untrustworthy.75 Notably, in the 
same survey, subjective patient comments included alongside objective CAHPS and/or 
HEDIS data were perceived as no more trustworthy as the objective measures75 despite 
evidence that many patients find narrative comments desirable.76 Focus group participants 
have also expressed skepticism towards metrics on the use of evidence-based medicine.77 
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When presented with a hypothetical quality metric, “uses treatments proven to get results,” 
many participants wanted to know who had decided that a treatment was proven effective 
and were concerned about bias from industry-sponsored trials.77 
Published opinions of former patients were also viewed with skepticism among 
patients in cognitive testing of health plan quality information, with one patient remarking, 
“the ‘opinion of ex-patients;’ Well maybe only two patients were questioned? So I’d like to 
know more about this.”65 A participant in the same study noted regarding the quality 
information on health plans, “I’d never make a decision based on this kind of information.  
Perhaps rather on personal experiences of others, I would ask others,”65 reflecting again 
the perception that the opinions of family and friends are more trustworthy than agency-
developed quality metrics. Participants in another focus group questioned the credibility of 
comparative information and expressed a desire to see the sources of the information as 
well as a disclaimer about the reliability of specific measures and a declaration of conflicts 
of interest.71 
Demographic characteristics have been shown to impact the degree of trust that 
patients have towards healthcare quality information received from varying sources. Males 
have demonstrated higher levels of trust in provider sources of information and are less 
likely to trust personal sources than females.73 Evidence on the impact of age and education 
on attitudes towards information sources is conflicting. One study reported that age had no 
impact on the level of trust that patients had on different sources of quality information.73 
Higher levels of education have been associated with increased trust in provider and 
institutional sources of information and decreased trust in information provided by family 
and friends.73  
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In conclusion, patients exhibit some skepticism towards quality metrics provided by 
insurers, employers, or government, expressing concerns about bias and ulterior motives. 
They feel significantly more comfortable with quality as assessed by trusted physicians, 
family, or friends. The degree to which demographic characteristics like age and education 
level influence patients’ perceptions of objective quality information as credible is debated 
and should be explored in future research.  
 
2.5 Patient Selection of Healthcare Providers 
Healthcare is increasingly focused on shared decision-making between patients and 
practitioners.78,79 However, prior to shared decision-making taking place, patients must 
first select a healthcare provider. The degree to which patients feel that they have sufficient 
choice of physicians80 is associated with patient trust in their doctors which, in turn, may 
increase self-efficacy, self-rated health, health related quality of life, and adherence to 
physician recommendations.81,82 Therefore, a clear understanding of the factors involved in 
patient selection of healthcare providers may ultimately promote increased patient 
engagement and outcomes.  
 
2.5.1 Patient Selection of Healthcare Providers: Functional Quality 
Patients looking to select a high-quality healthcare provider often look for a 
provider with a high degree of functional quality. In contrast to technical quality, which 
reflects staff competence, compliance to professional standards of care, and technical 
accuracy in diagnosis and treatment, functional quality refers to the manner in which care 
is delivered.83 In surveys and focus groups, patients often discuss quality by describing 
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provider courtesy, communication, understanding, caring, and physical environment, all of 
which describe attributes of functional quality.83 When moderators of focus groups among 
Medicaid beneficiaries posed the question, ‘what are the most important things for getting 
good quality care,” participants focused the discussion primarily on interpersonal themes, 
including attentiveness, communication, and respect.84 One participant remarked, “When 
I’m talkin’ to my doctor, is he listening, does he know my fears, does he understand what 
my needs are when I leave him, what my concerns are?”84  
Among surveys specifically focused on patient selection of healthcare providers, 
physician bedside manner and communication consistently rate highly among patients as 
determinant factors. When patients in one survey were asked to denote the importance of 
40 different factors when selecting a primary care physician, nearly all patients considered 
‘physician spends adequate time answering questions’ (94%) and ‘physician discusses 
illness in a way I can understand’ (91%) to be important or very important.85   In another 
survey, female patients were asked to rate the importance of a variety of physician 
characteristics on a scale of 1-6 when considering selecting three types of physicians: an 
obstetrician-gynecologist (OBGYN), a family physician, and a surgeon.86 For OBGYN and 
family physicians, factors related to interpersonal communication, including ‘listens to me,’ 
‘explains things clearly,’ ‘respectful,’ ‘easy to talk to,’ and ‘caring,’ were rated more highly 
(mean ratings: 5.7-5.9) than those related to clinical competence (mean ratings: 4.8-5.5). In 
contrast, clinical competence was rated as more important to patients when selecting a 
surgeon; patients responded that ‘expert in my particular problem’ (mean rating: 5.8) was 
equally as important as interpersonal communication factors (mean ratings: 5.7-5.9) when 
evaluating surgeons.86 Bedside manner was also important to patients selecting a spine 
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surgeon (mean rating, on a scale of 1-10: 8.01), though this indicator of functional quality 
was not as important to that patient population as board-certification (9.26).87 Among 
patients undergoing elective joint arthroplasty, physician manner and physician quality 
were rated as similarly important to patients (mean ratings 4.68 and 4.64, respectively, on 
a scale of 1-5).88 
Functional quality encompasses not only characteristics related to interpersonal 
communication but also physical appearances of providers and facilities. In a survey on the 
selection of a primary care physician, the physical appearance of the doctor and the 
doctor’s office were rated by patients as more important (mean rating 8.00-8.15 on a scale 
of 1-10) than wait time as at the office (7.39), cost of care to the patient (6.46), and 
proximity of the office (5.94), factors often assumed to be the most important to American 
patients.89 Similarly, the appearance of clinic facilities was more important to patients 
selecting spine surgeons (mean rating 7.47 on a scale of 1-10) than recommendations by 
family members, friends (6.51), or other physicians (6.37) and online reviews (6.11-6.26). 
87 
In addition to prioritizing communication and facilities, patients consistently view 
convenience as an important, but not necessarily critical, factor when selecting a healthcare 
provider. Factors related to convenience, including waiting time, proximity, and the 
availability of weekend and evening hours, were viewed as only moderately important 
among patients selecting primary care physicians.89 Convenient location and out-of-pocket 
costs were also reported as moderately important to patients when selecting a surgeon for 
total joint arthroplasty (mean rating 3.5, on a scale of 1-5); these factors were significantly 
less important to that patient population than physician manner (4.68) and quality 
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(4.64).88 In another survey, only about half of patients (55%) reported that convenient 
office location was important or very important when selecting a primary care physician; 
far more felt that factors relating to communication and reputation were important (89-
94%). 85  
Overall, patients consistently report placing considerable value on aspects of 
functional quality when they select healthcare providers. Patients demonstrate strong 
preferences for physicians with superior bedside manner and communication skills. The 
importance of these attributes, which also include respectfulness, willingness to answer 
questions, and a caring nature, exceeds that of convenience. Patients also prefer providers 
and offices with professional appearances, again more strongly than they prefer 
convenience, suggesting that outward appearance may serve for patients as a proxy 
measure for quality.  
 
2.5.2 Patient Selection of Healthcare Providers: Technical Quality 
When surveyed on their priorities when selecting physicians, patients commonly 
place substantial emphasis on physician board certification. When asked to rate the 
importance of a variety of factors when choosing a spine surgeon, patients rated board 
certification highest (mean rating: 9.26, on a scale of 1-10).87 This rating exceeded the 
ratings patients assigned to being within their insurance network (8.1) and bedside 
manner (8.01). In the same way, a different set of patients considered board certification to 
be the most important factor when selecting a primary care physician (average rating: 
9.31) and scored certification significantly higher than the second and third most 
important factors, physical appearance of the doctor’s office (8.15) and doctor (8.0).89 
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These results were again echoed in a survey of primarily female plastic surgery patients, 
with board certification (average rating: 9.2) tying surgeon reputation (average rating: 9.2) 
as the most important factor during physician selection.90 In another survey asking 
patients to rank the importance of primary care physician characteristics, board 
certification lagged behind satisfaction ratings but was consistently ranked as more 
important than objective quality metrics.91 This suggests that board certification may be a 
more readily understood measure of technical quality than specific metrics.  
The relative importance of provider reputation, as assessed by friends, family or 
other providers, when patients select providers is debated in the literature. Reputation was 
viewed as less important than interpersonal communication and technical expertise among 
women surveyed about preferences for OBGYNs, family physicians, and surgeons.86 In 
contrast, recommendations from friends and family were rated as more important than 
several potential measures of technical expertise in a different survey of patients on 
selecting a primary care physician. 89 Yet another survey reported that similar proportions 
of patients considered physician reputation (89%) and provider communication (91%) to 
be important or very important when selecting a primary care physician.85 Therefore, 
though the literature is not conclusive on the importance of reputation relative to other 
factors when selecting providers, reputation is consistently shown to be important to 
patients. Consistent with this assertion, the vast majority of older adults interviewed on 
how they selected a surgeon reported that surgeon and hospital reputation were 
“extremely” or “very” important to deciding on a surgeon (80% and 79%, respectively).74  
The impact of the source of the provider reputation, namely, friends/family versus 
other physicians, on its perceived importance also varies by study. The women surveyed in 
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the Mavis et al. study rated reputation among other doctors (mean rating, scale 1-6: 5.2-
5.5) as more important than reputation among friends or family (4.8-5.0).86 When asked 
why they felt that a particular surgeon or hospital had a good reputation, twice as many 
older adults responded that comments from their referring doctor (64%), rather than 
comments from friends or family (31%), had influenced their perception of the provider’s 
reputation.74 Patients selecting a spine surgeon rated recommendations by family and 
friends members (mean rating, scale 1-10: 6.51) as similarly important to physician 
recommendations (6.51). 
Information on provider reputation in the form of recommendations by family, 
friends, or a physician, may be more important to patients than objective quality 
information. Sinaiko conducted a survey to examine patient decision-making in the context 
of a hypothetical tiered insurance plan.92 In the presented insurance plan, higher quality 
physicians were assigned to Tier 1 and lower quality physicians to Tier 2.92 In the absence 
of any information beyond tier classification, the vast majority of participants selected high 
quality, Tier 1 physicians (84%) and indicated that the doctor’s tier ranking was ‘very 
important’ to their choice (59%). However, when told that a friend or family had seen a 
Tier 2 doctor and had a good experience, far fewer participants selected a Tier 1 doctor 
(44%), and nearly as many selected the “recommended” Tier 2 doctor (39%). When a 
primary care physician had recommended a Tier 2 physician, two-thirds (67%) of patients 
selected the recommended physician over the higher quality, Tier 1 physician (24%).92 
Simulations of the effect of introducing higher copayments for Tier 2 physicians suggested 
that the differential between Tier 1 and Tier 2 copayments would need to exceed $300 to 
counteract the impact of the peer or provider recommendations for lower quality 
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physicians.92 Peer and physician recommendations were also more important to patients 
selecting a plastic surgeon than objective quality ratings, though only marginally.90 
Specifically, patients asked to rate the importance of various factors when choosing a 
plastic surgeon rated reputation (mean rating 9.2, on a scale of 1-10), friend referral (7.77) 
and physician referral (7.76) as slightly more important than physician quality (7.56).90  
Information regarding providers’ reputations may not only be shared by friends, 
family, and other providers but also in the form of anonymous patient satisfaction ratings. 
Patients selecting healthcare providers have generally expressed views that anonymous 
satisfaction ratings are important to decision-making. Patient satisfaction ratings were 
viewed as more important when selecting a primary care physician than quality metrics, 
credentials, and health plan ratings.91 However, anonymous reviews have consistently been 
rated as less important than recommendations from friends and family.87 
In conclusion, board certification is the most commonly reported objective technical 
quality measure used by patients to select providers. However, given that nearly 80% of 
physicians are board certified,93 measure is unlikely to serve as a differentiating factor 
between physicians. Beyond board certification, patients are much less likely to use 
objective quality metrics in decision-making than other factors they perceive to be credible 
sources of quality information, including provider reputation and recommendations from 
physicians, family, and friends.  
 
2.5.3 Patient Selection of Healthcare Providers: Effect of Demographic 
Characteristics 
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Demographic characteristics have consistently been associated with small but 
significant differences in patient preferences during healthcare provider selection. When 
selecting an OBGYN, older patients and those with less education placed a higher priority 
on factors related to interpersonal communication.86 Furthermore, women at either end of 
the age spectrum (≥40 years or ≤ 26 years), minority, and unmarried women placed a 
higher value on having a female OBGYN than their white, median age, married 
counterparts.86 However, women placed a much lower emphasis on provider gender when 
selecting other types of physicians, including primary care physicians89 and surgeons.94 
Patient education level may also impact the relative priority that patients place on 
functional and technical characteristics during provider selection. In one study, those with 
lower levels of education placed a greater emphasis on attributes related to functional 
quality and less priority on technical competence.  Specifically, women with a high school 
education or less rated interpersonal communication attributes as more important when 
selecting family physicians and surgeons than did women with at least some college.86 
Similarly, interpersonal skills were ranked as more important to primary care physician 
selection among those with a high school education than their more educated 
counterparts.91 Another study found that increasing education level was positively 
correlated with the importance that patients assigned to the prestige of a provider’s 
medical school, residence, or fellowship.94 Patients who considered ‘convenient office 
location’ to be an important factor when selecting a primary care physician were more 
likely to be those with lower education levels, a finding attributed by the authors to 
difficulty with transportation in that group.85 In conclusion, a variety of demographic 
 35 
characteristics have been associated with patient preferences for healthcare providers, 
including age, race, gender, and education level.  
 
2.6 Patient Perceptions of Pharmacists as Healthcare Providers 
The role of pharmacists has expanded considerably over the last 20 years. 
According to the Pharmacy Workforce Center’s 2014 National Pharmacist Workforce 
Survey, the proportion of pharmacists who provided medication therapy management and 
immunizations increased from 13% and 15% respectively, in 2004 to 60% and 53% in 
2014.95 While the growing emphasis on the role of pharmacists as healthcare providers is 
clearly evident to those within pharmacy practice, the diffusion of pharmacists’ new roles is 
likely slower among patients. A longitudinal segmentation analysis by Schommer et al. 
identified market segments based patient perceptions of the pharmacist’s role.96 The 
largest segment, to which nearly half of patients belonged, was characterized by the 
perception that medication information should be, and/or is, provided primarily by the 
physician. Another segment contained the approximately one-fifth of patients who 
maintained not only the aforementioned reliance on physicians but also believed talking 
with a pharmacist takes too much time and that pharmacist roles should be legally or 
ethically restricted.96 The proportion of patients in each of these segments remained steady 
over the 15 year study period from 1995-2010 despite efforts to promote the role of 
pharmacists as healthcare providers during that time.96 Additional literature on pharmacist 
expectations of community pharmacists is summarized in Chapter 2.8.  
These findings suggest that a significant subgroup of patients may be unlikely to 
view pharmacists as healthcare providers or select a pharmacy in a manner consistent with 
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preferences for healthcare providers. As a result, these patients’ preferences during 
pharmacy selection may be more analogous to their preferences during retail or grocery 
store selection than their priorities during physician selection. Notably, however, 
marketing research suggests that many of the same variables that impact health care 
decision-making play a role in retail or grocery store selection. For example, individuals 
with higher incomes are more likely to frequent a specialty grocery or warehouse club,97,98 
while those with lower incomes and education levels are more likely to shop at a 
supercenter.97 Men have also demonstrated stronger preferences for fast grocery store 
service but weaker preferences for friendly service than their female counterparts.99,100 
Preferences for grocery stores may also vary by age; a study of older adults (55+) reported 
that the importance of convenience and special discounts decreased and increased, 
respectively, with age.101 Grocery store shoppers also cite factors regarding location 
convenience, hours of operation, wait time, and service quality as important during store 
selection.99,102,103 In conclusion, customer priorities for healthcare providers and retail 
services maintain considerable overlap such that most of the attributes used in this study 
of patient selection of community pharmacies are likely to be relevant to respondents 
regardless of whether or not they perceive pharmacists to be healthcare providers.  
 
2.7 Patient Selection of Pharmacy Channel 
Before patients select a community pharmacy, they must first make the decision to 
visit a brick-and-mortar pharmacy over a mail order or internet pharmacy. Mail order 
pharmacies have grown in size and popularity, in large part due to insurance mandates or 
incentives to use this channel. The market share of mail order pharmacies doubled from 
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6% in the late 1980s to 12% in 2000 and again to 23.5% in 2010.104 Nearly every (96.7%) 
employer sponsored insurance plan now offers a mail service pharmacy option.104 Because 
the decision between pharmacy channels acts as a form of selection bias to filter the 
population of patients deciding on community pharmacies, consideration of the 
distribution of mail order pharmacy usage is warranted.  
A study examining channel selection in insurance programs that incentivize or 
mandate mail order pharmacy use reported that the strongest predictors of using a 
community pharmacy were living within a 5-minute drive of a community pharmacy, 
having filled previous prescriptions exclusively at community pharmacies, and having no 
maintenance medications.105 Younger adults (<55 years) also more commonly selected 
community pharmacies than older patients.105 Nevertheless, mail order pharmacy use 
remains high among older adults, with 56.7% of surveyed adults over 65 years of age 
indicating that they had used a mail-order pharmacy at least once.104 Approximately one in 
eight (12.3%) reported using mail order based on insurance plan requirements,104 and one 
in four for insurance reasons that included price incentivization.106 Mail-order users in a 
rural, elderly population were primarily male, non-Hispanic white, retirees with employer-
provided insurance. Additionally, each additional prescription drug taken by a patient 
increased the likelihood of mail-order pharmacy use by 21%.106  
Although online pharmacies vary considerably in their legitimacy, accredited online 
pharmacies present a credible alternative to mail order and community pharmacies. The 
number of online pharmacies – both accredited and not – has increased rapidly in the past 
decade,107 yet awareness and patronage of this channel remains limited. A 2012 study 
among emergency department patients reported that a slight majority (57%) of patients 
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were aware that online pharmacies existed, but very few (5.4%) had ever used one.108 
Despite concerns that patients use illegitimate pharmacies to circumvent the need to 
obtain a prescription,109 the majority of online pharmacy users used pharmacies 
administered by their insurance companies. Additionally, a much higher proportion of 
patients who used online pharmacies used them for convenience (66%), cost (40%), or 
because it was required by their insurance carrier (7%) than to avoid obtaining a 
prescription (2%).108 Patients who select community pharmacy as their pharmacy 
distribution channel may therefore systematically differ in their priorities and preferences 
for pharmacy care than patients who opt to receive their medications from mail order 
and/or internet pharmacies. 
 
2.8 Patient Perceptions of Community Pharmacies: A Systematic Literature Review 
Understanding consumer perceptions is a fundamental task of all businesses 
including pharmacies. That understanding can be used to better serve customers and 
influence perceptions of the business. The complex interplay between consumer 
preferences, expectations, perceptions, and satisfaction has been extensively explored in 
marketing literature. It has been posited that a customer’s satisfaction, or dissatisfaction, 
with a service experience reflects their perceptions of the service meeting, exceeding, or 
failing to meet their expectations for that service.110–112 Evidence also suggests that some 
attributes of the service experience have greater impact on perceptions than others.110,113  
The importance of understanding perceptions of healthcare consumers has 
intensified light of the inclusion of patient satisfaction measures in the Centers for 
Medicare and Medicaid Services’ value-based purchasing program114 and the growing 
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emphasis on incorporating patient preferences into treatment approaches.115 Associations 
between patient expectations, preferences, and satisfaction have been explored for a 
number of healthcare settings and services.116–118 In primary care settings,119 total knee 
arthroplasty,120 and orthopedic interventions to the hand,121 patient expectations were 
significant determinants of post-visit or post-intervention satisfaction. Treatment 
preferences and patient expectations have also been found to be predictors of satisfaction 
among patients with acute and sub-acute low back pain.122 Similarly, patient preferences 
for strength improvement over pain reduction were associated with satisfaction with 
carpel tunnel release surgery.123 
Patient satisfaction is associated with a number of meaningful outcomes for 
healthcare providers, including patient appointment attendance and retention. A survey of 
specialty pharmacy customers who switched pharmacies over the course of a year 
reported that 12% of patients switched due dissatisfaction with customer service.124 
Dissatisfaction has also been given as a reason for patients not keeping appointments with 
their dieticians125 and general practitioners.126 Visit satisfaction has also been identified as 
a determinant of intent to keep follow-up appointments127 and customer loyalty in retail 
and service markets.128,129 
The pharmacy literature has examined patient preferences and expectations for 
community pharmacies. Internationally, pharmacy preferences have been found to differ 
between countries because of differences in medication out-of-pocket costs, pharmacist 
roles and available services, medical culture, and other factors.130,131 A comparison of 
pharmacy preferences in Poland and the UK found that patients in the UK gave greater 
preference to pharmacy consultations than Polish patients, who placed greater emphasis 
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on medication prices and promotions.131 These differences may reflect the higher prices 
Polish patients pay for their medications compared to their UK counterparts. Patients in 
Australia rated location as less important than Polish and British patients.130,131 A recent 
discrete choice experiment conducted on patient preferences for community pharmacies 
focused on attributes surrounding the UK’s pharmacist-managed Minor Ailments Service; a 
comparable service does not yet exist in the US. 132  
 
2.8.1 Literature Review Aims 
Because of the difficulty in comparing pharmacy preferences in different countries 
with corresponding structural and cultural differences, this paper will limit its literature 
review to patient perceptions of community pharmacies in the United States. Specifically, 
this paper will summarize the body of knowledge on patient preferences for, expectations 
of, and satisfaction with community pharmacies in the United States.  
 
2.8.2 Literature Review Methods 
A systematic literature review was conducted in October 2016. MEDLINE and 
CINAHL were searched for the following terms in the title or abstract: “patient choice” OR 
“consumer choice” OR “patient selection” OR “consumer selection” OR “patient 
preferences” OR “consumer preferences” AND “ pharmacy” OR “community pharmacy” OR 
“pharmacy services.” Google Scholar was searched using three sets of search terms: 
“patient preferences” AND “community pharmacy”; “patient expectations” AND 
“community pharmacy”; and “patient satisfaction” AND “community pharmacy.” Title and 
abstracts were first screened for inclusion and exclusion criteria, and duplicates were 
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removed. Full-text articles were then screened for eligibility, with reasons for exclusion 
recorded, according to the PRISMA guidelines.133 Inclusion criteria included: (1) directly 
evaluates patient expectations of, preferences for, or satisfaction with general community 
pharmacy practice; and (2) published in the last 10 years (2006-present). Exclusion criteria 
included: (1) Does not directly assess patient expectations, preferences, or satisfaction; (2) 
Does not broadly assess patient perceptions for community pharmacy practice, or focuses 
on specific pharmacy services; and (3) was not conducted in the United States. The search 
over all databases yielded 3,114 results. In addition, the citations included in review 
articles and articles included in the full-text screens were searched for relevant literature 
not captured in the systematic literature search. After applying the inclusion and exclusion 
criteria at the title, abstract, and full-text screening stages, a total of ten original research 
articles were found. The flow of articles throughout these stages is depicted in the PRISMA-
style diagram contained in Figure 1. Articles are summarized in Table 1, and results are 
presented in Figure 2. 
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Figure 1. PRISMA diagram of systematic literature review on patient preferences for, 
expectations of, and satisfaction with community pharmacies in the United States. 
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Table 1.  Summary of literature assessing patient preferences for, expectations of, and satisfaction with community pharmacies in the United 
States. 
 
Author 
(Year) 
Construct 
Assessed Population  Method Findings 
Patterson 
(2013) 
Patient satisfaction 
with and 
preferences for 
community 
pharmacies; Patient 
awareness of 
pharmacy services 
Stratified random sample 
from prescription and 
clinical pharmacy service 
records of a single 
independent pharmacy (n = 
241) 
Survey; 21 items on patient 
satisfaction, 8 items on service 
awareness and use, open 
ended question on patronage 
motive 
Service awareness: The majority of patients were 
aware that pharmacists dispensed prescriptions 
(92.5%). Patients were less commonly aware that the 
pharmacy offered herpes zoster vaccinations (34.9%) 
and adherence packaging (34.0%). Patronage motives: 
Patients most commonly selected their pharmacy 
based on relationships with staff (43.6%), convenience 
(28.2%), and local pharmacy ownership (15.4%). 
Satisfaction: The majority of patients reported that 
the pharmacy services they received were excellent 
(70.5%) or very good (22.9%). A lower proportion 
(40.1%) felt that the pharmacist’s efforts to help them 
improve their health or stay health were “excellent.”  
Other areas of lower satisfaction included the 
pharmacist’s interest in their health and the amount 
of time the pharmacist offers to spend with patients. 
Collum (2013) Patient 
expectations for 
and satisfaction 
with community 
pharmacist 
communication 
Purposive sample of 
patients who receive care 
at a clinic-based community 
pharmacy; Patients aged 65 
years or older who filled at 
least 8 unique prescription 
medications between 
November 1, 2011, and 
January 31, 2011 (n = 19) 
Structured telephonic 
interview conducted by one 
trained data collector using an 
established script; 52 
questions on patient 
expectations and use of 
literacy-based communication 
techniques 
Patient expectations: A minority of patients expected 
the pharmacist to counsel on a new medication's 
indication (33%), how to take a new medication 
(44.4%), and what may happen if the patient is 
nonadherent (22.2%). A slightly higher proportion 
expected to be counseled on a new medication’s side 
effects (55.6%). Satisfaction: Most patients (73.7%) 
reported being very satisfied with pharmacy 
counseling. Many more patients felt that the 
pharmacist spends enough time answering questions 
on new prescriptions (94.7%) than on old 
prescriptions (58.8%). 
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Table 1.  Summary of literature assessing patient preferences for, expectations of, and satisfaction with community pharmacies in the United 
States. 
 
Author 
(Year) 
Construct 
Assessed Population  Method Findings 
Cretton-Scott 
et al. (2011) 
Patient preferences 
for pharmacist 
attire 
Convenience sample of 
adult patients at a chain 
pharmacy (n = 43) and an 
independent pharmacy (n = 
43) 
Survey; Patients were shown 
four sets of photographs with 
different combinations of 
pharmacist attire (business 
casual or business formal; with 
or without white coat) 
Most patients reported that the pharmacists in formal 
business attire and white coats were most 
professional (62.8%), knowledgeable (54.1%), and 
competent (58.2%). However, the majority of patients 
saw pharmacists in business casual attire as most 
approachable (52%).  
Franic et al.  
(2008) 
Patient preferences 
for community 
pharmacies 
Convenience sample of 
adult patients at two 
independent pharmacies (n 
= 81), two grocery store 
pharmacies (n = 44), two 
community chain (n = 27), 
and three discount store 
pharmacies (n = 23) 
Survey; Rated, on a scale of 1 
to 5 for each of 26 attributes 
the attribute’s importance 
when selecting a pharmacy 
and the degree to which a 
perceived difference exists 
between pharmacies 
Competent, knowledgeable, and friendly staff and 
pharmacists were seen as the most important and 
differentiating attributes. Location, confidentiality, 
prescription prices, and hours of operation were also 
important but not differentiating. Pharmacy hours of 
operation were important to patrons of all types of 
pharmacies except independent community 
pharmacies. Location was a determinant attribute 
only for patients patronizing grocery store and 
discount store pharmacies. 
Malewski 
(2015) 
Patient satisfaction 
with community 
pharmacies 
Convenience sample of 
adult pharmacy patients at 
10 chain pharmacies (n = 
326) 
Survey; 30 items addressing 4 
areas of patient satisfaction: 
satisfaction with the 
relationship with and service 
received from the pharmacist, 
pharmacy facility satisfaction, 
pharmacy accessibility, and 
pharmacy financial concerns 
Overall satisfaction with pharmacist customer service 
(88.4%) and the pharmacy experience (92.5%) was 
high and higher among suburban patients than urban 
patients. Patients expressed high degrees of 
confidence in pharmacists’ ability to dispense 
prescriptions correctly (85.7%) and trust that 
pharmacists give accurate information about their 
medication therapy (91.1%). The vast majority of 
patients agreed with statements that pharmacists are 
understanding (81.2%), listen carefully (81.8%), and 
explain things in an understandable way (81.2%).  
Fewer patients felt that pharmacists are willing to 
establish a personal relationship (67.3%).  
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Table 1.  Summary of literature assessing patient preferences for, expectations of, and satisfaction with community pharmacies in the United 
States. 
 
Author 
(Year) 
Construct 
Assessed Population  Method Findings 
Worley 
(2006) 
Patient perceptions 
of pharmacist-
patient 
communication, 
commitment, and 
relationship quality  
Random sample of 
community dwelling older 
adults (≥ 65 years) filling at 
least one prescription 
medication for diabetes at 
a nonmail order pharmacy 
(n = 221) 
Survey; Questions on patients' 
perceptions of their 
pharmacist's participative 
behavior/ patient-
centeredness (13 items) their 
own participative behavior (12 
items), pharmacist - patient 
communication (5 items), 
relationship quality (8 items, 
including satisfaction), and 
relationship commitment (5 
items). 
Predictors of patient perceptions of a high-quality 
pharmacist-patient relationship included pharmacist 
participative behavior/patient-centeredness and 
pharmacist-patient interpersonal communication. 
Relationship quality was, in turn, predictive of a 
patient's relationship commitment to their 
pharmacist. 
Shiyanbola 
(2014) 
Patient preferences 
for pharmacy 
quality information 
Convenience sample 
recruited from a rural and 
urban geographical location 
(n = 34) 
Surveys + a semi-structured 
focus group; surveys assessed 
demographic and health 
characteristics of participants 
as well as their understanding 
of specific quality metrics.  
Several focus group participants stated that they 
would access pharmacy quality information that was 
made publicly available.  Many rural patients, 
however, expressed a reluctance to use quality 
measures given their relationships with their 
pharmacy’s owner(s) and the credibility of their local 
pharmacies. Additionally, patients felt that customer 
service, including feeling comfortable with a 
pharmacist, feeling like you can ask questions, and 
knowing that the pharmacist is going to take time to 
answer questions, are important attributes during 
pharmacy selection that are not captured in objective 
quality metrics. 
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Table 1.  Summary of literature assessing patient preferences for, expectations of, and satisfaction with community pharmacies in the United States. 
 
Author 
(Year) 
Construct 
Assessed Population  Method Findings 
Shiyanbola 
(2015; Int J 
Clin Pharm) 
Patient perceptions 
and expectations of 
a quality pharmacy 
Purposive sample of older 
adults (≥65 years) who had 
filled a prescription at a 
community pharmacy in 
the last 90 days (n = 60) 
Six semi-structured focus 
groups conducted in a group 
interview format  
The most commonly identified expectation for 
pharmacists’ roles was that staff would inform them 
when the refill medications looked different than they 
had in previous fills. Participants expected that 
pharmacists deliver care in a manner that is friendly, 
respectful, and private. They did not expect 
pharmacists to look through their medications, which 
they perceived as the physician’s role. Structural 
pharmacy characteristics, including convenient 
location, short wait times, and home delivery, as well 
as relationship-oriented attributes like pharmacist and 
staff responsiveness, helpfulness, and friendliness, 
were very important to the focus group participants. It 
was noted that “good” pharmacies have pharmacists 
that are friendly and willing to establish a long-term 
relationship. 
Shiyanbola 
(2015; BMJ 
Open) 
 
 
 
 
Patient preferences 
during pharmacy 
selection 
Convenience sample 
recruited from a rural and 
urban geographical location 
(n = 34) 
Semi-structured focus group Participants expressed preferences for pharmacies 
scoring highly on validated quality measures, but only 
in certain situations. These situations included if they 
or someone they knew had a negative experience or 
error and if they were moving to a new area. 
Worley 
(2007) 
Patient 
expectations of a 
community 
pharmacist 
Nationwide sample of adult 
(≥ 18 years) patients (n = 
500) 
Survey; Patients were asked to 
indicate on a Likert Scale (1 = 
very strongly disagree to 7 = 
very strongly agree) the 
degree to which they agreed 
with statements regarding the 
role of the community 
pharmacist and patient 
Patients most commonly agreed that pharmacists 
should listen to patients when they have a medication 
question (mean, 6.0), be approachable to discuss a 
patient’s medication concerns (6.0), and make sure 
that patients understand how to use their medications 
(5.8). They felt less strongly that pharmacists should 
talk with patients if the patient does not have any 
medication questions (4.4), greet patients at the 
counter (4.7), and show an interest in working with 
patients to meet their healthcare needs (5.2). 
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Figure 2.  Summary of the Patient Experience at Community Pharmacies
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2.8.3 Literature Review Results 
Patient Expectations for Community Pharmacies 
Consistent with the early, product-focused nature of pharmacy practice,134 patient 
expectations for community pharmacy practice often center on dispensing roles.  In one 
study, patients who were asked about their awareness of services offered by pharmacists 
most commonly reported awareness of prescription dispensing (92.5%) and influenza 
vaccinations (87.1%).13 Similarly, the most commonly identified expectation for 
pharmacists’ roles in the medication refill process among a group of older adults was that 
staff would inform them when the refill medications looked different than they had in 
previous fills.28 The same older adults also expected pharmacists to provide good customer 
service by delivering care in a manner that is friendly, respectful, and private.28  
Patient expectations of pharmacist activities beyond simple dispensing were more 
varied are relatively low. Patients in one study strongly agreed that pharmacists should be 
approachable, listen to patients’ medication concerns, and make sure that patients 
understand how to use their medications.135 However, in a survey of older adults 
prescribed at least eight unique medications, only 44.4% expected the pharmacist to 
counsel on how to take a new medication.136 While a slightly higher proportion expected to 
be counseled on a new medication’s side effects (55.6%), only a third of those patients 
expected the pharmacist to provide counseling on the medication’s indication.136 Similarly, 
many older adult focus group participants did not expect pharmacists to look through their 
medications, as they felt that their physicians were responsible for medication 
management.28 This finding was consistent with the relatively weak level of expectation in 
another study that pharmacists show an interest in working with patients to meet their 
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healthcare needs.135 Finally, the independent pharmacy patients who were nearly all aware 
of pharmacist dispensing roles were much less commonly aware that pharmacists could 
provide compounded prescriptions (52.5%) and herpes zoster vaccinations (34.9%).13 
 
Patient Preferences for Community Pharmacies 
Evidence for pharmacy preferences has come primarily from qualitative research 
assessing patient perspectives on preferred attributes when selecting a pharmacy.  One 
study presented participants with an open-ended question asking why they chose their 
pharmacy.13 The most common reasons offered were relationships with staff (43.6%), 
convenience (28.2%), and local pharmacy ownership (15.4%). Some respondents (<10%) 
also mentioned pharmacy atmosphere, personnel competency, pharmacy reputation, and 
wait times as motives for pharmacy patronage.13 Similar findings were reported following 
a series of focus groups among older adults.28 Those patients preferred certain structural 
pharmacy characteristics, including convenient location, short wait times, and home 
delivery, as well as relationship-oriented attributes like pharmacist and staff 
responsiveness, helpfulness, and friendliness.28 Pharmacist and staff characteristics were 
also consistently rated as very important by patients who were asked to indicate, on a 
scale of one to five, the degree to which each of 26 attribute was important to them when 
choosing a pharmacy.12 In that survey, respondents expressed strong preferences for 
pharmacies with competent, knowledgeable, and friendly pharmacists and staff. 
Furthermore, these attributes were perceived as most differentiating between competing 
pharmacies.12 Location, prescription prices, and hours of operation were also important to 
most patients but were not seen as differentiating factors.12 The authors concluded that 
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pharmacy personnel, rather than characteristics of the pharmacy site, were the primary 
determinant attributes for pharmacy selection.12 
Pharmacy patrons maintain preferences for not only specific attributes of 
pharmacies but also general pharmacy settings (i.e., independent, chain, grocery store, and 
mass merchandiser). In a survey among older adults with diabetes, patients most 
commonly reported patronizing a retail chain pharmacy (48.6%), independent pharmacies 
(26.2%), and grocery store pharmacies (12.9%).137 Specific pharmacy preferences may also 
drive selection of one pharmacy setting over another. In a survey by Franic et al.,12 
pharmacy hours of operation were important to patrons of all types of pharmacies except 
independent community pharmacies. Location was a determinant attribute, or an attribute 
that was viewed as both important and differentiating, only for patients patronizing 
grocery store and discount store pharmacies.12 Finally, certain preferences may drive 
pharmacy loyalty. In one survey, patients who had selected a pharmacy based on pharmacy 
atmosphere, the availability of a unique service, and personnel competency were 
significantly less likely than those without those specific motives to have visited another 
pharmacy in the last 12 months.13  
Cretton-Scott et al. explored patient preferences for a very different pharmacy 
attribute: pharmacist attire.138 Patients were presented with four sets of photographs 
featuring a pair of pharmacists in casual or formal business attire with or without white 
coats.138 Patients commonly reported that the pharmacists in formal business attire and 
white coats were most professional (62.8%), knowledgeable (54.1%), and competent 
(58.2%). However, the majority of patients saw pharmacists in business casual attire as 
most approachable (52%). Over three-fourths of patients (77.5%) preferred pharmacists in 
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white coats, but preferences for the attire under the white coats were split between 
business casual and business, likely reflecting a perceived trade-off between 
professionalism and approachability.138  
The degree to which patients prefer pharmacies that provide high quality 
medication management has not yet been extensively explored; patient preferences for 
these services may be poorly formed due to low expectations for and limited experience 
with pharmacist cognitive services.13,28,136 When presented with validated pharmacy 
quality measures established by the Pharmacy Quality Alliance (PQA), many patients 
maintained that these measures were not appropriate for rating pharmacies.14 Still, when 
the same patients were asked whether they would use quality measures to choose a 
pharmacy, they often responded affirmatively.14 Many rural patients, however, expressed a 
reluctance to use quality measures given their relationships with their pharmacy’s 
owner(s) and the credibility of their local pharmacies. One patient asserted that he or she 
couldn’t imagine anybody not wanting to know whether their pharmacy was doing what 
they’re supposed to be doing.14 Participants in another set of focus groups expressed 
preferences for pharmacies that scored well on validated quality measures, but only in 
certain situations.15 These situations included a scenario in which they or someone they 
knew had a negative experience or error and if they were moving to a new area.15  
 
Patient Satisfaction with Community Pharmacies 
Satisfaction, a complex construct associated with both preferences and expectations, 
is generally high among community pharmacy patrons. In a survey of 241 patients at an 
independent community pharmacy, the majority of patients reported that the pharmacy 
 52 
services they received were excellent (70.5%) or very good (22.9%).13 Similar levels of 
satisfaction were seen among older adults prescribed at least eight medications, with 
73.7% reporting being very satisfied with pharmacy counseling.136 Another study 
compared the satisfaction of 326 patients at urban and suburban chain-pharmacies.139 
Overall satisfaction with pharmacist customer service (88.4%) and the pharmacy 
experience (92.5%) was high, though satisfaction differed by location, with suburban 
patients reporting higher levels of satisfaction than their urban counterparts. High levels of 
satisfaction reflected patients’ high degrees of confidence in their pharmacists’ abilities to 
fulfill the common patient expectations for pharmacists discussed above. Specifically, the 
vast majority of patients expressed confidence in their pharmacists’ abilities to dispense 
prescriptions correctly (85.7%) and trusted their pharmacists to give accurate information 
about their medication therapy (91.1%).139  
Beyond general satisfaction, patients have consistently reported high degrees of 
satisfaction with the specific manners in which pharmacists provided care. The vast 
majority of surveyed patients in one study agreed with statements that pharmacists are 
understanding (81.2%), listen carefully (81.8%), and explain things in an understandable 
way (81.2%).139 In another survey, over 90% of patients marked as “excellent” or “very 
good” the ability of pharmacists to answer questions, the degree of courtesy and respect 
shown by the pharmacy staff, and the professionalism of the staff.13 Although not directly 
assessing satisfaction, most participants in a series of focus groups among older adults felt 
that “good” pharmacies have pharmacists that are friendly and willing to establish a long-
term relationship.28 Patients also reported appreciating helpful staff at their current 
pharmacies.28 A group of older adults with diabetes reported maintaining a relationship 
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with the same pharmacist for an average of 11.2 years,137 suggesting a high degree of 
satisfaction.140  
Though patients are generally satisfied with pharmacists’ communication skills and 
abilities to fulfill basic expectations for prescription dispensing, pharmacy patrons report 
lower levels of satisfaction with more complex pharmacist services. Far more patients in 
one survey were satisfied with pharmacists’ provision of medication information (91.1%) 
than their willingness to establish a personal relationship (67.3%).139 Additionally, many 
more patients in another survey felt that their pharmacist spends enough time answering 
questions on new prescriptions (94.7%) than on old prescriptions (58.8%).136 An even 
lower proportion (40.1%) felt that the pharmacist’s efforts to help them improve their 
health or stay health were “excellent.”13 The other areas in which patients were least 
satisfied included the pharmacist’s interest in their health and the amount of time the 
pharmacist offers to spend with patients.13 
Patient satisfaction with pharmacy services reflects their satisfaction with not only 
pharmacists and their staff but also with the pharmacy’s location and appearance. In two 
studies, most patients reported that pharmacies are conveniently located.28,139 The vast 
majority of those surveyed in another study (87.4%) felt that pharmacies have good 
appearances.139 However, fewer patients in that study maintained that pharmacy layouts 
are organized in a way to ensure privacy,139 and satisfaction with the privacy of 
conversations with the pharmacist was relatively low in another group of patients.13 
 
2.8.4 Literature Review Discussion  
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Overall, patient expectations and preferences for community pharmacies revolve 
predominately around dispensing functions and relationship-oriented attributes, and 
satisfaction with these aspects and overall pharmacy practice is high. Patients expect that 
pharmacists will dispense their prescriptions accurately while providing good customer 
service. Additionally, patients prioritize long-term relationships with pharmacists that are 
fostered by friendly and responsive care. This priority is consistent with patient 
preferences for other healthcare providers, including physicians. Fostering long-term 
patient-pharmacist relationships may further improve satisfaction with care141 and reduce 
healthcare costs,142 as is seen in studies on the impact of long-term patient-physician 
relationships.  
Satisfaction with the customer service and medication information provided by 
pharmacists is notably high and exceeds consumer satisfaction with the general 
environments in which pharmacists practice, including supermarkets, retail stores, and 
discount stores.143 Patients also report a greater degree of satisfaction with the medication 
information they receive from community pharmacists than they do during a 
hospitalization.144 However, community pharmacies have been less successful in ensuring 
that patients feel that they have spent adequate time with their pharmacist. Many patients 
reported that they do not feel that pharmacists are willing to establish a long-term 
relationship or spend ongoing time with them. This challenge is not unique to pharmacy, as 
patients’ satisfaction with the amount of time spent with physicians is lower than their 
satisfaction with other aspects of care.145 Indeed, community pharmacists have expressed a 
desire to devote more of their time to patient consultations and medication 
management,146 but time pressures often limit opportunities for increasing time spent with 
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patients.147 Given the association between increased pharmacist counseling and improved 
medication adherence148,149 as well as the low levels of patient satisfaction with the amount 
of time spent with pharmacists, future community pharmacy practice models should focus 
on increasing the ability of pharmacists to dedicate time to patient-centered, rather than 
dispensing, functions to improve outcomes and satisfaction.  
Patient expectations for more cognitively demanding pharmacist tasks, including 
health and medication management, are more limited, and few patients appear likely to 
select pharmacies based on these services. However, further research is needed to explore 
the modern patient’s decision-making process during pharmacy selection and patients’ 
relative preferences for new and/or high-quality pharmacy services. As the scope of 
pharmacy practice continues to increase, efforts should be made to increase patient 
expectations for pharmacists and encourage patients to select pharmacies based on the 
provision of high-quality medication management. At the same time, pharmacists should 
focus on increasing patient satisfaction with pharmacists’ efforts to improve their health by 
embracing their burgeoning role as healthcare providers and prioritizing the development 
of long-term relationships with patients.  
 
2.8.5 Literature Review Conclusion 
Patients express high levels of satisfaction with most attributes of pharmacy 
practice. However, these satisfaction levels may reflect relatively low expectations for 
pharmacists focused primarily on dispensing roles and customer service. Many patients 
maintain preferences for long-term relationships with their pharmacists but do not feel 
that their pharmacists are willing to establish such relationships. New models of pharmacy 
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practice should focus on expanding patients’ expectations for cognitive services and 
improving the capacity for pharmacists to dedicate time to patient-centered activities. 
 
2.9 Multiple Pharmacy Use 
Underlying many of the aforementioned studies on patient interactions with 
community pharmacies are assumptions that patients select a single pharmacy according 
to consistent expectations and preferences. Though the majority of patients fill their 
prescriptions at only one pharmacy, the proportion of patients who use two or more 
pharmacies simultaneously may be increasing. An analysis of Medical Expenditure Panel 
Survey data over seven years reported that multiple pharmacy use increased 18.7% from 
2003 to 2009, from 36.4% to 43.2%.150 Individuals more likely to use multiple pharmacies 
include those who use a mail order pharmacy, are less than 40 years, and are female.151 
Consistent with this finding, multiple pharmacy users most commonly used two 
pharmacies (vs. three or more) per year (70%), most frequently combining use of a mail 
order pharmacy and a community pharmacy.150 The overall prevalence of the simultaneous 
use of mail order and community pharmacies is debated in the literature. Nearly a quarter 
(23.3%) of older adults in Texas reported use of both a mail order and a community 
pharmacy.152 However, in another study, only 6.9% of 324,968 patients with multiple 
prescriptions split their prescriptions between the two channels.105 
The current literature on patient selection of pharmacies has not examined the 
process of patient decision-making surrounding the use of multiple pharmacies. 
Accordingly, it is not well understood whether patients have different priorities for 
pharmacy selection depending on the medication(s) to be filled at that pharmacy. For 
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example, given the demographics of individuals who most commonly use multiple 
pharmacies, a young adult female may choose to receive birth control by mail order 
pharmacy given the consistency of this prescription. She may simultaneously elect to fill 
her antidepressant at a community pharmacy as she works with a physician to optimize the 
drug and dosage.  
 In conclusion, an assumption that an individual patient has consistent preferences 
for a community pharmacy may be violated if that patient maintains different priorities for 
pharmacy services based upon the specific medication to be filed there. However, although 
multiple pharmacy use is increasing, patients who patronize multiple pharmacies most 
commonly combine use of a community pharmacy and a mail order pharmacy. It may still 
therefore be reasonably assumed that a patient will exhibit consistent decision-making 
preferences when selecting a community pharmacy.  
 
2.10 Segmentation in the Healthcare Market 
Market segmentation identifies consumer subsets based on common behaviors, 
attitudes, and preferences, enabling businesses to more effectively create tailored 
messaging and targeted marketing. Although traditionally used to study retail markets, 
healthcare providers and facilities have increasingly recognized the utility of market 
segmentation in identifying patient segments with different healthcare needs and 
preferences. The Deloitte Center for Health Solutions conducted and disseminated one of 
the most widely recognized healthcare market segmentation efforts. Patients in each of 
Deloitte’s market segments differ with regards to their views and attitudes towards the 
healthcare system and health policy; healthcare resource utilization; satisfaction with 
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healthcare providers; use of information sources and technology; and payment systems.153 
While the Deloitte market segmentation offers insight into segments based on broad 
healthcare utilization and preferences, many other studies have taken more targeted 
approaches to segmenting patients by their needs and priorities for specific healthcare 
services. 
Segments in the market for primary care practitioners often consist of patients who 
prioritize either cost, convenience, technical quality of care, or interpersonal aspects of 
care. In a latent class analysis of British patients’ preferences for general practitioner 
appointments, three classes of patients were identified.154 Members of the class with the 
highest probability of membership (0.54) preferred attributes reflecting cost and 
convenience. The other classes, with membership probabilities of 0.20 and 0.26, strongly 
preferred a thorough examination and having a doctor that knows you well, respectively.154 
Segmentation studies of pharmacy customers have largely focused on identifying 
market segments based on patient perceptions of pharmacist roles or preferences for 
specific pharmacy services. A longitudinal segmentation analysis of community pharmacy 
patients reported that the majority of patients belonged to a segment termed “reliance on 
physician,” reflecting the prevalence of perceptions that physicians are better qualified 
than pharmacists to give medication-related information.96 Another segmentation analysis, 
a latent class analysis conducted among Australian pharmacy patrons, identified classes 
based on patient preferences for pharmacy-based asthma services.155 The classes varied 
primarily based on preferences for the intensity of the asthma services and level of 
pharmacist involvement and ranged from a class preferring a lower intensity service 
(“Minimalistic Model” class) to higher intensity service (“Holistic Model” class). The highest 
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proportion of patients belonged to the intermediate class characterized by preferences for 
a medium intensity service (“Partial Model” class).155 This latent class analysis was 
conducted among a specific patient population, namely, asthma patients who were poorly 
controlled, and examined preferences for a specific and specialized pharmacy service. A far 
broader segmentation analysis of the community pharmacy market was conducted using 
cluster analysis but was published over 30 years ago.10 
 
2.11 Theoretical Foundations 
2.11.1 Donabedian Model of Healthcare Quality 
First proposed by Donabedian in 1966,156 the Donabedian structure, process, and 
outcome model was conceived as a theoretical foundation for the assessment of healthcare 
quality.156 Donabedian recognized that healthcare outcomes that are often influenced by 
many factors other than the quality of care received. Accordingly, he recommended that 
structures and processes of care be considered alongside outcomes in the evaluation of 
healthcare quality. He considered processes of care, defined as the activities associated 
with care provision and the manner in which care is provided, to be a reflection of whether 
“good” medical care had been applied.156 Structures of care were defined as the settings in 
which care takes place and the structures and operations that support the processes of 
care.156 
The Donabedian model has frequently been employed as a theoretical basis for 
community pharmacy-based research.  A 2013 effort to define professional pharmacy 
services within the community pharmacy setting centered on Donabedian’s framework, 
incorporating organizational structure, processes of care, and outcome measures into the 
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definition.157 Additionally, the model has informed much of the existing literature on 
patient perceptions and understanding of pharmacy.15,27,28 Structures, as they specifically 
relate to community pharmacy, may include the ability to request refills online, the 
availability of programs like appointment-based medication synchronization and home 
delivery, and location.28 Processes within the community pharmacy setting often reflect the 
nature of the interpersonal relationship between the patient and the pharmacist or 
pharmacy staff. These may include the amount of time a pharmacist takes to communicate 
with patients, the friendliness and helpfulness of the staff, and the degree to which the 
pharmacy staff shows concern and knows an individual’s needs.28 Community pharmacy 
outcomes, though traditionally limited to the ability of the pharmacist to accurately fill 
prescriptions, have expanded to include clinically-focused measures.16 
 
2.11.2 SERVQUAL Framework 
 SERVQUAL is a multi-item instrument for measuring customer perceptions of 
service quality111 based on a conceptual framework of the way in which consumers 
compare their expectations for a service with their perceptions of the service they 
received.111 Critics of SERVQUAL assert that service quality is better conceptualized 
through an attitudinal model than an expectations/disconfirmation model and that the 
framework fails to incorporate foundational research in the social sciences.158 However, 
the framework is widely used to study service quality in diverse industries, and even 
developers of competing frameworks suggest that the elements of SERVQUAL “should 
probably be put on any first pass at a list of attributes for a service.”159  
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Ten determinants of service quality underlie the SERVQUAL framework: tangibles, 
reliability, responsiveness, communication, credibility, security, competence, courtesy, 
understanding/knowing the customer, and access. Hedvall et al. applied a body of 
qualitative pharmacy research to define each of these determinants in the context of 
community pharmacy (Table 1). 160 Additionally, a critical examination of the performance 
of an adapted SERVQUAL instrument161 when assessing customer satisfaction with 
community pharmacy services reported that the instrument demonstrated high convergent 
and criterion validity as well as high overall internal reliability.162  
For this study, both the Donabedian Model and the SERVQUAL framework were 
used to inform the attribute selection process in order to more comprehensively approach 
the complex nature of community pharmacy practice, in which healthcare services are 
provided in a retail setting.163 
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Table 1. SERVQUAL dimensions, as understood in a community pharmacy settings, adapted 
from Hedvall et al.160  
 
Dimension Pharmacy-Specific Definition 
Accessibility 
Approachability and ease of contact; the pharmacy is easy to 
locate, opening hours are convenient, the products are well 
displayed, items in the self-service sector are easy to find, and 
the pharmacy is easy to contact by phone 
Communication 
Customers are informed about prescription and non-
prescription medicines, questions concerning health and related 
matters, prices of services and products in a language the 
consumers understand 
Competence 
The pharmacists possess the skills and knowledge necessary to 
perform their duties in the pharmacy 
Courtesy The staff is polite, respectful, considerate, and friendly 
Credibility 
The pharmacist is trustworthy and honest and has the 
customer’s best interests at heart 
Reliability 
The medicine is dispensed accurately, is correctly priced, and is 
available at the time promised to the customer 
Responsiveness 
The staff is willing and ready to perform the service required by 
the customer, and there is an available stock of all medicines 
required 
Security 
Freedom from risk or doubt that confidential information about 
the customer’s medicines and health status will go beyond the 
pharmacy. 
Tangibles 
The pharmacy has adequate physical attributes, such as the size 
of the premises, equipment, furnishings, and a comfortable 
place to wait while prescriptions are being made up 
Understanding/Knowing 
the Customer 
The staff makes the effort to understand his/her needs, findings 
out his/her specific requirements, and gives individual 
attention 
 
2.11.3 Random Utility Theory 
Random utility theory provides a theoretical basis for analyzing the choices made by 
participants in a discrete choice experiment. Underlying discrete choice experiments is an 
assumption that the choices that participants make reveal their preferences for the 
attributes used to differentiate alternatives. That is, it is assumed that consumers have 
preferences for attributes and, when presented with a choice of alternatives, will choose a 
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particular alternative if and only if that option conveys higher utility than any of the 
presented alternatives.164 Furthermore, random utility theory posits that the utility for a 
given individual is a latent construct that cannot be directly observed by researchers.165 
The latent utilities are thought to be a function of both explainable preferences and a 
random component.164,165 This random component, which comprises all unobserved or 
unidentified factors that impact respondents’ choices in a DCE,165 may be attributed to 
unobservable or unobserved attributes, preference variations within or between 
individuals, or error.164 The random utility theory necessarily underlies this research given 
the use of a discrete choice experiment to assess patient preferences.     
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Chapter 3: Methods 
 
3.1 Introduction to Discrete Choice Experiments 
 
This study elicited patient preferences for community pharmacy attributes using a 
discrete choice experiment (DCE). In discrete choice experiments, participants are 
presented with a series of choices in which they must select their preferred choice between 
two or more alternatives that differ on a number of selected attributes. Through analysis of 
participants’ choices, the effects of specific attributes on choice selection can be estimated.  
 
3.2 Survey Instrument 
 
3.2.1 Model Identification 
 
For the discrete choice experiment, participants received a series of choices 
between pharmacies that differ on the basis of six attributes reflecting pharmacy 
structures, processes, and outcomes. Each of the six attributes had no more than three 
levels. The inclusion of six attributes was consistent with International Society for 
Pharmacoeconomics and Outcomes Research (ISPOR) guidelines166 and common practices 
in pharmacy DCEs.167 The selection of an appropriate number of attributes and levels may 
improve choice consistency, or the variability in stated preferences that is not explained by 
attributes and preference weights.168 As the number of attributes and the variability in the 
levels of the attributes increase, the difficulty of the choice decision increases, and choice 
consistency is reduced.169  
A status quo or opt-out option was not included. The omission of a status quo option 
allowed this experiment to assess patient preferences in the absence of status quo bias and 
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pharmacy loyalty, known to be dominating factors in pharmacy selection.15,170 The lack of a 
status quo option is consistent with the majority of discrete choice experiments of 
pharmacy services.167  
Cost and location were held constant throughout the experiment to control for these 
potentially dominating factors.171 Although guidelines for appropriate attribute selection 
recommend the inclusion of all attributes important to an individual’s decision-making to 
prevent respondents from making inferences about omitted variables, the exclusion of 
dominant attributes has been recommended to prevent participant decision-making from 
becoming deterministic based on a single attribute.164,172 In order to reduce the likelihood 
of introducing omitted variable bias by excluding salient attributes, participant instructions 
included above each choice set delineated the assumptions of constant cost and location. 164 
The presentation of these instructions is consistent with ISPOR recommendations for 
studies that do not include a cost attribute.166 Keeping cost and location consistent also 
reflects real world pharmacy selection for many patients. Medication costs for insured 
patients are often identical at in-network pharmacies, and most patients live within a five-
mile radius of several pharmacies.173  
 
 
3.2.2 Attribute Selection 
 
An initial list of sixteen potential attributes for inclusion in the discrete choice 
experiment was formed based on published literature on patient selection of healthcare 
providers and expert opinion. Pilot testing (n=12) of a DCE with these sixteen attributes 
was then conducted. Pilot test participants were selected through purposive sampling, and 
testing was continued until saturation was reached. Pilot testing sessions lasted 25-45 
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minutes. Feedback from the pilot tests was used to reduce the number of attributes to six, 
refine the wording of specific attributes, and select the final levels for the included 
attributes.  
The sixteen attributes evaluated in the pilot tests are presented in Table 2. The 
following criteria were then applied during the attribute reduction process based on 
feedback received during the pilot tests. First, attributes that were confusing or not well 
understood by a majority of patients were eliminated if the confusion regarding the 
attribute would not be ameliorated by a change in its wording. This step reflects 
recommendations that pilot tests be used to identify and exclude attributes that are not 
well understood and/or not relevant to the participant population.164,174 Specifically, 
appropriate attributes have been described as those that are salient, plausible, and capable 
of being traded.172 Secondly, attributes that left substantial room for participant 
interpretation were eliminated to lessen the impact of unnecessary variability based on 
differences of interpretation. This step is consistent with recommendations that the 
attribute development process ensure that the desired meaning is evoked during attribute 
presentation.172 
Thirdly, where focus groups revealed a consensus of participant opinion that an 
attribute was unimportant, the inconsequential attribute was eliminated. Universally 
unimportant attributes do not necessarily require elimination from discrete choice 
experiments, as they will simply yield very low importance scores, but inclusion of these 
attributes would be contrary to recommendations that all included attributes be salient to 
the respondent population.172  Furthermore, the inclusion of unimportant attributes may 
unnecessarily increase the task complexity, thereby introducing random variability into the 
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responses.174 Lastly, the reduction in the number of attributes from sixteen to six 
necessitated the final inclusion of only those attributes that would best advance the 
experiment’s ability to capture meaningful data on why patients choose pharmacies and 
differentiate market segments. The inclusion of attributes that were not meaningful to any 
patients would not have advanced either of these goals.  
Finally, a decision was made to include an hours of operation attribute while 
eliminating the wait time attribute. While pilot test participants ascribed varying levels of 
importance to each of these attributes, both assessed the degree to which patients 
prioritize the underlying construct of accessibility. Conceptual overlap between attributes, 
or inter-attribute correlation, can obscure the estimation of the main effects of each 
attribute individually.175,176  Hours of operation was selected over wait time for a number 
of reasons, primarily due to the attribute’s superior ability to produce novel, actionable 
findings. While it is well understood from existing pharmacy and medical literature that 
many or most patients prioritize short wait times for healthcare services, much less is 
known about the degree to which the differences in the typical hours of operation for 
grocery, mass merchandiser, chain, and independent pharmacies impact the pharmacy 
selection process. While hours of operation may be an important factor in the ability of 
community pharmacies to best serve their patients, the long shifts characteristic of 
pharmacies with extended hours of operation are associated with decreased pharmacist 
job satisfaction.177 The negative effects of shifts ≥ 12 hours on job satisfaction, intention to 
leave current job, and burnout are well documented in other healthcare professionals.178,179 
A clearer understanding of the hours most important to patients may improve pharmacies’ 
ability to create schedules that balance patient accessibility and pharmacist engagement.  
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Specific details about the data reduction process for specific attributes are included 
in Table 3. Based on expert opinion and pilot testing feedback, a new attribute, “The 
pharmacist is willing to establish a personal relationship with me”, was selected for 
inclusion.  
Feedback on attribute levels was also gathered in the pilot tests and used to select 
the most appropriate levels for the included attributes. The initial levels presented during 
the pilot testing phase of the experiment were selected based on real world levels. During 
the pilot testing, participants were asked to provide their interpretation of those levels and 
indicate where a change from one level to another would provide meaningful information 
for pharmacy selection. The final selection of attribute levels required an assessment of the 
balance between the need for sufficient variation to yield precise, meaningful utility 
estimates 174,175,180 and the demonstrated reduction in choice consistency as the number of 
attribute levels increases.169 Two levels were specified for half of the attributes, and the 
remaining three attributes each had three levels, consistent with recommendations to limit 
levels to three or four per attribute.166 
 Following pilot testing, the number of levels for the attributes “staff 
friendliness/courtesy” and “pharmacist communication” was reduced from four (Always, 
Very Often, Sometimes, Rarely) to two (Always, Sometimes). This change was made for two 
reasons. First, pilot test participants indicated that they felt that a “rarely” level was 
implausible. Secondly, there was considerable variability in pilot test participants’ 
interpretation of the “very often” level. Some respondents felt that “very often” is “almost 
always,” while others felt that “very often” was considerably closer to “sometimes” than 
“always.” The ISPOR Task Force recommendations for Conjoint Analysis note that levels 
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which require subjective interpretation by the respondents should be excluded in order to 
avoid the introduction of unnecessary ambiguity and variability.166 Finally, pilot test 
participants noted that the difference between “always” and “sometimes” for those two 
attributes was both meaningful and plausible.  
The number of levels for the two quality-specific attributes was also reduced 
following pilot test feedback. Participants maintained that little meaningful difference 
existed when two alternatives varied by only one star level but felt that a difference of two 
star levels did indicate variability between the options. Therefore, the five levels differing 
by one star (,,,,) were reduced to three levels differing by 
two stars (,,).  The final six attributes and their levels are included in 
Table 4.  
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  Table 2. Sixteen Attributes Initially Included in Pilot Testing, based on Donabedian Framework 
Attributes Levels Source 
Pharmacy Structure   
Pharmacy Closing Time Traditional hours (8:00am-8:00pm) 
Extended hours on weekdays (7:00am-10:00pm) 
Extended hours on weekdays and weekends (7:00am-10:00pm weekdays; open Saturday and Sunday) 
12,181,182  
Counseling Space No Private Space (e.g. counsel at pharmacy counter);  
Semi-Private Space (e.g. extension of pharmacy counter);  
Private Space (e.g. closed room) 
183 
Ease of Prescription Fill Process 
 
The pharmacy has systems in place that make it easier to fill your medications. Examples of these systems 
may include medication synchronization, automatic refill notification via phone call or text, and online 
prescription management 
Levels: Yes, No 
183 
The staff is available to reduce wait times Always; Very Often; Sometimes; Rarely  
Pharmacy Processes   
The Pharmacy Staff is Friendly and 
Courteous  
Always; Very Often; Sometimes; Rarely 10,12,132,154,18
3,184 
The Pharmacist Shows Concern and Knows 
Your Needs  
Always; Very Often; Sometimes; Rarely 12,15,185 
Health and Medication-focused 
Communication; Existing Prescriptions 
The staff at the pharmacy level asks if you are having any problems with your medicine 
Levels: Always; Very Often; Sometimes; Rarely 
183,184 
Health and Medication-focused 
Communication; New Prescriptions 
When you have a new prescription filled the staff level tells you what to avoid when taking your medicine or 
what to do if you have bad reactions 
Levels: Always; Very Often; Sometimes; Rarely 
183 
Health and Medication-focused 
Communication; Oral Communication 
The pharmacist explains things about your medications in a way that is easy to understand 
Levels: Always; Very Often; Sometimes; Rarely  
Waiting Time 10 minutes; 20 minutes 12,132,186 
Resolving Medication-Related Problems When problems arise, your pharmacist level works with you to resolve them. 
Level: Always; Very Often; Sometimes; Rarely 
183 
Medication Appropriateness Your pharmacist level reviews your medications to make sure they are the best for you 
Levels: Always; Very Often; Sometimes; Rarely 
183 
Pharmacy Outcomes   
Drug-Drug Interactions   (Much Below Average);  (Below Average);  (Average);  (Above Average);  
(Much Above Average) 
14,15 
Helping Patients Get Needed Medications 
(Medication Adherence) 
 (Much Below Average);  (Below Average);  (Average);  (Above Average);  
(Much Above Average) 
14,15 
Overall Pharmacy Quality  (Much Below Average);  (Below Average);  (Average);  (Above Average);  
(Much Above Average) 
14,15 
Patient Satisfaction - Yelp.Com Rating  ; ; ; ;  
 
56,187,188 
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Table 3. Attribution Reduction Process: Reasons for Exclusion  
 
Reason for Exclusion 
Unclear/Misunderstood Variability in Interpretation 
Consensus of 
Unimportance Redundancy 
Staff availability to reduce 
wait times 
Yelp.com rating Medication appropriateness 
Communication regarding new 
prescriptions 
The pharmacist shows 
concern and knows your 
needs 
Ease of prescription fill 
process 
 Wait Time 
Communication regarding 
existing prescriptions 
   
Resolving medication-
related problems 
   
Medication adherence 
quality measure 
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Table 4. Final Attributes and Levels for Inclusion in the Discrete Choice Experiment 
 
Attribute Levels 
Donabedian 
Framework 
Service Quality 
Dimension 
Pharmacy Hours of Operation189 9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
 
8am-10pm 7 days/week  
 
8am-6pm Weekdays; 10am-3pm 
Saturday; Closed Sunday 
Structure  Access 
Staff Friendliness/Courtesy Always 
Sometimes 
Process Courtesy 
Pharmacist Communication Always 
Sometimes  
Process Communication 
The pharmacist is willing to 
establish a personal relationship 
with me139  
Yes 
No 
Process Understanding/Knowing 
the Customer 
Quality Measure, Overall  
 
  
Outcome Competence 
Quality Measure, DDI14,15  
 
  
Outcome Safety 
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3.2.3 Experimental Design 
A fractional factorial design was employed. Only full factorial designs allow for the 
independent estimation of all main and interaction effects, including three-way and higher 
order interactions. In contrast, fractional factorial design limits the analysis to estimating 
main and two-way interaction effects. Therefore, the use of a fractional factorial design 
requires the assumption that three-way and higher order interaction effects do not 
confound the main and two-way interaction effects. Despite the limitation that this 
potentially unmet assumption may bias the estimates of effect, fractional factorial designs 
are considered sufficient for a model used to estimate only main effects or in a subset of 
possible interactions.180,190 Furthermore, the full factorial design is simply not feasible 
without a prohibitively large sample size and number of choice sets. A 2014 review of 
discrete choice experiments in healthcare reported that 88% of healthcare-related DCEs 
published from 2009-2012 reported using a fractional factorial design, compared with 6% 
using a full factorial design.191 
Sawtooth Lighthouse Studio v9.2 (Orem, UT) was used to assign profiles for a total 
of 120 random choice tasks using complete enumeration. In complete enumeration, the 
alternatives presented within each task are as different as possible.192,193 This minimal 
overlap improves statistical efficiency and the precision of main effect estimates. 
Furthermore, minimal overlap in one study did not increase fatigue, perceived difficulty, or 
consistency compared to more moderate overlap.194 In this study, the use of complete 
enumeration rather than balanced overlap, which allows for a greater degree of overlap, 
was associated with a 23% increase in efficiency. 
 Two prohibitions were introduced into the study design based on pilot testing 
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feedback. Pilot test participants found the combination of a one star rating on one of the 
quality metrics and a five-star rating on the other metric to be implausible. When this 
combination appeared, they expressed distrust of the pharmacy quality ratings and placed 
little to no value on the metrics when making their selections. Therefore, for each of the 
quality metrics, a prohibition was introduced such that a single pharmacy could not have a 
one star rating on one of the quality metrics (overall or DDI) and a five-star rating on the 
other. The efficiency of the design with the prohibitions was only 91% of that without the 
prohibitions, but this loss of design efficiency was considered acceptable given the likely 
increase in response efficiency as a result of eliminating implausible scenarios. Indeed, the 
ISPOR task force on experimental designs for discrete choice experiments cautions that 
implausible combinations may increase the potential for bias; introduce unobserved, 
heterogenous interpretations by respondents; and/or lower response efficiency. 180 
Participants were randomly assigned to one of 12 blocks consisting of 10 random 
choice tasks. The profiles of two additional choice sets were created separately for the 
assessment of internal validity. First, a dominant scenario was created. Secondly, a single 
hold-out scenario for all participants, regardless of block placement, was created using a 
separate complete enumeration design process. These two fixed scenarios were added for 
the assessment of internal validity, as discussed later in this chapter. Thus, the total 
number of choice tasks provided to each participant was 12.   
The number of choice tasks was selected based on empirical literature and expert 
opinions on the effects of the number of tasks on experimental precision and reliability. 
Additional consideration was given to the appropriate number of tasks when individual-
level utility estimates will be made, as was done for the latent class analysis. The optimal 
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balance of minimizing task complexity and optimizing design efficiency when selecting the 
number of choice tasks is debated in the literature. Several studies have assessed changes 
in response variability when study participants are provided with varying numbers of 
choice tasks. The results have commonly suggested that the number of attributes, the 
number of attribute level differences, and the number of alternatives presented in each 
task have a greater impact on respondent fatigue and choice consistency than the number 
of choice tasks.195–198 An appropriate number of tasks for a typical discrete choice 
experiment may range from 5199 or 6200 to 24 or more.201,202 However, several researchers 
have recommended an intermediate number (8-16) of choice tasks given diminishing 
empirical gains from additional choice tasks.198,201,203,204 Accordingly, the mean number of 
choice tasks used in healthcare-related discrete choice experiments is reportedly 12-14 
tasks per respondent.205–207  
The selection of the number of choice tasks per respondent for this study required 
additional consideration given the proposed use of individual-level utility estimates during 
latent class modeling. Sawtooth recommends the inclusion of at least 10 choice tasks if 
individual-level utility estimates are intended.208 Health-related discrete choice 
experiments that employed latent class modeling for segmentation have predominately 
used 12-16 choice sets per respondent.209–211 
Blocking was introduced into the experimental design in order to lower the number 
of tasks required of each participant while maintaining acceptable levels of statistical 
efficiency. 164 Two ISPOR task force reports on conjoint analysis note that blocking is often 
necessary to increase the response efficiency of large designs,166,180 and the vast majority of 
DCEs on pharmacy services used blocked designs167 The 12-block design increased the 
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efficiency of the study 8-fold compared with a design consisting of only one block. Though 
Sawtooth is capable of generating up to 999 questionnaire versions, or blocks, the 12-block 
design was selected due to diminishing returns of efficiency with additional blocks. 
Furthermore, with the 12-block design, approximately 40 participants were assigned to 
each block, well above the recommended minimum of 20 participants per version.164 
 Because there is no gold standard for evaluating experimental design,166 the 
strength of the study design was evaluated from a number of perspectives. First, an 
efficiency test was conducted through Sawtooth’s “test design” feature. The logit report 
with simulated responses for 500 participants estimated the standard errors for the effect 
estimates to range from 0.01417 to 0.03191. These estimates meet the suggested guideline 
that effect estimates for main effects be no larger than 0.05.212 Secondly D-efficiency, a 
relative measure, was compared between several potential experimental designs, including 
complete enumeration vs. balanced overlap, designs with different number of 
questionnaire versions, and designs with and without prohibitions. Finally, it was 
confirmed that Sawtooth’s internal assessment for design deficiencies did not flag any 
attributes or levels as deficient.  
 Internal validity was assessed using a hold-out and a dominant scenario. The use of 
tests for rationality and validity is common213 and recommended166 but raises theoretical 
concerns about rational explanations for irrational responses. For example, participants 
may exhibit lexicographic preferences, in which they select an alternative based on the 
attribute they believe is most important rather than the overall trade-offs of all 
alternatives. Such preferences may result in the rational selection of the dominated 
alternative.214 It has also been suggested that participants may base their choices on 
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assumptions and inferences about how the alternatives may differ on attributes not 
included in the experiment.214  Because these participants are indeed expressing rational 
and valid preferences, deleting those who fail the dominant scenario may lead to bias and 
reduced efficiency.164 Accordingly, and based on ISPOR recommendations, respondents 
failing the internal validity assessment were not dropped from the data set. Rather, the 
frequency of response errors and a discussion of associations between response errors and 
demographic characteristics are presented in the results.166  
Attribute randomization was used to reduce the potential for bias that would 
adversely impact the study’s internal validity. The Sawtooth attribute randomization 
feature randomizes the order in which attributes are presented across respondents while 
holding that order constant within each respondent. Pilot test participants strongly favored 
a consistent attribute order, reporting that consistency dramatically decreased cognitive 
burden. Furthermore, attribute randomization was consistent with ISPOR 
recommendations166 
 
3.2.4 Sociodemographic and Health Information 
 
Health and sociodemographic characteristics included in the survey as well as the 
levels presented to survey respondents are listed in Tables 5-8. Patient-specific health and 
sociodemographic characteristics have been shown to influence preferences for health 
providers and/or understanding of quality ratings. Basic demographic information 
collected included sex, age, race, household annual income, and highest level of education 
completed. These characteristics have been associated with preferences during healthcare 
provider selection215,216 as well as use and understanding healthcare quality metrics and 
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ratings.217,218 Several of these demographic characteristics are also mentioned as individual 
characteristics of clinical and policy interest in the ISPOR Good Research Practices for 
Conjoint Analysis Workforce.166 
In addition to basic demographic information, the survey collected information on 
marital status, urbanicity, and US census region of residence. Marital status was included in 
light of a study on hospital selection among elderly males reporting that widowed men 
were less likely to select a high-quality hospital, as assessed by US News & World Report, 
than their married counterparts.219 Urbanicity data was collected given the documented 
impact of urbanicity on patient priorities for and satisfaction with their 
pharmacies.5,12,14,139 US census region of residence was included in the survey because a 
recent study found that greater proportions of patients in the Midwest and West used mail 
order pharmacies than those in the Northeast and South,105 suggesting that priorities 
during pharmacy selection may vary by region. 
Several health-related characteristics were also collected in the questionnaire. A 
single, validated screening question was used to identify participants with inadequate 
health literacy.220 Health literacy may influence patient understanding of quality 
information and the extent to which quality data is prioritized during health care provider 
selection.61,221,222 Current pharmacy patronage was also collected. In a determinant 
attribute analysis conducted by Franic et al., patients who patronized independent 
community pharmacies ascribed less importance to pharmacy hours of operation than 
customers of other types of community pharmacies.12  
Self-reported health status was collected with the survey question “would you say 
that your health is excellent, very good, good, fair, or poor?” Self-reported health status has 
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been associated with awareness of quality information, but its impact on the use of such 
information during healthcare decision-making may be limited. A study among older adults 
found that patients with better self-reported health were less likely to be aware of 
physician quality information.218 However, patients in another study who reported good or 
excellent health were more likely to report having seen comparative quality information 
than their less healthy counterparts.51 However, this increased exposure to quality 
information was not associated with increased use of the information when choosing a 
healthcare provider.51 Harris surveyed patients regarding their use of formal quality 
information, information from doctors and nurses, and recommendations from friends and 
family when selecting a healthcare provider. In that survey, health status was not shown to 
impact the likelihood of using quality information.223  
Patient activation, measured in this study with a single question assessing patient 
confidence in their ability to manage their health, has garnered attention in healthcare 
research due to its association with health outcomes and patient perceptions of their care 
experiences.224 In a study examining patient awareness and use of comparative quality 
information, patients with lower activation scores were less likely than highly activated 
patients to have seen and used comparative quality information for physicians and 
hospitals.51 Similarly, Hibbard et al. reported that patients with high activation 
demonstrated higher comprehension of quality information and were more likely to choose 
a high quality hospital in a hypothetical scenario than less activated patients.72  However, 
activation was not associated with awareness of physician quality information in a study 
among older adults.218 Patient confidence, as used in this study, is associated with health 
outcomes and health behaviors, and the measure is closely correlated with other 
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engagement measures.225 Furthermore, the assessment of patient confidence requires only 
a single question and does not necessitate payment of a licensing fee.   
Finally, this survey collected information on a patient’s current number of chronic 
medications and the number of chronic medications which they currently manage for an 
individual for whom they serve as a primary caregiver. This measure impacted choice of 
pharmacy setting among older adult Department of Defense beneficiaries6 and emergency 
department patients.108 The number of chronic medications used was also associated with 
multiple pharmacy use among US adults.151 Additionally, the proportion of patients with 
chronic diseases varied substantially in the healthcare market segments identified by the 
Deloitte Center for Health Solutions.153 Information on both the patient’s and their care 
recipients’ medication use was collected given the high prevalence of informal caregiving in 
the US226 documented role of caregivers in medication management.227,228 Furthermore, a 
discrete choice experiment of community pharmacy preferences among Australian 
consumers specifically included both patients and unpaid caregivers.130   
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Table 5. Sociodemographic Characteristics Included in Questionnaire 
 
 
 
 
Sociodemographic 
Characteristics Levels Source 
Sex Male; Female 166,215–218 
Age 18-24; 25-34; 35-44; 45-54; 55-64; 65-74; ≥75 166,215–218 
Race Non-Hispanic, White; Non-Hispanic, Black; Hispanic, Other 166,215,218,223 
Household Annual Income 
≤$25,000; $25,001-$50,000, $50,001-$75,000; $75,001-
$100,000; $100,001-$150,000; >$150,000 
166,215,218 
Highest Level of Education 
Less than High School; High School Degree; Some College; 
Bachelor’s Degree; Some Post-Graduate; Post-Graduate Degree 
166,215–218 
Marital Status Never Married; Married; Separated/divorced/widowed 219 
US Census Region of Residence Northeast; Midwest; South; West 105 
Urbanicity Urban; Suburban; Rural 5,12,14,139 
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Table 6. Health Characteristics Included in Questionnaire 
 
 
 
Health Characteristics Levels Source 
Health Literacy Screening 
Question 
Adequate, Inadequate 215 
Self-Reported Health Status Excellent, very good, good, fair, poor 51,218,223 
Number of Chronic 
Medications, Self 
None; 1-3; 4-7; 8-11, ≥11 6,108,229 
Current Pharmacy 
Patronage 
Chain pharmacy (i.e. CVS); Independent 
Pharmacy; Grocery Pharmacy (i.e. Kroger); 
Mass Merchandiser Pharmacy (i.e. Walmart); 
Mail Order Pharmacy 
12 
Number of Chronic 
Medications, Care Recipients 
None; 1-3; 4-7; 8-11, ≥11 6,108,229 
Know Pharmacist’s Name Yes/No 12,230 
Health Confidence High (≥ 7), Low (<7) 218,225 
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Table 7. Level Selection for Demographic Characteristics on Questionnaire 
 
 
 
 
 
 
Characteristic Levels 
Source for Level 
Selection 
Sex Male; Female 231 
Age 18-24; 25-34; 35-44; 45-54; 55-64; 65-74; ≥75 231 
Race Non-Hispanic, White; Non-Hispanic, Black; Hispanic, Other 231 
Household Annual Income 
<$25,000; $25,000-$49,999; $50,000-$74,999; $75,000-$99,999; $100,000-
$149,999; ≥$150,000 
232,233 
Highest Level of Education 
Less than High School; High School Degree; Some College; Bachelor’s Degree; 
Some Post-Graduate; Post-Graduate Degree 
231,234 
Marital Status Never Married; Married; Separated/divorced/widowed 234,235 
US Census Region of Residence Northeast; Midwest; South; West 235 
Urbanicity Urban; Suburban; Small Town, Rural  236 
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Table 8. Level Selection for Health Characteristics in Questionnaire 
Characteristic Levels 
Source for 
Level Selection 
Single Question Health Literacy Screening Adequate, Inadequate 220 
Self-Perceived Health Status Excellent, very good, good, fair, poor 237  
Number of Chronic Medications, Self  Interval  229 
Current Pharmacy Patronage 
Chain pharmacy (i.e. CVS); Independent Pharmacy; Grocery Pharmacy 
(i.e. Kroger); Mass Merchandiser Pharmacy (i.e. Walmart); Mail Order 
Pharmacy  
12 
Number of Chronic Medications, Care 
Recipients 
Interval 229 
I Know My Pharmacist’s Name Yes; No 12,230 
Health Confidence High (≥ 7), Low (<7) 225,238   
Pharmacy Services 
Automatic Refill; E-mail or Text Message Refill Reminders; 
Appointment-Based Medication Synchronization; Medication 
Synchronization (without an appointment); Medication 
Adherence Packaging (e.g. blister packaging, pill box 
organization); Medication Therapy Management; Immunization, 
Influenza; Immunization, Non-Influenza; Prescription 
Compounding; Home Delivery; Smartphone App 
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3.3 Participant Selection and Data Collection 
 
3.3.1 Administration of Discrete Choice Experiment 
 
A Qualtrics research panel was used to gather a sample of American adults (≥ 18 
years) for the online administration of the discrete choice experiment. Online 
administration of DCEs is increasingly common in health economics,213 and patient 
preferences did not significantly differ between those responding to the health state 
valuation instrument face-to-face and online.239 In order to proceed to the survey, 
participants must have answered “yes” to the question “Have you filled a prescription at a 
pharmacy, other than a mail-order pharmacy, within the last 12 months.” This screening 
criteria was instituted to exclude those who had not recently filled a prescription at a brick-
and-mortar pharmacy. A gender quota was implemented to ensure that the proportions of 
males and females did not exceed a 60/40 split for either gender.  While the Qualtrics panel 
is opt-in such that participants are not randomly selected, the panel has been shown to 
have an acceptable level of national representativeness.240 Furthermore, compared with 
the demographic composition of other opt-in panels, Qualtrics has more representative 
proportions of older adults,  racial minorities, those with low levels of educational 
attainment, and those living in urban and rural areas.240 This study was approved by the 
Virginia Commonwealth University Institutional Review Board.   
Prior to the discrete choice experiment, participants were provided information 
about the forthcoming choice tasks and the pharmacy quality measures.  The specific 
wording and information presented was selected based on expert opinion, ISPOR 
guidelines for discrete choice experiments, existing literature, and feedback from the pilot 
testing.  Because past literature has identified the potential for patient confusion over 
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whether a higher or lower number is better for a specific quality indicator,53 participants 
were supplied with specific information that the ratings would appear on a scale of one to 
five stars, where more stars were better.  A scale of the star levels, along with their 
evaluative word labels (i.e. “much below average” to “much above average”) was also 
presented prior to the start of the experiment. The addition of word labels to the star 
ratings reflects the real-world presentation format of quality metrics on Medicare’s 
Hospital Compare and Nursing Home Compare websites. The addition of world labels is 
also associated with improved understanding of quality stars.65,69 Based on pilot testing 
feedback, a statement was added to the survey instructions noting, “An overall rating is 
computed based on a number of scores on specific aspects of pharmacy practice. 
Accordingly, an overall quality rating may differ from any single, specific rating.” While 
past studies have reported that the presentation of an overall performance measure in 
addition to specific quality metrics aids in the identification of high-quality providers,14,53,71 
pilot test participants commonly felt confused when the two scores differed.   
The instructions prior to each choice task presented the hypothetical scenario under 
which participants would be making their choice (i.e. having moved to a new location) and 
the key assumptions of this DCE, namely that price and location were held constant. Finally, 
an example choice task was provided. The three primary elements included in the pre-
survey introduction – the context of the study scenario, a description of the quality 
attributes and levels, and the example choice task – are consistent with ISPOR 
recommendations.166 
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3.3.2 Sample Size 
There is no gold standard for determining the sample size for a DCE.166 Sample size 
recommendations vary considerably and include both set sample sizes (e.g. 100 
respondents) and sample sizes calculated based on parametric approaches.166,241 Formulas 
for sample size calculation may require input of population proportions, variance, expected 
parameter values, statistical power and/or the number of parameters estimated, choice 
sets, and alternatives.241  Considerable variability exists in the sample sizes used in 
published healthcare-related DCEs, and very few (6%) report use of parametric approaches 
for sample size estimation.241 Given the lack of consensus on optimal approaches for 
sample size calculations, the need for parameter value estimates for sample size 
calculations, and the limited use of parametric approaches in health economics thus far, a 
calculation-based approach to sample size calculation was not used in this study.180,241   
This study targeted a sample size of 500. The target sample size was decided upon 
after considering expert recommendations, common practices for healthcare-related DCEs, 
and the a priori plan to conduct a latent class analysis. Two reports from the  ISPOR Good 
Research Practices for Conjoint Analysis Task Force cite recommendations that conjoint 
analyses include at least 300 study participants.166,180 A review article of discrete choice 
experiments in healthcare stated that the mean sample size of conjoint analysis studies in 
health care was 259 respondents.166 Furthermore, Monte-Carlo simulations suggest that 
sample sizes over 100 are acceptable for latent class analysis, with sample sizes of 500 
resulting in precise parameter estimates even under conditions of low data quality.242 
Accordingly,  recent latent class analyses in healthcare report sample sizes of 
approximately 200-500.209,210,243  
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Additional consideration was given to the a priori analysis plan to evaluate the 
community pharmacy preferences of the subgroup of patients taking chronic medications. 
An estimated 50% of all Americans live with a chronic condition. 244–246 With the use of 
chronic medications come concerns about high levels of nonadherence247 and an increased 
risk for drug-drug interactions between two prescribed medications248 or a prescribed and 
an over-the-counter (OTC) medication.249 A sample size of at least 250 patients taking 
chronic medications was targeted in order to have a sufficient number of patients for a 
valid and meaningful subgroup analysis.  All study participants, per the inclusion criteria, 
must have reported filling a prescription at a non-mail order pharmacy in the last 12 
months.  In an average month, the vast majority (>80%) of prescriptions filled for adult 
patients are chronic medications.250 Additionally, the prescribing rate for antibiotics, the 
most commonly prescribed acute medications, among non-elderly adults is approximately 
350 prescriptions per 1,000 patients.251 The assumption was thus made that at least half of 
the 500 study participants would be taking at least one chronic medication, yielding a 
predicted sample size of 250 for the subgroup analysis.  
 
3.4 Data Analysis 
3.4.1 Data Analysis, Sample Characteristics 
 
 The sample characteristics were summarized using Sawtooth v9.2.  Continuous 
variables were presented as mean (SD), and categorical variables were presented as the 
proportion of respondents in each group. The number of participants failing the dominant 
scenario was also summarized. Chi-square and ANOVA tests were used to assess whether 
categorical and continuous, respectively, health and demographic characteristics varied 
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between those who failed the scenario and those who did not, with p < 0.05 denoting 
statistical significance. 
 
3.4.2 Data Analysis, Study Aim 1 
Sawtooth v.9.2 (Sawtooth Software, Orem, UT) was used to conduct a conditional 
logit regression (CL) to analyze the effect of attribute levels on consumer preferences for 
community pharmacies. For the primary CL analysis, only main effects were 
considered,192,213 and preferences were estimated using effects coding166,252,253 with the 
following model:254 
 
𝑈𝑖 =  𝛽1𝐺𝑟𝑜𝑐𝑒𝑟𝑦𝐻𝑜𝑢𝑟𝑠𝑖 +  𝛽2𝐶ℎ𝑎𝑖𝑛 𝐻𝑜𝑢𝑟𝑠𝑖 +  𝛽3𝐴𝑙𝑤𝑎𝑦𝑠𝐹𝑟𝑖𝑒𝑛𝑑𝑙𝑦𝑖 + 𝛽4𝐴𝑙𝑤𝑎𝑦𝑠𝐸𝑥𝑝𝑙𝑎𝑖𝑛𝑠𝑖  
+  𝛽5𝑅𝑒𝑙𝑎𝑡𝑖𝑜𝑛𝑠ℎ𝑖𝑝𝑖 +  𝛽6𝑄𝑢𝑎𝑙𝑖𝑡𝑦3𝑆𝑡𝑎𝑟𝑖 + 𝛽7𝑄𝑢𝑎𝑙𝑖𝑡𝑦5𝑆𝑡𝑎𝑟𝑖 +  𝛽8𝐷𝐷𝐼3𝑆𝑡𝑎𝑟𝑖
+  𝛽9𝐷𝐷𝐼5𝑆𝑡𝑎𝑟𝑖 +  𝜀𝑖  
 
Where the overall utility of alternative i is a function of estimated coefficients 𝛽1to 𝛽9, the 
attribute levels of alternative i, and a random error term. Estimated regression coefficients 
were expressed as part-worth utilities. Sawtooth was also used to calculate attribute 
importance values, which reflect the difference each attribute could make in an 
alternative’s utility and are used to characterize the relative importance of each attribute. 
The model fit was assessed by evaluating the chi-square comparing the log 
likelihood of the full and null models, with the degrees of freedom calculated by subtracting 
the number of attributes from the total number of levels to obtain the number of additional 
effects in the full model.192,252 T-ratios were used to evaluate the significance of  individual 
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attributes. A p-value < 0.05 denoted statistical significance. 
 
3.4.3 Data Analysis, Study Aim 2 
 
 For Study Aim 2, the effects of sociodemographic and health characteristics on 
patient preferences for community pharmacy attributes were described. Though this aim 
was descriptive in nature, subgroup comparisons were made using Sawtooth Software’s 
CBC/Hierarchical Bayes (CBC/HB) module. CBC/HB estimates individual-level utility data 
and normalizes it using zero-centered differentials. Through this process, individuals are 
made to having same utility scaling, ensuring that they will be equally weighted within the 
population. T-tests and one-way ANOVAs were then used to assess for the significance of 
the differences in part-worth utilities between subgroups, with understanding of the 
caution required with repeated testing of differences.  It is well known that repeated 
testing of differences between subgroups inflates the probability of a false positive result, 
and the p-value denoting statistical significance should be adjusted accordingly.255,256 The 
Bonferroni adjustment was used for post-hoc pairwise comparisons.  
 
3.4.4 Data Analysis, Study Aim 3 
The Sawtooth Latent Class Segmentation (CBC/LC) module was used for the 
proposed community pharmacy market segmentation.  Latent class models allow for 
preference heterogeneity by identifying segments with similar preferences, estimating 
those preferences, and assessing the probability that each study participant belongs to each 
segment.257 The CBC/LC module requires the user to pre-specify the number of segments, 
or classes, in the population. The module was run five times to create segmentation 
solutions with two to six segments. Measures of model fit were then compared between the 
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five solutions. The model that best described the patterns of participant responses was 
identified based on the Consistent Akaike Information Criterion (CAIC), where the smallest 
value or the inflection point indicates the appropriate number of segments.257 The CAIC is 
the evaluation criterion provided in the CBC/LC module and has performed well in 
independent simulations testing decision-making criteria for the number of classes in 
latent class analyses.258  In addition to CAIC, consideration was given to obtaining 
interpretable and meaningful market segments.   Once the optimal solution was selected, 
the sizes, part-worth utilities, and attribute importance values were estimated and 
reported for each segment. 
Descriptive statistics, mean/SD for continuous variables and proportions for 
categorical variables, were calculated for each market segment. The health and 
demographic characteristics of the members in each class were compared with chi-square 
and one-way ANOVA tests for categorical and continuous variables, respectively, where p < 
0.05 denoted statistical significance.  
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Chapter 4: Results 
4.1 Sample Size and Characteristics 
A total of 773 respondents began the survey. Thirty-two participants were excluded, 
including thirty who entered the survey through the survey panel administrator but did not 
begin the choice task and two who failed to complete the choice experiment, for a total 
sample size of 741. The two participants who began the choice tasks but did not complete 
the experiment withdrew after the third and eighth choice tasks. 
Demographic and health characteristics of the survey respondents and the US adult 
population are presented in Table 9. The sample was predominately female (55.8%), non-
Hispanic white (83.1%), and married (63.2%). Middle-aged adults were slightly 
overrepresented relative to national estimates, with participants most commonly reporting 
an age of 35-54 years (40.9% vs. 35% nationally) or 55-64 years (22.9% vs. 16% 
nationally).259 Young adults (18-24 years) and older adults (≥65 years) were 
underrepresented in the study population (3.5% vs. 12.9% nationally and 12.2% and 
18.3% nationally). Nearly two-thirds of participants (62.7%) reported an annual household 
income level above the median US household income. Study respondents were more highly 
educated than the general population. Compared to the population at large, participants 
were more likely to report attaining at least a high school diploma/GED (98.8% vs. 87.1%) 
and at least a Bachelor’s degree (47.4% vs. 30.6%).260 Consistent with national estimates of 
population by US Census region of residence, approximately one-third of study participants 
reported residing in the South (34.0% vs. 37.1% nationally), and a quarter lived in the 
Midwest (25.3% vs. 21.7% nationally).261 However, respondents were much more likely to 
live in the Northeast (29.5% vs. 17.9% nationally) and much less likely to live in the West 
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(11.3% vs 23.3% nationally) than the general population.261 Survey participants more 
commonly reported living in a suburban area (47.2%) than an urban (24.8%) or rural 
(17.2%) area.  
The estimated prevalence of inadequate health literacy in the study population was 
6.1%. Low health confidence was more common (15.2%) than low health literacy. Most 
participants perceived their health to be very good (38.6%) or good (31.2%). The 
proportion of participants reporting fair or poor health (14.0%) was slightly lower than 
has been reported nationally (17.5%).  The vast majority of respondents reported use of at 
least one chronic medication (85.1%), with an average of 2.7 medications reported per 
study participant. Among only those study participants who reported chronic medication 
use, the average utilization was 3.2 chronic medications. 
The proportion of participants reporting any chronic medication use did not vary 
significantly by age (p = 0.559) and ranged from 81.5% in the youngest respondents (18-24 
years) to 88.9% in those over 65 years of age. However, the mean number of chronic 
medications did increase significantly with age (p = 0.0179), from 2.3 among 18-24 year 
olds to 4.6 in those over 75 years of age.  The reported use (p = 0.284) and number (p = 
0.122) of chronic medications did not vary by sex.  The majority (58.9%) of participants 
reported responsibility for at least one medication for a direct care recipient. The mean 
number of chronic medications taken by care recipient(s) was 3.5. Caregivers were most 
commonly 35-44 (26.4%) and 25-34 years old (23.5%). The majority of respondents 
reported filling their prescriptions primarily at a chain pharmacy (51.5%), and 
approximately one-third (35.1%) stated that they know their pharmacist’s name. 
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Pharmacy Patronage and Demographic Characteristics 
A number of demographic and health characteristics were associated with type of 
pharmacy patronized (Table 10). Mail order pharmacy use was significantly higher among 
older adults (≥ 65 years; 18.9%) than those under 65 years of age (4.2%). Consequently, 
while older adults comprised only 12.2% of the total study sample, nearly 4 in 10 (38.7%) 
of those reporting primary use of a mail order pharmacy were older than 65 years.  A 
greater proportion of the lowest income respondents (<$25,000; 21.7%) patronized 
independent pharmacies than the highest income participants (≥$150,000; 6.8%), who 
more often reported use of a chain pharmacy (61.0% vs. 45.4%).  Independent pharmacy 
patronage was least common (4.8%) amongst participants living in the West, where mail 
order pharmacy use was more common than in other areas of the country (10.8% vs 5.1-
5.9%). Compared with their rural counterparts, suburban participants more commonly 
patronized chain pharmacies (58.8% vs. 40.9%) and less commonly used independent 
pharmacies (6.6% vs. 16.5%). The proportion of independent pharmacy patrons reporting 
that they knew their pharmacist’s name (59.3%) was nearly double that of those using 
chain (32.7%), grocery (35.2%), and mass merchandiser pharmacies (31.0%).  
 
Pharmacy Services Utilization 
Of the eleven services surveyed, automatic refill service was the most commonly 
utilized, with 57.9% of participants reporting use (Table 11). The proportion of 
respondents using automatic refill was higher among those patronizing grocery (65.1%), 
mail order (63.6%) and chain (60.4%) pharmacies than independent pharmacies (45.7%).  
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The use of technological services, including e-mail or text message reminders and 
smartphone apps, was highest among patrons of chain and mail order pharmacies.  Nearly 
half of chain (45.4%) and mail order (47.7%) patrons reported using e-mail or text 
message reminders, compared with 17.3%-31.0% among patients at other types of 
pharmacies. Similarly, pharmacy-based smartphone apps were more commonly used by 
chain and mail order pharmacy patrons (13.7% and 11.4%, respectively) than by 
customers of independent, grocery, and mass merchandiser pharmacies (4.9%-7.1%). The 
use of appointment-based medication synchronization was highest among patients at 
independent pharmacies (16.1%). Among patrons of brick-and-mortar pharmacies, home 
delivery was most commonly used by patients at independent pharmacies (24.7%).  
 
4.2 Survey Responses 
The median time to survey completion was 5 minutes, 38 seconds (IQR: 3 minutes, 
58 seconds - 8 minutes, 11 seconds). Median elapsed time did not vary by health literacy, 
age, sex, level of education, or health confidence.  The median time per choice task was 12 
seconds. Respondents’ time per choice task significantly decreased as they progressed 
through the experiment (p<0.001).  Median time per choice task was 29 seconds for the 
first completed choice task, 19 for the second, 15 for the third, and 10-13 for the remaining 
tasks. The median time for the dominant choice task was 13 seconds. 
In the dominant scenario, 93.4% of participants selected the dominant choice. Males 
more commonly failed the dominant scenario (8.9%) than females (4.9%). Respondents in 
rural areas who, on average reported lower levels of education and health literacy than 
their more urban counterparts, less commonly failed the dominant scenario (1.6%) than 
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those from small towns (5.1%) and suburban (6.0%) and urban (12.0%) areas. The median 
time spent on the survey by participants failing the dominant scenario was not significantly 
different than that of those who did not fail. Thirteen (1.8%) and two (0.3%) respondents 
always selected the alternative on the left or right, respectively.  Overall, the left alternative 
was selected in 47.3% of random choice tasks. 
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Table 9. Baseline Characteristics of the Study Respondents, Overall, Compared with the US 
Adult Population 
 
 
Baseline Characteristics Study Respondents, n (%) U.S. Adult Population (%) 
Male Sex 325 (44.2) 48.6 
Age   
18-24 years 26 (3.5) 12.9 
25-34 years 151 (20.5) 17.8 
35-44 years 164 (22.3) 16.8 
45-54 years 137 (18.6) 18.2 
55-64 years 169 (22.9) 16.2 
65-74 years 81 (11.0) 10.3 
≥75 years 9 (1.2) 8.0 
Race   
Non-Hispanic, White 608 (83.1) 62.4 
Non-Hispanic, Black 54 (7.4) 12.3 
Hispanic 34 (4.6) 17.1 
Other 36 (4.9) 8.2 
Household Annual Income   
<$25,000 98 (13.3) 22.2 
$25,000-$49,999 176 (24.0) 22.7 
$50,000-$74,999 170 (23.1) 16.7 
$75,000-$99,999 131 (18.0) 12.1 
$100,000-$149,999 100 (13.6) 14.1 
≥$150,000 59 (8.0) 12.3 
Highest Level of Education   
Less Than High School/GED 9 (1.2) 12.9 
High School Degree 140 (19.1) 27.6 
Some College 151 (20.5) 
29.0 
Associate’s Degree 87 (11.8) 
Bachelor’s Degree 219 (29.8) 19.0 
Some Post-Graduate 33 (4.5) 
11.6 
Graduate Degree 96 (13.1) 
Marital Status   
Never Married 161 (22.0) 36.7 
Married 463 (63.2) 49.2 
Separated/Divorced/Widowed 109 (14.9) 18.9 
 98 
Table 9. Baseline Characteristics of the Study Respondents, Overall, Compared with the US 
Adult Population, Continued 
Baseline Characteristics Study Respondents, n (%) U.S. Adult Population (%) 
Region of Residence   
Northeast 217 (29.5) 17.9 
Midwest 186 (25.3) 21.7 
South 250 (34.0) 37.1 
West 83 (11.3) 23.3 
Urbanicity   
Urban 184 (24.8) 
71.2 
Suburban 348 (47.2) 
Small Town 79 (10.7) 9.5 
Rural 127 (17.2) 19.3 
Health Literacy   
Inadequate 45 (6.1) 26 
Self-Perceived Health    
Excellent 120 (16.3) 
82.5 Very Good 285 (38.6) 
Good 230 (31.2) 
Fair 84 (11.4) 
17.5 
Poor 19 (2.6) 
No. of Chronic Medications   
Self, mean (SD) 2.74 (3.32)  
Care Recipients, mean(SD) 2.03 (3.56)  
Type of Pharmacy   
Chain 379 (51.5)  
Independent 81 (11.0)  
Grocery 106 (14.4)  
Mass Merchandiser 126 (17.1)  
Mail Order 44 (6.0)  
I Know My Pharmacist’s Name    
Yes 258 (35.1)  
No 316 (42.9)  
Unsure 76 (10.3)  
I do not interact with the same 
pharmacist regularly 
86 (11.7) 
 
Health Confidence   
Mean (SD) 8.56 (2.03)  
High (≥7) 628 (84.8)  
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Table 10. Population Characteristics, Overall, by Current Pharmacy Patronage 
 
 Number (%), by current pharmacy patronage  
 
Chain Independent Grocery 
Mass 
Merchandiser Mail Order 
Number (%) 381 (51.6) 81 (11.0) 106 (14.4) 126 (17.1) 44 (6.0) 
Male Sex 155 (40.9) 38 (46.9) 48 (45.7) 60 (47.6) 24 (54.6) 
Agec      
18-24 years 16 (4.2) 4 (4.9) 1 (0.9) 4 (3.2) 1 (2.3) 
25-34 years 86 (22.7) 23 (28.4) 20 (18.9) 21 (16.7) 1 (2.3) 
35-44 years 89 (23.5) 19 (23.5) 22 (20.8) 29 (23.0) 5 (11.4) 
45-54 years 66 (17.4) 15 (18.5) 23 (21.7) 25 (19.8) 7 (15.9) 
55-64 years 85 (22.4) 11 (13.6) 26 (24.5) 34 (27.0) 13 (29.6) 
65-74 years 32 (8.4) 9 (11.1) 12 (11.3) 13 (10.3) 15 (34.1) 
≥75 years 5 (1.3) 0 2 (1.9) 0 2 (4.6) 
Race      
Non-Hispanic, White 304 (81.3) 71 (87.7) 90 (84.9) 105 (83.3) 37 (84.1) 
Non-Hispanic, Black 30 (8.0) 4 (4.9) 10 (9.4) 7 (5.6) 3 (6.8) 
Hispanic 21 (5.6) 1 (1.2) 4 (3.8) 6 (4.8) 2 (4.6) 
Other 19 (5.1) 5 (6.2) 2 (1.9) 8 (6.4) 2 (4.6) 
Household Annual Incomec      
<$25,000 44 (11.7) 21 (25.9) 10 (9.4) 16 (12.7) 6 (13.6) 
$25,000-$49,999 83 (22.0) 20 (24.7) 20 (18.9) 41 (32.5) 12 (27.3) 
$50,000-$74,999 79 (21.0) 17 (21.0) 33 (31.1) 34 (27.0) 7 (15.9) 
$75,000-$99,999 78 (20.7) 12 (14.8) 18 (17.0) 18 (14.3) 6 (13.6) 
$100,000-$149,999 57 (15.1) 7 (8.6) 18 (17.0) 8 (6.4) 10 (22.7) 
≥$150,000 36 (9.6) 4 (4.9) 7 (6.6) 9 (7.1) 3 (6.8) 
Highest Level of Educationa      
Less Than High School/GED 3 (0.8) 4 (4.9) 1 (1.0) 0 (0) 1 (2.3) 
High School Degree 70 (18.5) 10 (12.4) 19 (18.1) 31 (24.8) 8 (18.2) 
Some College 79 (20.9) 26 (32.1) 19 (18.1) 22 (17.6) 5 (11.4) 
Associate’s Degree 39 (10.3) 8 (9.9) 15 (14.3) 19 (15.2) 6 (13.6) 
Bachelor’s Degree 123 (32.3) 21 (25.9) 32 (30.5) 34 (27.2) 10 (22.7) 
Some Post-Graduate 15 (4.0) 5 (6.2) 5 (4.8) 3 (2.4) 5 (11.4) 
Graduate Degree 50 (13.2) 7 (8.6) 14 (13.3) 16 (12.8) 9 (20.5) 
a p < 0.05; c p < 0.001  
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Table 10. Population Characteristics, Overall, by Current Pharmacy Patronage, Cont.
 Number (%), by current pharmacy patronage 
 
Chain Independent Grocery 
Mass 
Merchandiser 
Mail 
Order 
Marital Status  
Never Married 87 (23.2) 24 (29.6) 18 (17.1) 28 (22.2) 4 (9.1) 
Married 243 (64.8) 42 (51.9) 68 (64.8) 76 (60.3) 33 (75.0) 
Separated/Divorced/Widowed 45 (12.0) 15 (18.5) 19 (18.1) 22 (17.5) 7 (15.9) 
Region of Residencea      
Northeast 127 (33.7) 26 (32.1) 20 (18.9) 32 (25.4) 
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(25.0) 
Midwest 85 (22.6) 20 (24.7) 29 (27.4) 41 (32.5) 11(25.0) 
South 129 (34.2) 31 (38.3) 38 (35.9) 38 (30.2) 13 (29.6) 
West 36 (9.6) 4 (4.9) 19 (17.9) 15 (11.9) 9 (20.5) 
Urbanicityc      
Urban 91 (24.0) 28 (34.6) 29 (27.4) 29 (23.0) 7 (15.9) 
Suburban 204 (53.8) 23 (28.4) 50 (47.2) 50 (39.7) 20 (45.5) 
Small Town 32 (8.4) 9 (11.1) 9 (8.5) 23 (18.3) 5 (11.4) 
Rural 52 (13.7) 21 (25.9) 18 (17.0) 24 (19.1) 12 (27.3) 
Health Literacy      
Inadequate 22 (5.8) 9 (11.1) 7 (6.6) 7 (5.6) 0 
Self-Perceived Health       
Excellent 67 (17.7) 15 (18.5) 16 (15.1) 18 (14.3) 4 (9.1) 
Very Good 156 (41.2) 26 (32.1) 43 (40.6) 42 (33.3) 18 (40.9) 
Good 106 (28.0) 25 (30.9) 34 (32.1) 48 (38.1) 15 (34.1) 
Fair 43 (11.4) 10 (12.4) 12 (11.3) 15 (11.9) 4 (9.1) 
Poor 7 (1.9) 5 (6.2) 1 (0.9) 3 (2.4) 3 (6.8) 
Chronic Medications      
Self, mean (SD) 2.4 (2.7) 2.8 (2.5) 3.3 (5.2) 2.7 (3.4) 4.5 (2.8) 
Care Recipients, mean(SD) 1.8 (2.8) 2.6 (4.5) 2.6 (5.6) 1.7 (2.5) 2.9 (3.9) 
I Know My Pharmacist’s 
Namec 
     
Yes 124 (32.7) 48 (59.3) 37 (35.2) 39 (31.0) 10 (22.7) 
No 165 (43.5) 21 (25.9) 42 (40.0) 68 (54.0) 19 (43.2) 
Unsure 39 (10.3) 10 (12.4) 12 (11.4) 8 (6.4) 7 (15.9) 
I do not interact with the same 
pharmacist regularly 
51 (13.5) 2 (2.5) 14 (13.3) 11 (8.7) 8 (18.2) 
Health Confidence      
Mean (SD) 8.6 (2.0) 8.1 (2.0) 8.6 (1.9) 8.4 (2.1) 8.9 (2.4) 
High (≥7) 326 (86.0) 63 (77.8) 93 (87.7) 104 (82.5) 38 (86.4) 
a p < 0.05; c p < 0.001  
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Table 11. Pharmacy Services Utilization by Current Pharmacy Patronage  
 
 
 
  Number (%), by current pharmacy patronage 
 
Number (%) Chain Independent Grocery 
Mass 
Merchandiser Mail Order 
Automatic Refilla 
 
429 (57.9) 229 (60.4) 37 (45.7) 69 (65.1) 63 (50.0) 28 (63.6) 
E-mail or Text Message 
Remindersa 
 
276 (37.2) 172 (45.4) 14 (17.3) 30 (28.3) 39 (31.0) 21 (47.7) 
Appointment-Based 
Medication 
Synchronizationa 
44 (5.9) 18 (4.8) 13 (16.1) 4 (3.8) 6 (4.8) 3 (6.8) 
Medication 
Synchronization 
42 (5.7) 17 (4.5) 6 (7.4) 6 (5.7) 10 (7.9) 
3 (6.8) 
Adherence Packaging 60 (8.1) 26 (6.9) 12 (14.8) 10 (9.4) 8 (6.4) 4 (9.1) 
Medication Therapy 
Management 
19 (2.6) 8 (2.1) 2 (2.5) 5 (4.7) 3 (2.4) 1 (2.3) 
Influenza Vaccine 198 (26.8) 101 (26.7) 18 (22.2) 30 (28.3) 33 (26.2) 15 (34.1) 
Non-Influenza Vaccine 57 (7.7) 37 (9.8) 2 (2.5) 6 (5.7) 7 (5.6) 4 (9.1) 
Prescription 
Compounding 
25 (3.4) 12 (3.2) 3 (3.7) 3 (2.8) 6 (4.8) 
1 (2.3) 
Home Deliverya 90 (12.2) 30 (7.9) 20 (24.7) 3 (2.8) 7 (5.6) 30 (68.2) 
Smartphone Appa 77 (10.4) 52 (13.7) 4 (4.9) 7 (6.6) 9 (7.1) 5 (11.4) 
a p < 0.05 
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Table 12. Characteristics of Those Who Failed the Dominant Scenario 
 
a p < 0.05 
Baseline Characteristics 
Failed Dominant 
Scenario, n (%) All Respondents, n (%) 
Male Sexa 29 (59.2) 325 (44.2) 
Age   
18-34 years 20 (40.8) 177 (24.0) 
35-44 years 10 (20.4) 164 (22.3) 
45-54 years 9 (18.4) 137 (18.6) 
55-64 years 7 (14.3) 169 (22.9) 
 ≥ 65 years 3 (6.1) 90 (12.2) 
Race   
Non-Hispanic, White 38 (79.2) 608 (83.1) 
Non-Hispanic, Black 2 (4.2) 54 (7.4) 
Hispanic 6 (12.5) 34 (4.6) 
Other 2 (4.2) 36 (4.9) 
Household Annual Income   
<$25,000 7 (14.3) 98 (13.3) 
$25,000-$49,999 12 (24.5) 176 (24.0) 
$50,000-$74,999 12 (25.5) 170 (23.1) 
$75,000-$99,999 10 (20.4) 132 (18.0) 
≥ $100,000 8 (16.3) 159 (21.6) 
Highest Level of Education   
Less Than High School/GED 1 (2.0) 9 (1.2) 
High School Degree 14 (28.6) 140 (19.1) 
At Least Some College 14 (28.6) 238 (32.4) 
Bachelor’s Degree 11 (22.5) 219 (29.8) 
At Least Some Post-Graduate 9 (18.4) 129 (17.6) 
Marital Status   
Never Married 12 (24.5) 161 (22.0) 
Married 33 (67.4) 463 (63.2) 
Separated/Divorced/Widowed 4 (8.2) 109 (14.9) 
Region of Residence   
Northeast 17 (35.4) 217 (29.5) 
Midwest 10 (20.8) 186 (25.3) 
South 12 (25.0) 250 (34.0) 
West 9 (18.8) 83 (11.3) 
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Table 12. Characteristics of Those Who Failed the Dominant Scenario, Continued 
a p < 0.05 
Baseline Characteristics 
Failed Dominant Scenario, 
n (%) Study Respondents, n (%) 
Urbanicitya   
Urban 22 (44.9) 184 (24.9) 
Suburban 21 (42.9) 348 (47.2) 
Small Town 4 (8.2) 79 (10.7) 
Rural 2 (4.1) 127 (17.2) 
Health Literacy   
Inadequate 5 (10.2) 45 (6.1) 
Self-Perceived Health    
Excellent 14 (28.6) 120 (16.3) 
Very Good 12 (24.5) 285 (38.6) 
Good 17 (34.7) 230 (31.2) 
Fair 5 (10.2) 84 (11.4) 
Poor 1 (2.0) 19 (2.6) 
No. of Chronic Medications   
Self, mean (SD) 2.77 (2.4) 2.74 (3.32) 
Care Recipients, mean(SD) 1.96 (2.2) 2.03 (3.56) 
Type of Pharmacy   
Chain 27 (55.1) 379 (51.5) 
Independent 7(14.3) 81 (11.0) 
Grocery 3 (6.1) 106 (14.4) 
Mass Merchandiser 11 (22.5) 126 (17.1) 
Mail Order 1 (2.0) 44 (6.0) 
I Know My Pharmacist’s Namea   
Yes 30 (61.2) 263 (35.5) 
No/Unsure/No Regular 
Pharmacist 
19 (38.8) 478 (64.5) 
Health Confidence   
Mean (SD)a 7.98 (2.7) 8.56 (2.0) 
High (≥7) 38 (77.6) 628 (84.8) 
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4.3 Main Model Results 
 The log likelihood for the conditional (CL) logit model was -3136.5, and the chi-
square value for the difference between the full and null model was 3999.5. At nine  
degrees of freedom, this value is statistically significant at a level of p < 0.001.  The utility 
values and attribute importance values from the main model are presented in Tables 13 
and 14, respectively. The preference estimates had the anticipated directions. Expanded 
hours, pharmacist effort to establish a patient-pharmacist relationship, and improved 
communication, quality, and friendliness were all significantly associated with increased 
utility.  
 Overall, study participants expressed the strongest preferences for quality-related 
pharmacy attributes. The attribute importance value (AIV) was highest for the specific, 
drug-drug interaction quality measure presented as, “Pharmacy ensured there were no 
patients who were dispensed two medications that can cause harm when taken together” 
(40.3). The overall pharmacy quality measure yielded the second-highest AIV (31.3). 
Patients, on average, expressed weaker preferences for pharmacy hours of operation (AIV: 
9.6), staff friendliness/courtesy (7.6), pharmacist communication (5.1), and pharmacist 
efforts to get to know them (6.1).  
 In addition to examining the direction of the model’s utility values and the 
proportion of participants selecting the dominant alternative, the validity of this discrete 
choice experiment was further assessed by analyzing the results of the fixed, holdout 
scenario. First, the individual utility values calculated through Sawtooth’s Hierarchical 
Bayes estimation function were used to predict responses to the holdout scenario.262 
Accurate predictions were made for 62.6% of participants. Then, the Sawooth Software 
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Market Research Tool (SMRT) was used to predict, on a group level, the proportion of 
participants expected to select each alternative in the fixed scenario. SMRT predicted that 
59.1% of participants would choose the first alternative; in practice, 65.3% of patients 
selected that alternative.   
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 Table 13. Main Model Results, Utility Values
Quality Dimension Attribute Levels Utility SE  
Access 
 
Pharmacy Hours of Operation 
8am-6pm Weekdays; 10am-3pm 
Saturday; Closed Sunday -0.23150 0.02600 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
0.08449 0.02635 
8am-10pm 7 days/week  0.14701 0.02685 
Courtesy Staff Friendliness/Courtesy Sometimes -0.15092 0.01613 
  Always 0.15092 0.01613 
Communication Pharmacist Communication Sometimes -0.10049 0.01631 
  Always 0.10049 0.01631 
Understanding/ 
Knowing the Customer 
The Pharmacist Makes an 
Effort to Get to Know Me 
No -0.12117 0.01618 
  Yes 0.12117 0.01618 
Competence Quality Measure, Overall  -0.65055 0.03323 
   0.06208 0.02623 
   0.58847 0.03264 
Safety Quality Measure, DDI  -0.82821 0.03385 
   0.06647 0.02619 
   0.76174 0.03317 
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Table 14. Main Model Results, Attribute Importance Values 
 
 
 
 
 
 
Quality Dimension Attribute Mean Importance Value Rank 
Access Pharmacy Hours of Operation 9.61 3 
Courtesy Staff Friendliness/Courtesy 7.61 4 
Communication Pharmacist Communication 5.09 6 
Knowing the Customer Pharmacist Makes an Effort to Get to Know Me 6.10 5 
Competence Quality Measure, Overall 31.34 2 
Safety Quality Measure, DDI 40.25 1 
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Figure 3. Main Model Attribute Importance Values 
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4.3. Subgroup Results 
Comparisons of the zero-centered Hierarchical Bayes individual utility estimates 
across demographic and health characteristics suggest that a number of these traits are 
associated with patient preferences for community pharmacy attributes.  The utility values 
and attribute importance values of demographic and health characteristic-based subgroups 
are presented in Tables 15-39.   
 The utility values of both the overall and drug-drug interaction (DDI)-specific 
quality metrics varied across several demographic subgroups. When utilities were 
compared by sex, women had higher utilities for five star ratings on the overall quality 
metric (83.0) and the drug-drug interaction (DDI)-specific metric (103.8) than their male 
counterparts (76.2 and 94.5, respectively).  The utility values ascribed to a five-star rating 
on the DDI metric were also higher among white, non-Hispanic respondents compared to 
those who identified as a member of an “other” race (101.1 vs. 69.5). Patients who 
indicated that they do not know their pharmacist’s name, were unsure, or reported that 
they did not regularly interact with the same pharmacist more strongly preferred a 5-star 
score on the DDI metric (100.8) than those who did know their pharmacist’s name 
(96.6).Finally, excellent (102.5) and very good health (106.7) were associated with 
stronger preferences for 5-star scores on the DDI metric than good (92.2), fair (90.5), and 
poor self-reported health (92.7), though only the difference between those with very good 
and good health was significant in pairwise comparisons.  
The utility values associated with pharmacists’ efforts to get to know their patients 
also varied significantly across different populations, including residence-, health status- 
and health literacy-based subgroups.  Rural (20.6) patients more strongly preferred this 
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attribute than those in suburban areas (14.1), and utility values were higher among those 
with inadequate health literacy (26.0) than for their higher literacy counterparts (16.3). 
The utility ascribed to pharmacist effort to establish a patient-pharmacist relationship was 
also higher in those who reported being in good health (19.9) compared to those with very 
good (13.6) health. However, the effect of self-perceived health status on strength of 
respondents’ preferences for this attribute was not consistent, as the utilities among those 
with excellent (18.3) and poor health (20.0) were not significantly different. 
 Few subgroup differences were seen in the utility ascribed to the 
friendliness/courtesy, communication, and hours of operation attributes. The utility values 
of friendliness/courtesy varied significantly only across residence-based subgroups, with 
rural and small town respondents expressing stronger preferences than their suburban 
and urban counterparts for friendliness and courtesy (small town: 23.7; urban: 16.4). The 
comparison of utilities by race revealed that white, non-Hispanic respondents had, on 
average, a lower utility value for pharmacist communication (13.6) than participants who 
identified as members of an “other” race (23.8).  Patients who knew their pharmacist’s 
name also assigned higher utility to pharmacist communication (16.7) than those without a 
patient-pharmacist relationship (13.4). Finally, only the number of chronic medications 
was associated with a difference in the strength of respondent preferences for the most 
extended pharmacy hours (“chain hours”; 8am-10pm 7 days/week). Those who reported 
that they or their direct care recipient take at least 11 different prescription medications 
were the only subgroups for whom the utility of the second most extensive hours (“grocery 
hours”; 9am-9pm Weekdays, 9am-7pm Saturday, 10am-6pm Sunday) was negative (-5.2 
and -0.47, respectively). Consequently, in increase in utility when moving from “grocery” to 
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“chain” hours was much larger among the highest medication users (>11 medications, 
32.0) than for those reporting use of fewer than 11 medications (8.5-19.5).  
Utility values did not significantly vary by age, income level, highest level of 
education attained, or level of health confidence. However, a number of trends were 
identified in the comparison of these subgroups. The importance of a patient-pharmacist 
relationship declined as education increased, decreasing from 25.4 and 19.9 for those with 
less than a high school education and a high school degree, respectively, to 14.1 and 15.8 
among those with a bachelor’s degree and at least some post-graduate education.  
Additionally, the utility value of the most extended pharmacy hours presented (“chain 
hours”; 8am-10pm 7 days/week) was 1.9 among those with less than a high school 
education, far lower than the 14.8-22.8 among those with higher levels of education. The 
utility of chain pharmacy hours was also higher among survey respondents in the 
Northeast (24.4) and West (26.3) than in the Midwest (19.9) and South (16.4).  
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Table 15. Subgroup Results, Utilities, by Sex  
 
 
Sex 
Male Female 
Attribute Levels Utility Utility 
Hours of Operation 
8am-6pm Weekdays; 10am-3pm 
Saturday; Closed Sunday 
-27.9 (48.8) -25.7 (47.0) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
5.7 (30.9) 7.2 (28.6) 
8am-10pm 7 days/week 22.2 (42.5) 18.6 (38.4) 
Friendliness/Courtesy 
Sometimes -19.7 (21.2) -19.2 (19.8) 
Always 19.7 (21.2) 19.2 (19.8) 
Communication 
Sometimes -15.4 (16.1) -13.8 (19.4) 
Always 15.4 (16.1) 13.8 (19.4) 
Pharmacist Knows Me 
No -16.0 (22.4) -17.6 (22.7) 
Yes 16.0 (22.4) 17.6 (22.7) 
Overall Quality 
 -88.2 (37.5) -93.3 (36.3) 
 12.0 (18.2) 10.3 (16.5) 
 a 76.2 (41.7) 83.0 (38.4) 
DDI Quality 
 -106.9 (64.8) -114.4 (54.1) 
 12.4 (17.3) 10.6 (14.9) 
 a 94.5 (64.0) 103.8 (51.0) 
a p < 0.05 
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Table 16. Subgroup Results, Utilities, by Urbanicity 
 
a p < 0.05 
 
Urbanicity 
Urban Suburban Small Town Rural 
Attribute Levels Utility Utility Utility Utility 
Hours of Operation 
8am-6pm Weekdays; 10am-3pm 
Saturday; Closed Sunday -23.2 (50.5) -27.8 (46.7) -29.0 (48.6) -27.6 (46.7) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
4.8 (29.0) 5.6 (28.4) 13.2 (34.1) 7.5 (30.3) 
8am-10pm 7 days/week 18.4 (41.8) 22.2 (41.0) 15.8 (41.8) 20.1 (35.2) 
Friendliness/Courtesy 
Sometimes -16.4 (22.1) -19.0 (18.4) -23.7 (20.3) -22.6 (22.8) 
Always a 16.4 (22.1) 19.0 (18.4) 23.7 (20.3) 22.6 (22.8) 
Communication 
Sometimes -16.1 (18.3) -13.3 (17.4) -14.1 (20.1) 15.6 (17.6) 
Always 16.1 (18.3) 13.3 (17.4) 14.1 (20.1) 15.6 (17.6) 
Pharmacist Knows Me 
No -17.9 (25.0) -14.1 (20.3) -20.6 (20.4) -20.6 (25.0) 
Yes 17.9 (25.0) 14.1 (20.3) 20.6 (20.4) 20.6 (25.0) 
Overall Quality 
 -89.9 (37.2) -91.1 (39.3) -89.9 (36.0) -92.4 (31.2) 
 11.3 (21.4) 11.1 (16.8) 9.4 (13.1) 11.3 (16.1) 
 78.6 (40.9) 80.0 (42.9) 80.5 (35.8) 81.2 (32.0) 
DDI Quality 
 -102.8 (67.8) -117.3 (55.0) -102.0 (62.6) -109.8 (57.4) 
 10.3 (17.1) 11.2 (16.0) 13.8 (14.4) 11.9 (16.1) 
 92.5 (64.7) 105.9 (52.8) 88.2 (63.6) 97.9 (55.3) 
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Table 17. Subgroup Results, Utilities, by Age 
 
Age 
Age 18-34 Age 35-44 Age 45-54 Age 55-64 Age ≥65 
Attribute Levels Utility Utility Utility Utility Utility 
Hours of Operation 
8am-6pm Weekdays; 
10am-3pm Saturday; 
Closed Sunday 
-26.6 (54.6) -28.3 (46.7) -22.3 (35.7) -24.7 (47.2) -35.1 (52.8) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
5.5 (29.9) 5.7 (29.0) 7.4 (29.2) 5.0 (29.1) 11.8 (31.6) 
8am-10pm 7 days/week  21.1 (45.8) 22.6 (37.4) 15.0 (34.5) 19.7 (40.1) 23.3 (43.0) 
Friendliness/Courtesy Sometimes -21.8 (25.1) -19.9 (18.9) -17.9 (20.0) -18.8 (16.8) -17.2 (19.5) 
 Always 21.8 (25.1) 19.9 (18.9) 17.9 (20.0) 18.8 (16.8) 17.2 (19.5) 
Communication Sometimes -14.3 (17.6) -17.2 (18.5) -13.3 (20.8) -12.4 (14.2) -15.9 (19.1) 
 Always 14.3 (17.6) 17.2 (18.5) 13.3 (20.8) 12.4 (14.2) 15.9 (19.1) 
Pharmacist Knows Me No -15.5 (21.3) -16.0 (21.9) -16.8 (22.6) -19.5 (24.7) -16.5 (22.0) 
 Yes 15.5 (21.3) 16.0 (21.9) 16.8 (22.6) 19.5 (24.7) 16.5 (22.0) 
Overall Quality  -88.9 (41.4) -89.0 (36.8) -96.9 (32.6) -92.5 (34.6) -87.5 (37.5) 
  10.7 (16.9) 13.2 (21.1) 11.9 (17.6) 8.9 (14.7) 11.0 (13.9) 
  78.2 (42.6) 75.8 (40.7) 85.0 (39.5) 83.6 (37.9) 76.5 (36.9) 
DDI Quality  -108.2 (59.0) -110.1 (61.6) -109.2 (62.3) -115.6 (54.7) -112.4 (58.6) 
  11.2 (16.8) 11.4 (15.7) 10.5 (17.3) 13.3 (14.7) 9.9 (15.8) 
  96.9 (56.2) 98.7 (61.7) 98.7 (59.4) 102.3 (54.3) 102.6 (54.0) 
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Table 18. Subgroup Results, Utilities, by Race  
a p < 0.05; c p < 0.001 
 
Race 
White, Non-
Hispanic 
Black, Non-
Hispanic Hispanic Other 
Attribute Levels Coeff. Coeff. Coeff. Coeff. 
Hours of Operation 
8am-6pm Weekdays; 10am-
3pm Saturday; Closed Sunday 
-28.4 (47.4) -28.5 (56.8) -10.0 (46.5) -13.8 (42.5) 
9am-9pm Weekdays; 
9am-7pm Saturday; 
10am-6pm Sunday 
7.6 (30.0) 2.3 (25.4) -0.4 (28.2) 2.8 (30.1) 
8am-10pm 7 days/week 20.8 (40.1) 26.3 (48.0) 10.4 (36.4) 10.9 (36.0) 
Friendliness/Courtesy 
Sometimes -18.9 (20.0) -20.7 (20.4) -26.7 (27.3) -20.3 (21.1) 
Always 18.9 (20.0) 20.7 (20.4) 26.7 (27.3) 20.3 (21.1) 
Communication 
Sometimes -13.6 (17.5) -17.0 (18.0) -18.2 (17.5) -23.8 (23.6) 
Always c 13.6 (17.5) 17.0 (18.0) 18.2 (17.5) 23.8 (23.6) 
Pharmacist Knows Me 
No -16.7 (22.6) -14.6 (19.7) -19.1 (11.8) -18.5 (29.7) 
Yes 16.7 (22.6) 14.6 (19.7) 19.1 (11.8) 18.5 (29.7) 
Overall Quality 
 -91.9 (35.5) -88.0 (38.2) -90.1 (44.5) -82.0 (49.2) 
 11.1 (17.2) 12.8 (15.7) 10.6 (15.8) 11.0 (21.7) 
 a 80.8 (38.0) 75.2 (43.7) 79.5 (43.9) 71.0 (59.6) 
DDI Quality 
 -112.7 (56.8) -110.7 (66.6) -111.2 (58.0) -80.7 (81.5) 
 11.6 (15.7) 10.2 (16.8) 9.6 (15.3) 11.2 (22.3) 
 101.1 (55.6) 100.6 (60.7) 101.6 (55.5) 69.5 (76.7) 
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Table 19. Subgroup Results, Utilities, by Annual Household Income 
 
 
 
 
Income 
<$25,000 
$25,000-
$49,999 
$50,000-
$74,999 
$75,000-
$99,999 ≥$100,000 
Attribute Levels Utility Utility Utility Utility Utility 
Hours of Operation 
8am-6pm Weekdays; 10am-
3pm Saturday; Closed Sunday 
-21.6 (57.4) -24.2 (43.8) -30.7 (45.5) -27.9 (50.8) -27.0 (44.6) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
3.5 (31.1) 5.6 (27.5) 9.9 (29.7) 2.4 (26.1) 8.8 (32.7) 
8am-10pm 7 days/week  18.1 (48.0) 18.6 (39.5) 20.8 (37.2) 25.5 (43.6) 18.2 (36.2) 
Friendliness/Courtesy 
Sometimes -22.6 (22.7) -19.7 (19.0) -18.0 (20.5) -20.7 (24.4) -17.5 (15.9) 
Always 22.6 (22.7) 19.7 (19.0) 18.0 (20.5) 20.7 (24.4) 17.5 (15.9) 
Communication 
Sometimes -14.3 (19.2) -16.0 (21.4) -12.8 (16.5) -15.6 (15.5) -14.0 (16.6) 
Always 14.3 (19.2) 16.0 (21.4) 12.8 (16.5) 15.6 (15.5) 14.0 (16.6) 
Pharmacist Knows Me 
No -16.6 (23.2) -19.6 (23.1) -17.5 (25.8) -16.6 (23.6) -13.6 (15.9) 
Yes 16.6 (23.2) 19.6 (23.1) 17.5 (25.8) 16.6 (23.6) 13.6 (15.9) 
Overall Quality 
 -89.8 (38.0) -90.7 (36.6) -92.1 (32.6) -87.4 (40.8) -94.3 (37.6) 
 11.8 (16.9) 10.5 (14.8) 13.5 (19.0) 8.9 (20.5) 10.8 (14.9) 
 78.0 (39.5) 80.2 (38.8) 78.7 (39.6) 78.5 (40.4) 83.5 (41.9) 
DDI Quality 
 -99.6 (65.2) -113.8 (56.0) -110.6 (59.3) -113.3 (55.9) -114.4 (60.5) 
 11.3 (19.3) 11.6 (16.1) 10.9 (16.3) 13.2 (13.6) 10.7 (15.4) 
 88.3 (63.4) 102.2 (54.7) 99.7 (56.0) 100.1 (57.3) 103.7 (57.5) 
 117 
 
Table 20. Subgroup Results, Utilities, by Education Level 
a p < 0.05 
 
Highest Level of Education Attained 
Less Than 
High School 
High School 
Degree Some College 
Bachelor’s 
Degree 
At Least Some 
Post-Graduate 
Attribute Levels Utility Utility Utility Utility Utility 
Hours of Operation 
8am-6pm Weekdays; 10am-
3pm Saturday; Closed Sunday 
-2.1 (78.3) -24.5 (46.8) -27.1 (50.1) -29.4 (49.7) -25.1 (37.0) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
0.2 (34.3) 9.7 (33.2) 4.3 (24.8) 6.2 (28.6) 7.9 (34.2) 
8am-10pm 7 days/week  1.9 (58.3) 14.8 (43.5) 22.7 (41.6) 23.2 (37.6) 17.2 (37.0) 
Friendliness/Courtesy 
Sometimes -12.8 (21.4) -20.2 (19.7) -21.4 (21.6) -18.9 (21.0) -16.8 (18.0) 
Always 12.8 (21.4) 20.2 (19.7) 21.4 (21.6) 18.9 (21.0) 16.8 (18.0) 
Communication 
Sometimes -26.7 (15.1) -12.2 (17.8) -15.0 (16.0) -14.4 (19.4) -15.8 (18.8) 
Always 26.7 (15.1) 12.2 (17.8) 15.0 (16.0) 14.4 (19.4) 15.8 (18.8) 
Pharmacist Knows Me 
No -25.4 (34.6) -19.9 (28.6) -17.8 (22.5) -14.2 (16.8) -15.8 (22.4) 
Yes a 25.4 (34.6) 19.9 (28.6) 17.8 (22.5) 14.2 (16.8) 15.8 (22.4) 
Overall Quality 
 -99.3 (46.6) -86.8 (38.3) -91.2 (33.9) -91.8 (36.8) -93.4 (40.0) 
 16.1 (13.4) 8.2 (18.3) 11.9 (17.2) 12.3 (17.1) 10.0 (18.5) 
 83.2 (42.8) 78.6 (40.4) 79.3 (37.3) 79.5 (41.0) 83.4 (41.9) 
DDI Quality 
 -78.0 (59.3) -104.7 (64.8) -111.2 (57.5) -117.3 (55.3) -108.1 (63.7) 
 6.5 (18.3) 11.6 (19.3) 11.2 (15.4) 12.4 (15.8) 10.0 (13.9) 
 71.5 (54.2) 93.1 (63.7) 100.0 (55.1) 105.0 (53.1) 98.1 (61.7) 
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Table 21. Subgroup Results, Utilities, by Marital Status 
 
 
Marital Status 
Never Married Married 
Separated/Divorced 
Widowed 
Attribute Levels Utility Utility Utility 
Hours of Operation 
8am-6pm Weekdays; 10am-3pm 
Saturday; Closed Sunday 
-25.0 (44.1) -28.7 (49.6) -22.2 (45.9) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
0.6 (24.8) 8.8 (31.8) 5.8 (25.5) 
8am-10pm 7 days/week  24.4 (41.1) 19.9 (40.3) 16.4 (39.1) 
Friendliness/Courtesy Sometimes -19.0 (20.7) -20.0 (21.5) -18.3 (15.4) 
 Always 19.0 (20.7) 20.0 (21.5) 18.3 (15.4) 
Communication Sometimes -14.9 (17.3) -14.4 (16.8) -14.5 (23.4) 
 Always 14.9 (17.3) 14.4 (16.8) 14.5 (23.4) 
Pharmacist Knows Me No -13.5 (17.4) -17.5 (23.1) -19.1 (26.4) 
 Yesa 13.5 (17.4) 17.5 (23.1) 19.1 (26.4) 
Overall Quality  -95.0 (33.7) -88.7 (38.0) -92.8 (37.8) 
  10.8 (14.3) 11.1 (18.4) 10.6 (19.1) 
  84.2 (35.3) 77.6 (41.4) 82.3 (40.2) 
DDI Quality  -117.2 (52.3) -108.7 (62.4) -109.4 (58.6) 
  12.9 (15.0) 10.5 (16.2) 13.3 (17.1) 
  104.3 (50.8) 98.2 (59.9) 96.1 (58.8) 
a p < 0.05 
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Table 22. Subgroup Results, Utilities, by Census Region of Residence 
 
 
US Census Region of Residence 
Northeast Midwest South West 
Attribute Levels Utility Utility Utility Utility 
Hours of Operation 
8am-6pm Weekdays; 10am-
3pm Saturday; Closed Sunday 
-27.2 (42.6) -29.5 (54.5) -24.2 (45.2) -27.9 (52.7) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sundayb 
9.9 (32.0) 8.2 (28.1) 4.3 (28.6) 1.7 (28.3) 
8am-10pm 7 days/week 17.3 (39.5) 21.2 (44.4) 19.9 (35.7) 26.3 (46.0) 
Friendliness/Courtesy Sometimes -20.2 (22.7) -19.1 (20.6) -19.0 (17.9) -18.6 (18.9) 
 Always 20.2 (22.7) 19.1 (20.6) 19.0 (17.9) 18.6 (18.9) 
Communication Sometimes -12.4 (17.3) -14.6 (18.6) -15.4 (18.3) -17.6 (17.0) 
 Alwaysa 12.4 (17.3) 14.6 (18.6) 15.4 (18.3) 17.6 (17.0) 
Pharmacist Knows Me No -18.8 (22.9) -16.0 (21.2) -15.1 (21.1) -19.0 (28.1) 
 Yes 18.8 (22.9) 16.0 (21.2) 15.1 (21.1) 19.0 (28.1) 
Overall Quality  -90.9 (37.9) -92.7 (35.3) -92.1 (35.6) -83.7 (42.8) 
  12.3 (17.5) 10.2 (16.3) 11.0 (17.3) 9.5 (21.4) 
  78.6 (40.7) 82.6 (38.0) 81.1 (38.0) 74.2 (47.6) 
DDI Quality  -110.4 (57.1) -109.3 (59.9) -113.9 (60.2) -104.6 (66.6) 
  11.4 (15.9) 11.1 (16.9) 11.5 (15.1) 11.5 (18.3) 
  99.1 (56.1) 98.2 (58.5) 102.4 (57.2) 93.1 (63.4) 
a p < 0.05; b p < 0.01 
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Table 23.  Subgroup Results, Utilities, by Health Literacy and Pharmacist Relationship 
 
Health Literacy Pharmacist Relationship 
Adequate 
Health Literacy 
Inadequate 
Health Literacy 
I Know My 
Pharmacist’s 
Name 
I Don’t Know My 
Pharmacist’s 
Name/Unsure/No 
Regular Pharmacist 
Attribute Levels Utility Utility Utility Utility 
Hours of Operation 
8am-6pm Weekdays; 10am-
3pm Saturday; Closed Sunday 
-26.5 (47.9) -31.4 (46.8) -25.8 (46.1) -27.2 (48.7) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
6.4 (29.5) 9.0 (30.8) 5.7 (29.0) 7.0 (29.8) 
8am-10pm 7 days/week  20.1 (40.6) 22.4 (36.5) 20.1 (38.1) 20.2 (41.5) 
Friendliness/Courtesy Sometimes -19.5 (20.4) -18.6 (21.3) -22.0 (20.9)a -18.1 (20.1)a 
 Always 19.5 (20.4) 18.6 (21.3) 22.0 (20.9)
a 18.1 (20.1)a 
Communication Sometimes -14.5 (17.7) -14.8 (22.0) -16.7 (20.0) -13.4 (16.7) 
 Always 14.5 (17.7) 14.8 (22.0) 16.7 (20.0) 13.4 (16.7) 
Pharmacist Knows Me No -16.3 (21.0)b -26.0 (38.5)b -18.5 (23.4)b -15.9 (22.0)b 
 Yes 16.3 (21.0)b 26.0 (38.5)b 18.5 (23.4)b 15.9 (22.0)b 
Overall Quality  -91.3 (36.7) -84.8 (43.4) -90.9 (36.1) -90.9 (37.7) 
  11.1 (17.5) 9.2 (18.5) 11.1 (18.9) 10.8 (16.9) 
  80.2 (39.4) 75.6 (48.3) 79.6 (37.8) 80.2 (41.1) 
DDI Quality  -111.1 (59.8) -103.1 (61.6) -107.4 (57.2) -112.5 (61.2) 
  11.2 (15.8) 13.6 (20.6) 10.8 (16.6) 11.7 (15.8) 
  99.9 (57.7) 89.5 (60.4) 96.6 (56.6) 100.8 (58.4) 
a p < 0.05; b p < 0.01 
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Table 24. Subgroup Results, Utilities, by Self-Perceived Health Status 
a p < 0.05 
 
 
Self-Perceived Health Status 
Excellent Very Good Good Fair Poor 
Attribute Levels Utility Utility Utility Utility Utility 
Hours of Operation 
8am-6pm Weekdays; 
10am-3pm Saturday; 
Closed Sunday 
-22.5 (43.0) -26.5 (47.5) -28.0 (46.1) -28.9 (59.4) -33.6 (47.4) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
4.9 (27.5) 4.7 (28.2) 9.7 (32.4) 5.5 (26.7) 11.8 (36.8) 
8am-10pm 7 days/week  17.6 (34.7) 21.8 (39.1) 18.2 (41.7) 23.5 (48.0) 21.8 (39.6) 
Friendliness/Courtesy Sometimes -20.0 (19.3) -18.3 (19.5) -21.2 (22.1) -18.5 (20.6) -17.4 (21.1) 
 Always 20.0 (19.3) 18.3 (19.5) 21.2 (22.1) 18.5 (20.6) 17.4 (21.1) 
Communication Sometimes -15.4 (18.3) -14.7 (18.4) -14.6 (17.9) -13.2 (16.8) -11.3 (15.7) 
 Always 15.4 (18.3) 14.7 (18.4) 14.6 (17.9) 13.2 (16.8) 11.3 (15.7) 
Pharmacist Knows Me No -18.4 (23.1) -13.6 (17.7) -19.9 (25.0) -16.8 (22.4) -20.0 (41.5) 
 Yes 18.4 (23.1) 13.6 (17.7) 19.9 (25.0) 16.8 (22.4) 20.0 (41.5) 
Overall Quality  -87.2 (37.5) -94.2 (34.6) -88.9 (39.4) -91.5 (38.7) -87.1 (34.7) 
  11.4 (17.3) 10.6 (18.7) 11.2 (17.3) 9.8 (14.4) 15.9 (20.1) 
  75.9 (41.7) 83.5 (37.8) 77.7 (41.4) 81.7 (39.0) 71.2 (44.7) 
DDI Quality  -113.3 (61.2) -117.6 (55.3) -103.9 (64.0) -102.2 (61.0) -109.2 (53.7) 
  10.7 (15.4) 11.0 (16.2) 11.7 (15.6) 11.7 (13.9) 16.5 (29.3) 
 a 102.5 (60.8) 106.7 (51.4) 92.2 (62.0) 90.5 (60.9) 92.7 (54.8) 
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Table 25. Subgroup Results, Utilities, by Number of Chronic Medications, Self 
 
 
 
Number of Chronic Medications, Self 
Zero 1-3 4-7 8-11 ≥11 
Attribute Levels Utility Utility Utility Utility Utility 
Hours of Operation 
8am-6pm Weekdays; 
10am-3pm Saturday; 
Closed Sunday 
-21.6 (53.3) -26.5 (46.1) -32.3 (49.2) -23.9 (54.4) -21.7 (24.3) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
3.7 (31.8) 6.2 (28.7) 11.9 (31.9) 2.2 (22.9) -5.2 (15.7) 
8am-10pm 7 days/week  18.0 (41.2) 20.3 (39.3) 20.4 (42.9) 21.7 (46.8) 26.8 (27.2) 
Friendliness/Courtesy Sometimes -20.7 (25.9) -18.7 (18.8) -20.3 (21.7) -20.9 (16.3) -21.9 (18.3) 
 Always 20.7 (25.9) 18.7 (18.8) 20.3 (21.7) 20.9 (16.3) 21.9 (18.3) 
Communication Sometimes -12.5 (18.9) -14.6 (18.0) -16.5 (18.9) -13.0 (10.3) -13.9 (11.7) 
 Always 12.5 (18.9) 14.6 (18.0) 16.5 (18.9) 13.0 (10.3) 13.9 (11.7) 
Pharmacist Knows Me No -14.6 (18.6) -16.7 (21.9) -19.8 (26.3) -18.0 (25.7) -6.6 (13.8) 
 Yes 14.6 (18.6) 16.7 (21.9) 19.8 (26.3) 18.0 (25.7) 6.6 (13.8) 
Overall Quality  -87.4 (41.6) -91.3 (36.6) -91.1 (36.7) -93.4 (34.1) -99.3 (29.5) 
  9.2 (21.2) 11.6 (17.8) 10.6 (14.9) 10.4 (17.8) 9.2 (8.9) 
  78.0 (44.6) 79.7 (40.4) 80.5 (36.4) 83.0 (39.0) 90.0 (29.4) 
DDI Quality  -107.0 (65.5) -113.9 (56.9) -101.5 (63.2) -109.5 (72.7) -133.7 (22.8) 
  7.8 (17.7) 12.2 (15.5) 10.9 (17.8) 13.1 (8.1) 13.6 (11.9) 
  99.2 (60.1) 101.7 (55.3) 90.6 (62.4) 96.4 (71.6) 120.1 (24.9) 
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Table 26. Subgroup Results, Utilities, by Number of Chronic Medications, Care Recipient 
a p < 0.05 
 
Number of Chronic Medications, Care Recipient 
Zero 1-3 4-7 8-11 ≥11 
Attribute Levels Utility Utility Utility Utility Utility 
Hours of Operation 
8am-6pm Weekdays; 
10am-3pm Saturday; 
Closed Sunday 
-32.3 (52.2) -23.1 (41.4) -26.4 (44.9) -20.5 (41.7) -12.8 (60.4) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
6.8 (30.8) 5.7 (28.4) 11.1 (30.4) 1.9 (21.3) -0.47 (27.4) 
8am-10pm 7 
days/week a 
25.5 (43.4) 17.4 (35.5) 15.2 (38.6) 18.6 (38.7) 13.3 (49.4) 
Friendliness/Courtesy Sometimes -18.6 (21.2) -20.5 (19.5) -19.8 (20.8) -18.9 (23.0) -19.1 (20.6) 
 Always 18.6 (21.2) 20.5 (19.5) 19.8 (20.8) 18.9 (23.0) 19.1 (20.6) 
Communication Sometimes -14.1 (16.1) -14.2 (18.9) -15.4 (17.7) -18.1 (22.1) -17.2 (23.7) 
 Always 14.1 (16.1) 14.2 (18.9) 15.4 (17.7) 18.1 (22.1) 17.2 (23.7) 
Pharmacist Knows Me No -15.8 (20.6) -18.3 (25.7) -17.1 (20.0) -15.2 (19.3) -14.4 (20.1) 
 Yes 15.8 (20.6) 18.3 (25.7) 17.1 (20.0) 15.2 (19.3) 14.4 (20.1) 
Overall Quality  -87.7 (39.1) -93.2 (34.4) -94.7 (36.1) -95.4 (38.9) -87.3 (41.3) 
  10.5 (17.4) 11.5 (19.5) 10.1 (13.9) 15.0 (17.9) 9.7 (13.3) 
  77.2 (41.3) 81.7 (39.1) 84.6 (36.1) 80.3 (44.1) 77.6 (42.3) 
DDI Quality  -115.4 (55.4) -107.9 (62.7) -107.4 (61.3) -114.1 (58.8) -100.1 (67.9) 
  11.1 (15.5) 12.4 (17.3) 9.2 (14.7) 11.8 (9.8) 11.1 (18.4) 
  104.3 (52.5) 95.4 (61.1) 98.3 (59.7) 102.3 (57.6) 89.0 (67.3) 
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Table 27. Subgroup Results, Utilities, by Pharmacy Patronage 
a p < 0.01 
 
 
Pharmacy Patronage 
Chain Independent Grocery 
Mass 
Merchandiser Mail Order 
Attribute Levels Utility Utility Utility Utility Utility 
Hours of Operation 
8am-6pm Weekdays; 
10am-3pm Saturday; 
Closed Sunday 
-31.4 (53.0) -19.1 (39.0) -25.1 (45.0) -21.5 (42.3) -21.4 (32.8) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
7.3 (30.0) 6.4 (31.0) 3.3 (25.1) 7.7 (32.9) 4.4 (23.6) 
8am-10pm 7 
days/weeka  
24.1 (42.5) 12.6 (34.8) 21.8 (38.6) 13.8 (39.3) 17.0 (34.7) 
Friendliness/Courtesy Sometimes -20.0 (22.2) -16.4 (23.1) -18.3 (16.7) -21.1 (17.8) -17.5 (14.0) 
 Always 20.0 (22.2) 16.4 (23.1) 18.3 (16.7) 21.1 (17.8) 17.5 (14.0) 
Communication Sometimes -13.6 (15.3) -15.7 (20.6) -13.9 (16.1) -17.2 (23.7) -15.8 (15.5) 
 Always 13.6 (15.3) 15.7 (20.6) 13.9 (16.1) 17.2 (23.7) 15.8 (15.5) 
Pharmacist Knows Me No -15.5 (22.3) -19.3 (25.0) -17.7 (20.7) -18.4 (21.8) -18.2 (25.8) 
 Yes 15.5 (22.3) 19.3 (25.0) 17.7 (20.7) 18.4 (21.8) 18.2 (25.8) 
Overall Quality  -89.2 (39.8) -98.5 (31.9) -91.3 (32.8) -89.7 (36.2) -96.6 (28.4) 
  a 10.8 (16.4) 17.0 (22.5) 9.5 (12.6) 10.3 (20.0) 9.3 (13.4) 
  78.3 (42.9) 81.6 (39.5) 81.8 (32.9) 79.4 (40.8) 87.3 (25.3) 
DDI Quality  -113.8 (52.8) -100.2 (62.6) -118.1 (59.7) -103.8 (69.2) -114.1 (64.9) 
  a 9.9 (15.9) 11.7 (17.2) 15.0 (16.0) 13.4 (17.4) 9.8 (8.8) 
  104.0 (48.8) 88.5 (60.6) 103.1 (63.3) 90.5 (67.0) 104.3 (64.0) 
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Table 28. Subgroup Results, Utilities, by Level of Health Confidence 
 
 
 
Health Confidence 
Low Health Confidence High Health Confidence 
Attribute Levels Utility Utility 
Hours of Operation 
8am-6pm Weekdays; 10am-3pm 
Saturday; Closed Sunday 
-24.8 (50.4) -27.1 (47.3) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
7.0 (28.7) 6.5 (29.7) 
8am-10pm 7 days/week  17.9 (41.7) 20.6 (40.0) 
Friendliness/Courtesy Sometimes -18.5 (21.5) -19.7 (20.3) 
 Always 18.5 (21.5) 19.7 (20.3) 
Communication Sometimes -13.8 (18.9) -14.7 (17.8) 
 Always 13.8 (18.9) 14.7 (17.8) 
Pharmacist Knows Me No -17.7 (30.9) -16.6 (20.7) 
 Yes 17.7 (30.9) 16.6 (20.7) 
Overall Quality  -88.8 (42.1) -91.3 (36.2) 
  12.6 (23.7) 10.6 (16.3) 
  76.2 (46.4) 80.7 (38.7) 
DDI Quality  -101.8 (65.3) -112.3 (58.7) 
  11.2 (20.9) 11.4 (15.1) 
  90.6 (58.8) 100.9 (57.5) 
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Table 29. Subgroup Results, Attribute Importance Values, by Sex  
 
 
 
 
 
 
 
 
 
Table 30. Subgroup Results, Attribute Importance Values, by Urbanicity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sex 
Male Female 
Attribute Mean (SD) Mean (SD) 
Hours of Operation 14.1 (12.7) 13.1 (11.9) 
Friendliness/Courtesy 7.3 (5.4) 6.9 (5.2) 
Communication 5.4 (4.3) 5.3 (5.2) 
Pharmacist Knows Me 6.1 (6.0) 6.1 (6.5) 
Overall Quality 29.2 (9.6) 30.6 (9.6) 
DDI Quality 38.0 (12.6) 38.1 (13.7) 
 
Urbanicity 
Urban Suburban Small Town Rural 
Attribute Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Hours of Operation 14.0 (12.0) 13.2 (12.5) 14.0 (12.8) 13.4 (11.7) 
Friendliness/Courtesy 7.0 (5.0) 6.7 (4.9) 7.8 (5.9) 7.8 (6.4) 
Communication 5.8 (4.7) 4.9 (4.8) 6.1 (4.5) 5.3 (5.0) 
Pharmacist Knows Meb 6.6 (6.8) 5.3 (5.6) 6.8 (6.1) 7.1 (7.1) 
Overall Quality 29.6 (10.0) 30.4 (9.6) 29.4 (9.8) 29.7 (9.0) 
DDI Qualitya 37.0 (13.7) 39.5 (12.2) 35.9 (13.1) 36.6 (14.7) 
a p < 0.05; b p < 0.01 
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Table 31. Subgroup Results, Attribute Importance Values, by Age 
 
 
 
 
 
 
 
 
 
 
 
 
a p < 0.05; b p < 0.01 
 
 
Table 32. Subgroup Results, Attribute Importance Values, by Race 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age 
Age 18-34 Age 35-54 Age 55-64 Age 65-74 Age ≥75 
Attribute Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Hours of Operation 14.5 (13.8) 13.7 (11.6) 12.4 (8.8) 12.8 (12.5) 14.7 (14.4) 
Friendliness/Courtesy 7.8 (7.0) 7.1 (4.8) 6.7 (5.0) 6.6 (4.3) 6.9 (4.3) 
Communication 5.4 (4.5) 5.6 (5.3) 5.1 (5.8) 4.9 (3.2) 5.6 (5.3) 
Pharmacist Knows Meb 5.9 (5.6) 6.0 (5.8) 6.0 (6.4) 6.5 (7.3) 6.1 (6.1) 
Overall Quality 29.5 (10.4) 29.3 (9.7) 31.7 (8.5) 30.4 (9.6) 28.8 (9.3) 
DDI Qualitya 36.9 (13.7) 38.3 (13.1) 38.0 (13.3) 38.8 (12.3) 37.9 (14.0) 
 
Race 
White, Non-
Hispanic 
Black, Non-
Hispanic Hispanic Other 
Attribute Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Hours of Operation 13.7 (12.4) 14.3 (14.7) 11.4 (11.0) 13.1 (8.5) 
Friendliness/Courtesy 7.0 (5.1) 6.8 (5.9) 8.7 (8.5) 7.5 (5.0) 
Communicationa 5.1 (4.6) 5.6 (5.0) 6.0 (5.0) 7.6 (6.9) 
Pharmacist Knows Me 6.0 (6.3) 5.2 (5.4) 6.0 (3.6) 7.7 (7.7) 
Overall Quality 30.1 (9.5) 29.0 (10.1) 30.4 (10.1) 29.4 (10.6) 
DDI Quality 38.1 (13.3) 39.0 (12.9) 37.6 (13.9) 34.7 (11.7) 
a p < 0.05 
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Table 33.  Subgroup Results, Attribute Importance Values, by Household Income 
 
 
 
 
 
 
 
 
 
 
Table 34. Subgroup Results, Attribute Importance Values, by Education Level 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Highest Level of Education Attained 
Less Than 
High School 
High School 
Degree Some College 
Bachelor’s 
Degree 
At Least Some 
Post-Graduate 
Attribute Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Hours of Operation 19.4 (14.0) 14.2 (11.9) 13.7 (12.6) 13.2 (12.9) 12.7 (10.7) 
Friendliness/Courtesy 6.8 (3.0) 7.1 (5.1) 7.4 (6.1) 7.1 (5.4) 6.6 (3.8) 
Communication 8.2 (4.6) 5.2 (4.1) 5.2 (4.4) 5.3 (5.4) 5.6 (5.2) 
Pharmacist Knows Mea 7.9 (10.9) 7.1 (8.2) 6.5 (6.1) 5.1 (4.6) 5.9 (6.2) 
Overall Quality 31.1 (12.8) 29.3 (9.3) 29.6 (9.6) 30.1 (9.6) 31.1 (9.8) 
DDI Quality 26.6 (16.6) 37.2 (13.5) 37.7 (13.1) 39.2 (12.9) 38.1 (13.0) 
a p < 0.05 
 
 
Annual Household Income 
≤25,000 
$25,001-
$50,000 
$50,001-
$100,000 
$100,001-
$150,000 >$150,000 
Attribute Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Hours of Operation 15.4 (13.2) 12.9 (11.2) 13.6 (12.0) 13.8 (13.3) 12.8 (12.0) 
Friendliness/Courtesy 7.7 (6.4) 6.8 (5.3) 7.1 (4.7) 7.7 (6.6) 6.4 (3.7) 
Communication 5.8 (4.5) 5.6 (6.2) 5.0 (4.0) 5.2 (4.4) 5.1 (4.3) 
Pharmacist Knows Me 6.2 (6.3) 6.5 (6.8) 6.7 (7.0) 6.1 (6.6) 4.9 (4.3) 
Overall Quality 29.3 (10.2) 30.0 (8.8) 30.0 (9.3) 29.0 (11.0) 31.2 (9.3) 
DDI Quality 35.6 (13.6) 38.2 (13.7) 37.6 (13.4) 38.2 (13.2) 39.6 (11.9) 
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Table 35. Subgroup Results, Attribute Importance Values, by Marital Status 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 36. Subgroup Results, Attribute Importance Values, by US Census Region of Residence 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
US Census Region of Residence 
Northeast Midwest South West 
Attribute Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Hours of Operation 13.7 (11.3) 14.2 (14.0) 12.7 (11.1) 14.1 (14.2) 
Friendliness/Courtesy 7.4 (6.0) 6.9 (5.4) 6.8 (4.4) 6.9 (4.6) 
Communication 5.0 (4.3) 5.4 (4.9) 5.3 (5.2) 5.9 (4.7) 
Pharmacist Knows Me 6.5 (6.6) 5.6 (6.1) 5.8 (5.5) 7.2 (7.9) 
Overall Quality 29.7 (10.2) 30.3 (9.6) 30.4 (8.9) 28.9 (10.1) 
DDI Quality 37.8 (12.5) 37.5 (13.8) 39.0 (12.9) 36.9 (14.5) 
 
 
Marital Status 
Never Married Married 
Separated/Divorced/
Widowed 
Attribute Mean (SD) Mean (SD) Mean (SD) 
Hours of Operation 13.2 (11.4) 13.8 (13.0) 13.3 (10.5) 
Friendliness/Courtesy 6.8 (5.5) 7.4 (5.5) 6.2 (4.2) 
Communication 5.3 (4.6) 5.3 (4.4) 5.7 (6.5) 
Pharmacist Knows Me 5.1 (4.5) 6.3 (6.5) 6.7 (7.6) 
Overall Quality 30.7 (9.5) 29.5 (9.6) 30.6 (9.6) 
DDI Quality 38.9 (12.5) 37.8 (13.5) 37.5 (12.7) 
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Table 37. Subgroup Results, Attribute Importance Values, by Health Literacy and Pharmacist Relationship 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 38. Subgroup Results, Attribute Importance Values, by Self-Perceived Health Status
 
 Health Literacy Pharmacist Relationship 
 Adequate  Inadequate  
I Know My 
Pharmacist’s 
Name 
I Don’t Know My 
Pharmacist’s 
Name/Unsure/No Regular 
Pharmacist 
Attribute Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Hours of Operation 13.5 (12.3)b 14.1 (12.0)b 13.6 (11.2) 13.5 (12.8) 
Friendliness/Courtesy 7.1 (5.3) 6.9 (5.5) 7.7 (5.6) 6.8 (5.2) 
Communication 5.2 (4.8) 6.5 (5.0) 5.8 (5.7) 5.1 (4.2) 
Pharmacist Knows Me 5.9 (5.7) 8.7 (11.6) 6.7 (6.4) 5.7 (6.2) 
Overall Quality 30.0 (9.6) 29.2 (10.1) 29.8 (9.8) 30.1 (9.5) 
DDI Quality 38.2 (12.9) 34.6 (16.4) 36.4 (13.9) 38.9 (12.7)b 
b p < 0.01 
 Health Literacy Pharmacist Relationship 
 
Self-Perceived Health Status 
Excellent Very Good Good Fair Poor 
Attribute Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Hours of Operation 12.8 (9.9) 12.6 (12.8) 13.8 (12.4) 16.5 (13.2) 16.5 (11.0) 
Friendliness/Courtesy 7.2 (4.9) 6.7 (5.0) 7.6 (5.9) 6.7 (5.5) 6.8 (4.8) 
Communication 5.3 (5.2) 5.3 (5.1) 5.5 (4.6) 5.2 (4.1) 4.8 (3.3) 
Pharmacist Knows Meb 6.5 (6.4) 5.0 (4.8) 7.0 (7.1) 6.4 (5.9) 7.7 (11.7) 
Overall Quality 29.0 (9.7) 30.8 (9.3) 29.6 (9.8) 30.0 (10.0) 28.4 (9.5) 
DDI Qualitya 39.2 (12.7) 39.5 (12.7) 36.6 (13.4) 35.3 (14.0) 35.7 (15.0) 
a p < 0.05;  b p < 0.01 
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Table 39. Subgroup Results, Attribute Importance Values, by Number of Chronic Medications, Self 
 
 
 
Table 40. Subgroup Results, Attribute Importance Values, by Number of Chronic Medications, Care Recipient(s) 
 
Number of Chronic Medications, Care Recipient(s) 
None 1-3 4-7 8-11 ≥11 
Attribute Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Hours of Operation 14.3 (14.1) 12.7 (10.1) 13.3 (11.7) 10.7 (11.4) 15.4 (13.0) 
Friendliness/Courtesy 6.9 (5.6) 7.3 (5.0) 7.0 (5.6) 7.6 (5.5) 7.3 (4.8) 
Communication 5.2 (4.1) 5.2 (5.3) 5.7 (4.4) 6.1 (6.2) 6.3 (6.5) 
Pharmacist Knows Me 5.7 (5.7) 6.6 (7.3) 5.9 (5.8) 6.1 (4.6) 5.7 (5.1) 
Overall Quality 29.2 (9.8) 30.6 (9.1) 30.6 (10.2) 31.1 (10.8) 29.2 (9.8) 
DDI Quality 38.8 (13.0) 37.6 (13.3) 37.4 (13.2) 38.4 (14.2) 36.1 (14.0) 
 
 
Number of Chronic Medications, Self 
None 1-3 4-7 8-11 ≥11 
Attribute Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Hours of Operation 14.0 (12.6) 13.1 (12.0) 14.7 (13.0) 13.0 (14.4) 11.0 (6.1) 
Friendliness/Courtesy 7.7 (6.8) 6.8 (4.8) 7.4 (5.7) 6.9 (4.8) 7.0 (5.5) 
Communication 5.3 (4.4) 5.3 (5.0) 5.8 (5.0) 4.3 (2.9) 4.3 (3.6) 
Pharmacist Knows Me 5.5 (4.8) 6.1 (6.0) 6.9 (7.6) 5.8 (8.2) 3.6 (3.0) 
Overall Quality 29.4 (10.3) 30.2 (9.2) 29.6 (10.2) 30.4 (9.6) 31.6 (9.3) 
DDI Quality 38.0 (13.2) 38.5 (12.9) 35.6 (14.2) 39.6 (13.2) 42.4 (7.1) 
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Table 41. Subgroup Results, Attribute Importance Values, by Pharmacy Patronage 
 
b p < 0.01 
 
 
Table 42. Subgroup Results, Attribute Importance Values, by Health Confidence 
 
 
Pharmacy Patronage 
Chain Independent Grocery 
Mass 
Merchandiser Mail Order 
Attribute Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Hours of Operation 14.6 (13.6) 12.7 (9.1) 12.5 (11.9) 12.8 (11.1) 11.4 (8.8) 
Friendliness/Courtesy 7.2 (6.0) 7.1 (5.2) 6.4 (4.3) 7.4 (4.5) 6.2 (3.3) 
Communicationb 4.9 (4.0) 6.1 (5.2) 4.8 (4.5) 6.5 (6.4) 4.9 (4.7) 
Pharmacist Knows Me 5.8 (6.2) 7.3 (6.5) 6.2 (5.8) 6.3 (6.2) 6.2 (7.7) 
Overall Quality 29.6 (10.4) 31.6 (8.5) 29.8 (8.4) 29.8 (9.3) 31.2 (8.3) 
DDI Quality 38.0 (12.9) 35.2 (13.7) 40.3 (12.5) 37.2 (14.3) 40.0 (12.5) 
 
Health Confidence 
Low Health Confidence High Health Confidence 
Attribute Mean (SD) Mean (SD) 
Hours of Operation 14.4 (11.9) 13.4 (12.3) 
Friendliness/Courtesy 7.0 (5.4) 7.1 (5.3) 
Communication 5.4 (4.7) 5.3 (4.8) 
Pharmacist Knows Mea 7.3 (8.2) 5.9 (5.8) 
Overall Quality 30.0 (9.9) 30.0 (9.6) 
DDI Quality 35.9 (13.5) 38.4 (13.1) 
a p < 0.05 
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4.4. Segmentation Analysis Results 
The Consistent Aikaike Information Criterion (CAIC) values were compared 
between latent class solutions with two to five groups. The CAIC was lower for the three-
class solution (5698.589) than for the solutions with two (5706.163), four (5741.502), and 
five solutions (5806.839). All of these CAIC values were lower than that of the CL analysis 
(6362.10), suggesting that respondent preferences for community pharmacy attributes 
were indeed heterogeneous. The three-class solution, selected based on its CAIC value, 
converged after 39 iterations. Furthermore, the average maximum membership probability 
of the three-class solution was 0.9445, similar to that of the two class (0.9460), and higher 
than that of the four (0.8092) and five (0.7596) class solutions.  
The utility values for each of the three identified classes are presented in Table 40.  
Based on the revealed preferences of the respondents in each class, the three classes were 
termed the “Quality Class,” the “Relationship Class,” and the “Convenience Class.” The 
probability of respondents belonging to the Quality Class was highest (67.6%), followed by 
the Relationship Class (28.3%), and the Convenience Class (4.2%). The attribute 
importance values (AIV)and relative importance of each attribute within each class are 
presented in Table 41 and Figures 4-5.  
The Quality Class was defined primarily by strong expressed preferences for the DDI 
(utility: 129.9, AIV: 45.5) and the overall (mean utility: 95.0, mean AIV: 33.3) quality 
measures. Differences in these two attributes combined could therefore account for nearly 
80% of the difference in the utility of two pharmacy alternatives.  The mean AIV of hours of 
operation, the third most strongly preferred attribute among members of the Quality Class), 
was only 7.9. In the Relationship Class, the quality measures were still the most strongly 
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preferred attributes, with AIVs of 24.7 for overall quality and 22.6 for DDI-specific quality. 
Notably, although these quality attributes were the most important attributes relative to 
the other attributes, they accounted for only 48% of the difference in the utility of two 
pharmacy alternatives, compared to the 78% seen in the Quality Class. The AIVs for 
friendliness/courtesy, communication, and pharmacist effort to get to know their patients 
(10.8, 9.0, and 11.5, respectively) were two to three times as high as those seen in the 
Convenience and Quality Classes.  Finally, the smallest class, the convenience class, was 
distinct in its high utility ascribed to the pharmacy hours of operation, for which the AIV 
exceeded 50% (50.3). In that class, the quality metrics accounted for only a third of utility 
differences (33.7).   
Significant differences in utility values were seen between at least two of the groups 
for all six attributes. The utilities of pharmacist effort to get to know their patients and 
friendliness/courtesy were significantly higher in the Relationship Class than the other two 
segments. The Quality Class significantly differed from the other two class in having a 
lower utility associated with pharmacist communication and higher utilities ascribed to 
five star ratings on either quality metric. Finally, the differences in the utility values for the 
most extended pharmacy hours were significant in the pairwise comparisons between the 
Convenience Class and the other two classes.  
Though the four-class solution was not selected due to its higher CAIC and lower 
maximum membership probability compared to the three-class solution, the difference 
between the solutions is of interest. The four-class solution resulted in similar probabilities 
of membership in a Relationship Class (26.4%), Service Class (3.9%), or Quality-Focused 
Class (69.7%); the difference between the three and four group solutions was that the 
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Quality Class seen in the three-class solution was separated in the four-class solution into a 
Drug-Drug Interaction (DDI) -Specific Quality Class (37.0%) and an Overall Quality Class 
(32.7%).  In the Drug-Drug Interaction (DDI) -Specific Quality Class, the attribute 
importance value for the DDI quality measure was much higher (53.9) than that for the 
Overall quality measure (16.0). The strength of these preferences was reversed (26.7 vs. 
51.0) in the Overall Quality Class. While this was a weaker class solution than that with 
three classes, it still suggests that underlying preference heterogeneity may exist within the 
Quality Class.  
Among the demographic and health characteristics gathered, only knowing one’s 
pharmacist’s name was significantly associated with class membership (Table 42), with 
those assigned to the Relationship Class were more likely to know their pharmacist’s name 
(42.9) than those in the Convenience (29.0) or Quality (32.67) Classes (p = 0.026). The 
ability to detect additional, significant demographic differences between segments was 
likely limited by the small size of the Convenience Class. Though not significant, members 
of the Relationship Class tended to be more urban (31.58% vs. 25.8% and 22.0% in the 
Convenience and Quality Classes, respectively) (p = 0.051) and less confident in their 
ability to manage their health conditions (prevalence of low health confidence: 20% vs. 
12.9% and 13.4%) (p = 0.074) than those in other segments. Additionally, women 
comprised 59.0% of those in the Quality Class but only 48.4% and 49.8% in the 
Convenience and Relationship Classes, respectively (p = 0.054).  
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Table 43. Main Latent Class Analysis Results, Utilities, by Segment  
 
 
 
 
Rescaled Utilities (Standard Error) 
Segment 1 Segment 2 Segment 3 
Attribute Levels Relationship Class Convenience Class Quality Class 
Hours of Operation 
8am-6pm Weekdays; 10am-3pm 
Saturday; Closed Sunday 
-47.75 (10.68) -206.85 (40.99) -15.65 (4.15) 
9am-9pm Weekdays;  
9am-7pm Saturday;  
10am-6pm Sunday  
43.25 (10.69) 34.79 (11.63) -2.42 (4.31) 
8am-10pm 7 days/week  4.50 (10.74) 172.06 (36.14) 18.06 (4.15) 
Friendliness/Courtesy Sometimes -39.27(6.58) 0.40 (8.07) -15.18 (2.49) 
 Always 39.27 (6.58) -0.40 (8.07) 15.18 (2.49) 
Communication Sometimes -35.85 (6.56) -11.60 (7.34) -11.09 (2.70) 
 Always 35.85 (6.56) 11.60 (7.34) 11.09 (2.70) 
Pharmacist Knows Me No -49.14 (6.57) -13.71 (6.91) -11.63 (2.53) 
 Yes 49.14 (6.57) 13.71 (6.91) 11.63 (2.53) 
Overall Quality  -101.36 (14.48) -54.50 (24.21) -113.00 (5.83) 
  20.37 (10.74) -14.70 (13.30) 17.37 (4.80) 
  80.99 (14.53) 69.20 (28.82) 95.63 (4.69) 
DDI Quality  -41.69 (14.34) -19.04 (16.05) -150.93 (5.13) 
  5.24 (11.04) -7.90 (12.07) 20.00 (4.81) 
  36.44 (14.14) 26.94 (16.84) 130.93 (5.13) 
 137 
0
10
20
30
40
50
60
70
Relationship Class Convenience Class Quality Class
Table 44. Latent Class Analysis Results, Attribute Importance Values, by Segment  
 
 
 
Figure 4. Latent Class Analysis Results, Attribute Importance Scores, by Segment 
  
 
 
 
 
 
 
 Segment 1 Segment 2 Segment 3 
 Relationship Class Convenience Class Quality Class 
Attribute Rank Mean  Rank Mean  Rank Mean  
Hours of Operation 2 15.17 1 63.15 3 5.62 
Friendliness/Courtesy 4 13.09 6 0.13 4 5.06 
Communication 6 11.95 5 3.87 6 3.70 
Pharmacist Knows Me 3 16.38 4 4.57 5 3.88 
Overall Quality 1 30.39 2 20.62 2 34.77 
DDI Quality 5 13.02 3 7.66 1 46.98 
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Figure 5. Latent Class Analysis Results, Attribute Importance Scores, by Segment 
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Table 45. Sociodemographic and Health Characteristics, by Segment 
 
 
Number (%), by Segment 
Relationship 
Class 
Convenience 
Class Quality Class 
Size 210 (28.3) 31 (4.2) 500 (67.5) 
Sociodemographic and Health Characteristics 
Male Sex 104 (50.2) 16 (51.6) 205 (41.2) 
Age    
18-34 years 48 (23.1) 10 (32.3) 119 (23.9) 
35-44 years 52 (25.0) 4 (12.9) 108 (21.7) 
45-54 years 41 (19.7) 2 (6.5) 94 (18.9) 
55-64 years 44 (21.2) 9 (29.0) 116 (23.3) 
≥ 65 years 23 (11.1) 6 (19.4) 61 (12.3) 
Race    
Non-Hispanic, White 166 (80.2) 27 (87.1) 415 (84.0) 
Non-Hispanic, Black 14 (6.8) 3 (9.7) 37 (7.5) 
Hispanic 11 (5.3) 1 (3.2) 22 (4.5) 
Other 16 (7.7) 0 (0) 20 (4.1) 
Household Annual Income    
<$25,000 39 (18.9) 4 (12.9) 55 (11.0) 
$25,000-$49,999 43 (20.9) 6 (19.4) 127 (25.5) 
$50,000-$74,999 49(23.8) 7 (22.6) 114 (22.9) 
$75,000-$99,999 36 (17.5) 9 (29.0) 87 (17.5) 
≥$100,0009 39 (18.9) 6 (16.1) 115 (23.1) 
Highest Level of Education    
Less Than High School/GED 4 (1.9) 1 (3.2) 4 (0.8) 
High School Degree 47 (22.6) 5 (16.1) 88 (17.7) 
At Least Some College 69 (33.2) 13 (41.9) 156 (31.5) 
Bachelor’s Degree 50 (24.0) 8 (25.8) 161 (32.5) 
At Least Some Graduate School 38 (18.3) 4 (12.9) 87 (17.5) 
Marital Status    
Never Married 38 (18.3) 6 (19.4) 117 (23.7) 
Married 135 (64.9) 23 (74.2) 305 (61.7) 
Separated/Divorced/Widowed 35 (16.8) 2 (6.5) 72 (14.6) 
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Table 45. Sociodemographic and Health Characteristics, by Segment, continued 
a p < 0.05 
 
Number (%), by Segment 
Relationship 
Class 
Convenience 
Class Quality Class 
US Census Region of Residence    
Northeast 66 (31.7) 7 (22.6) 144 (29.0) 
Midwest 48 (23.1) 11 (35.5) 127 (25.6) 
South 66 (31.7) 8 (25.8) 176 (35.4) 
West 28 (13.5) 5 (16.1) 50 (10.1) 
Urbanicity    
Urban 66 (31.6) 8 (25.8) 110 (22.1) 
Suburban 79 (37.8) 14 (45.2) 255 (51.2) 
Small Town 26 (12.4) 4 (12.9) 49 (9.8) 
Rural 38 (18.2) 5 (16.1) 84 (16.9) 
Health Literacy    
Adequate 193 (92.3) 30 (96.8) 470 (94.4) 
Self-Perceived Health Status    
Excellent 31 (14.8) 5 (16.1) 84 (16.9) 
Very Good 66 (31.6) 11 (35.5) 208 (41.8) 
Good 76 (36.4) 11 (35.5) 143 (28.7) 
Fair 29 (13.9) 3 (9.7) 52 (10.4) 
Poor 7 (3.4) 1 (3.2) 11 (2.2) 
Number of Chronic Medications, Self  2.7 (2.3) 2.5 (2.1) 2.8 (3.7) 
Number of Chronic Medications, Care 
Recipients 
2.2 (3.5) 1.7 (2.9) 2.0 (3.6) 
Type of Pharmacy    
Chain 102 (49.3) 22 (71.0) 255 (51.2) 
Independent 29 (14.0) 2 (6.5) 50 (10.0) 
Grocery 29(14.0) 3 (9.7) 74 (14.9) 
Mass Merchandiser 38 (18.4) 2 (6.5) 86 (17.3) 
Mail Order 9 (4.4) 2 (6.5) 33 (6.6) 
I Know My Pharmacist’s Name    
Yesa 90 (42.9) 9 (29.0) 164 (32.8) 
Health Confidence    
Mean (SD) 8.3 (2.3) 8.8 (2.2) 8.6 (1.9) 
High (≥7) 168 (80.0) 27 (87.1) 433 (86.6) 
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Chapter 5: Discussion 
5.1 Survey Responses and National Representativeness 
The Qualtrics Panel Study Population 
The demographics and health characteristics of the sample yielded by the Qualtrics 
survey panel for this study are relevant to an ongoing discussion about the use of easily and 
inexpensively accessible online study panels for research purposes. Opt-out study panels 
generated through random sampling may provide nationally representative samples but, at 
a cost of up to ten times that of opt-in panels, are often cost prohibitive for academic 
researchers. Comparisons between the participants in this survey and the US population as 
a whole may provide insights that inform the use of opt-in panels for healthcare research.  
Compared to the US population, the respondents of this survey were more 
commonly female, middle-aged, and residents of the Northeast. Participants also reported, 
on average, higher levels of education and annual household income than the US 
population as a whole. Furthermore, the prevalence of inadequate health literacy in the 
study population, 6.1%, was considerably lower than the pooled estimate of a 26% 
prevalence of limited health literacy in the US.263 Older age, black race, and lower levels of 
education are strongly associated with low health literacy, suggesting that the 
demographics of the study population likely played a significant role in the low level of 
inadequate health literacy observed in this survey. 263 However, the distribution of self-
reported health status264 and the proportions of respondents patronizing chain and 
independent pharmacies265 were similar to reports from nationally representative samples. 
Finally, the proportion of participants who reported any use of a chronic medication 
(85.1%) exceeded that reported in a study of nationally representative data from the 
 142 
National Health and Nutrition Examination Study (NHANES) (59%)250 and in an analysis of 
population-based drug prescription records in Minnesota (68%).266 This difference is likely 
a function of the screening question used in this study, “Have you filled a prescription at a 
pharmacy, other than a mail-order pharmacy, within the last 12 months,” which likely 
screened out many of the lowest drug utilizers.  The prevalence of polypharmacy, as 
defined by the use of at least 5 prescription drugs, in this study (19.3%) was consistent 
with that in the NHANES (15%)250 and Minnesota studies (21.2%). 266  
The generalizability and external validity of results obtained by opt-in and 
crowdsourced panels, particularly relative to nationally representative panels, have been 
explored by researchers in numerous social science fields. A group of researchers 
compared the average treatment effects of 20 social science experiments that were 
conducted twice, once among a nationally representative GfK sample and again with 
Amazon’s MTurk participants.267 They reported that the treatment effects in the two 
populations showed “considerable similarity.”267 Participants of MTurk or other opt-in 
panels have also responded similarly to those recruited through nationally representative 
samples or in-person convenience samples in other sociology,268,269 psychology270–272, and 
political science273 studies. However, several studies of internet behavior274 and political 
preferences275,276 have reported divergence between MTurk and census-representative 
web panel participants.  
Studies comparing the health beliefs, behaviors, and preferences reported by opt-in 
panel samples to those of nationally representative samples are much more limited. While 
this study does not compare the preferences of multiple samples, it does report the health 
characteristics, including chronic medication use, pharmacy patronage, and health literacy 
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and confidence, of an opt-in Qualtrics panel. The distribution of most health characteristics 
surveyed closely mirrored patterns obtained in nationally representative studies, though 
the low prevalence of health literacy among panel participants was notable. Together, these 
findings suggest that the Qualtrics panel may be a relatively inexpensive method for 
recruiting a study panel with nationally representative patterns of self-reported health, 
pharmacy patronage, and medication use. However, research into the complex causes and 
effects of health literacy277 may require a different source of study participants or the use 
of more restrictive inclusion criteria and quotas. Future research comparing the 
community pharmacy preferences of this or other opt-in survey panel participants (e.g. 
MTurk) to nationally representative samples could further inform the generalizability and 
validity of using these samples for pharmacy research.   
 
The Quality of Survey Responses 
 
The quality of the survey responses, as assessed by average time per task, the 
proportion of participants failing the dominant scenario, and the number of respondents 
always selecting the left or right alternatives, was acceptable and consistent with 
previously reported findings. Two studies assessing choice behavior in discrete choice 
experiments reported that 0.0%-13.3% of participants in a series of experiments always 
selected a right or left alternative, consistent with the 0.2%-1.3% reported in this 
study.199,201 Additionally, the median response time per choice task was consistent with 
those reported in the literature.278–280 The proportion of patients failing the dominant 
scenario, 5.6%, was consistent with the 5%-10%154,281–284 commonly reported in 
healthcare-related discrete choice experiments. The current ISPOR guidelines for conjoint 
analysis applications in health do not recommend a specific mode of administration for 
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DCEs,166but the use of computers for DCE administration has increased substantially over 
the last 20 years.213 The high quality of survey responses gathered in this study provides 
evidence supporting the acceptability of online survey administration for DCEs. 
 
5.2 Demographics and Service Utilization by Current Pharmacy Patronage 
 The demographic and health characteristics of respondents varied between patrons 
of different pharmacy settings and differed somewhat from past studies on pharmacy 
patronage. The majority of patients under the age of 45 years patronized chain pharmacies, 
but these patients were also overrepresented in the group of patients reporting use of 
independent pharmacies. In contrast, Franic et al. reported in 2008 that the average age of 
patrons of independent and chain pharmacy settings was nine to twelve years higher than 
that of grocery and discount store patrons.12 The increased use of mail order pharmacies 
with age reported in this study is, however, consistent with past reports of high utilization 
of mail order pharmacies among those over 65 years of age,104 often due to insurance plan 
requirements or price incentives. 104,106 Also consistent with previously published 
literature was this study’s finding that the likelihood of mail-order pharmacy use increased 
with the number of prescription drugs taken.106  
It is not immediately evident why chain and independent pharmacy use was higher 
among the younger participants in this study than has been reported in past studies. While 
independent and chain pharmacy patrons in this study prioritized pharmacist-patient 
relationships and extended hours, respectively, younger respondents did not consistently 
ascribe stronger preferences to these attributes than their older counterparts. Few studies 
have specifically examined the pharmacy preferences of the millennial generation. A recent 
Accenture study on millennial shoppers found that, contrary to popular perceptions that 
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millennials prefer online shopping, 91% prefer brick-and-mortar shopping for drugstores, 
a higher proportion than for consumer electronics (68%), discount stores (83%), and 
department stores (84%).285 Millennials commonly distrust big business and favor niche 
and local retailers,286,287 perhaps contributing to their patronage of independent 
pharmacies relative to their non-millennial counterparts. At the same time, the 
convenience of non-pharmacy purchases at chain pharmacies and rewards programs have 
been cited as drivers for millennial patronage.288Given that the vast majority of younger 
participants in this study reported use of chronic medications, future research is warranted 
to more comprehensively explore the motivations that are driving millennial shoppers to 
chain and independent pharmacies. 
Patient pharmacy experiences and service utilization also different by pharmacy 
setting. Independent pharmacy patrons were nearly twice as likely as those who patronize 
other types of pharmacies to report that they knew their pharmacist’s name. Similarly, in 
the 2008 Franic study of determinant attributes during pharmacy selection, patients at 
independent pharmacies were more likely to know their pharmacists’ names than patients 
at grocery, chain, and discount store pharmacies.12  These results suggest that patient-
pharmacist relationships may be more common in independent pharmacy settings, a 
finding echoed in industry surveys and reports. A 2015 J.D. Power survey reported that 
patient satisfaction with and loyalty to their pharmacy was strongly related to speaking 
with a pharmacist, and the pharmacies with the highest overall satisfaction ratings were 
locally owned chains, including Good Neighbor Pharmacy, Health Mart, and The Medicine 
Shoppe Pharmacy.289 Articles by Consumer Reports and Pharmacy Times have also 
stressed the strength of pharmacist-patient relationships at independent pharmacies.290,291  
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The proportions of patients using a number of pharmacy services, including 
appointment-based medication synchronization (ABMS), adherence packaging, and home 
delivery were also higher among patrons of independent pharmacies than other types of 
brick and mortar pharmacies. Both ABMS292,293 and adherence packaging294 are  associated 
with increased medication adherence, as is having a pharmacist who “knows you pretty 
well.”295 While numerous studies have examined the effect of mail order pharmacy use on 
medication adherence,296,297 few studies have specifically compared medication adherence 
across brick-and-mortar pharmacy types. Future research is needed to explore the impact 
of pharmacy patronage and the utilization of different combinations of pharmacy services 
on adherence. Such research is particularly pertinent given the growth of PBM-defined 
pharmacy networks and concerns about the systematic exclusion of independent 
pharmacies from these networks.  
Other pharmacy services, included automatic refill programs, technology-based 
reminders, and smartphone apps were more commonly utilized by patrons of chain 
pharmacies than those patronizing other types of pharmacies. These differences were 
likely driven by the overrepresentation of millennials among chain pharmacy patrons. 
While not statistically significant, millennials were more likely than their older 
counterparts to report use of technology-based reminders (42% vs. 36%) and smartphone 
apps (14% vs. 9%). did not exceed that of older patrons. In fact, the use of smart phone 
apps was higher (13.6%) among older respondents than millennials (9.5%), though this 
difference was not statistically significant. In the discrete choice experiment, millennials, 
who have been termed the “convenience generation,”298 commonly patronized chain 
pharmacies but did not exhibit strong preferences for extended pharmacy hours, a proxy 
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for convenience. This finding suggests that younger patients may feel that technology-
based programs do more to increase pharmacy-related convenience more than extended 
hours.  
Finally, the similar levels of automatic refill utilization among patrons of grocery, 
chain, and mail order pharmacies was notable given differences in pharmacy practices 
surrounding automatic refills. Mail order pharmacies, either in accordance with internal 
policies or the policies of plan sponsors, often provide opt-out framing for automatic refill 
systems, requiring patients to actively decide against the service. In contrast, opt-in 
systems are generally used to enroll patients in automatic refill programs at brick-and-
mortar pharmacies. Given the documented impact of opt-out defaults on enrollment 
behavior,299,300 this finding may warrant additional research surrounding the current 
choice architecture frameworks for pharmacy services at different pharmacy types and 
their impact on service utilization and adherence.     
 
5.3 Patient Preferences for Quality-Related Attributes  
 The participants in this discrete choice experiment exhibited strong preferences for 
quality-related attributes during pharmacy selection. This finding was somewhat contrary 
to expectations based on published pharmacy quality-centered focus groups and the 
feedback received in the pilot testing of this DCE. Specifically, participants in focus groups 
conducted by Shiyanbola et al. generally did not define pharmacy quality in terms of 
outcomes14 and were reluctant to use quality information to switch pharmacies.15 
Similarly, in pilot testing, participants repeatedly stressed that their expectation of a 
pharmacy was to receive the correct medication in a prompt and convenient manner. 
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Several factors may have contributed to the high attribute importance values of the quality 
metrics used in this study: the scenario in which participants were asked to make their 
decisions, the use of a quality metric that may have been more closely aligned with 
participant expectations for community pharmacists, and the framing of the drug-drug 
interaction quality metric. These factors are discussed in more detail below. 
 
The Scenario Presented to DCE Participants 
 In this discrete choice experiment, participants were asked to consider the scenario 
in which they had moved to a new town and needed to select a new pharmacy. This 
scenario was used to control for the =status quo bias previously observed during pharmacy 
selection.15,170 The absence of attributes related to subjective personal experiences or the 
recommendations of friends and family may have increased the strength of patient 
preferences for the objective quality attributes.  
 
Consistency Between Patient Preferences and Expectations for Community Pharmacies 
 As discussed in the literature review above, several theories posited in marketing 
literature emphasize the complex interplay between preferences, expectations, and 
satisfaction.110–112 Consistent with these theories, the patient preferences expressed in this 
discrete choice experiment are likely closely associated with their expectations for 
community pharmacists. Past studies have demonstrated that patient expectations for 
community pharmacies are primarily product-focused and centered on dispensing roles. 
Patients are far more familiar with the dispensing role of pharmacists than more clinical 
roles13 and generally do not expect that pharmacists counsel them on their medications136 
 149 
or be involved in medication management.28 Furthermore, when dispensing prescriptions, 
pharmacists are expected to protect patient safety by ensuring that medications are 
accurately filled. When asked about whether he or she would use quality information to 
select a pharmacy, one focus group participant noted, “if it’s something kind of serious like 
they’ve been dispensing the wrong drugs or something, then I would definitely go to a 
different one.”15 Another participant echoed that sentiment, saying, “if they are giving the 
wrong prescriptions, I don’t want to take that chance with me.”15 In another series of focus 
groups, participants said they wanted pharmacists to “serve me right” and “check to see if 
there’s any drug interactions with other things I’m taking.”28  Taken together, these 
findings suggest that the pharmacist’s role is primarily seen as one that promotes the safety 
of medication therapy rather than its effectiveness.   
Many of the PQA quality metrics studied in past focus groups,14,15 including those 
focused on medication use, dosing, and adherence, reflect pharmacists’ involvement in 
improving the therapeutic effectiveness of patients’ medication regimens. However, the 
role presented to patients through the specific quality metric used in this study – that 
pharmacists screen for drug-drug interactions – predominately reflects pharmacist 
involvement in the safe delivery of medication therapy. The strong preferences for quality 
metrics seen in this DCE may therefore reflect congruence between the DDI-specific quality 
metric and patient expectations that pharmacists ensure the safety, but not the 
effectiveness, of their medications. 
The interpretation that the strong observed patient preferences for high quality 
pharmacies reflect limited expectations for pharmacist roles tampers the potentially over-
optimistic interpretation of this study’s results as validation that patients recognize the 
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positive contributions of pharmacists to pharmacotherapy management. That is, it is 
unlikely that patients who selected the higher quality pharmacies in this DCE made their 
selections based on a perception that higher-quality pharmacies are associated with 
improved pharmacotherapy management and health outcomes. Rather, patients likely 
perceived higher quality pharmacies to be those that improve patient safety. Educational 
efforts that inform patients about the full scope of pharmacist expertise and scope of 
practice should continue, perhaps drawing upon patient expectations that pharmacists 
promote patient safety by presenting evidence of the association between pharmacist 
participation on the healthcare team and reductions in long-term harms associated with 
chronic conditions.301,302  
 
Risk Aversion and The Loss Framing of the DDI Quality Metric 
 The strong patient preferences for the DDI quality metric in this study may also 
reflect the wording of this attribute and the aversions to risk and loss that have been well 
documented in behavioral economics and social psychology.303 Specifically, loss aversion is 
defined as an emotional response or decision heuristic that occurs when the decision-
maker is more sensitive to a loss than to the equivalent gain.303 Consequently, decision-
makers are as much as two times more likely to select an alternative that will avoid a loss 
than will create a gain.304 Sensitivity to loss may be a consequence of systematically 
underestimating one’s ability to rationalize loss while overestimating the future time spent 
dwelling on that loss.303  
The DDI quality metric used in this study was phrased using a loss framework, “The 
pharmacy ensured that there were no patients who were dispensed two medications that 
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could cause harm when taken together.”15 Specifically, this wording frames the metric as a 
loss (i.e., patients at low quality pharmacies may experience harm) rather than as a gain (i.e. 
patients at high quality pharmacies may experience improved health). A review of loss 
framing versus gain framing in healthcare decision-making reported 3likely because loss 
framing triggers the large behavioral response associated with loss aversion.304  
Furthermore, loss-framed metrics on mock report cards were more important to patients 
in a study on health plan selection than gain-framed metrics.305 Reframing the DDI metric 
in a more gain-framed manner (e.g., “the pharmacy ensured that patients on multiple 
medications only took those drugs that are safe and effective when taken together”) may 
have decreased the perceived importance of the measure.  
The risk aversion explanation for the strength of observed participant preferences 
for the DDI quality metric in this DCE may offer insight into how to effectively promote 
patient use of quality information during healthcare decision-making by altering the 
presentation of quality data. Loss-framed quality metrics may resonate more strongly with 
patients and therefore be more likely to be prioritized during provider and facility selection. 
Future studies can, and should, explore the impact of loss and gain framing on patient 
preferences for pharmacy and healthcare quality information to gain a better 
understanding of how changes in the presentation of quality information may promote its 
use among patients during real-world decision-making.       
 
 
 
5.4 Patient Preferences for Non-Quality Attributes 
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Although several past studies reported that patients see value in friendly, 
relationship-oriented pharmacies and pharmacists,12,13,28 the utility values for attributes 
related to functional quality in this study were low relative to those of the technical quality 
metrics.  Several factors may have contributed to this finding. First, as previously discussed, 
patient preferences for the technical quality metrics were high in this study. Given that 
preferences for attributes in discrete choice experiments are, by definition, relative to one 
another, strong preferences for some attributes necessarily require that preferences for 
other attributes be relatively weak. Thus, obtaining relatively weak preferences for 
functional quality-related attributes does not necessarily mean that participants have 
absolutely weak preferences for pharmacist friendliness and communication. If the 
relatively low utilities for these functional quality-related attributes do indeed reflect low 
absolute preferences, this finding may reflect the role of functional quality as a “deal 
breaker” rather than a “deal maker” and/or limited patient expectations for pharmacists 
outside of safe dispensing.  
The Kano Model of Customer Satisfaction posits that the most basic of customer 
needs and expectations for a service may be regarded as prerequisites such that if met, 
they are taken for granted, but if not met, will be deal-breakers for a customer.306 For 
example, when asked about grocery store preferences, one focus group participant 
remarked, “it works in reverse. I won’t come to a store for good assistants, but poor 
service/bad assistants will mean that I won’t go there.”102 The relatively weak utilities for 
the attributes related to functional quality in this study may reflect patient perceptions that 
pharmacy customer service is a deal-breaker rather than a deal-maker. In focus groups 
conducted by Shiyanbola, Mott, and Croes, a participant stated, “It [choice of pharmacy] has 
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a lot to do with that [pharmacy staff], because the first one that I was going to, to get my 
prescriptions, it was because of convenience. But then the staff wasn’t as friendly and they 
didn’t ask you questions, and then somebody recommended someplace else but it was 
inconvenient. But it turned out to be worth the inconvenience.”28 In a broader study of 
customer switching, service encounter failures, including encounters with uncaring, 
impolite, or unresponsive employees, were second only to core service failures – mistakes, 
billing errors, and severe catastrophes – as the reason for service switching.307 Taken 
together, these findings suggest that pharmacy resources dedicated to customer service 
may, for many pharmacies, be most efficiently allocated to avoiding service mistakes rather 
than providing service far above patient expectations. 
Finally, the relatively weak preferences for relationship- and communication-
oriented attributes seen in this DCE may reflect limited patient expectations for 
pharmacists outside of safe dispensing. As previously discussed, patient expectations for 
pharmacists are predominately dispensing-based,13,28 and few patients expect that 
pharmacists show an interest in working with patients to meet their healthcare needs135 or 
provide counseling on a medication’s indication.136 Patients who do not expect pharmacists 
to be friendly, communicate well, or show a willingness to get to know them would be 
unlikely to have strong preferences for pharmacies scoring well on these attributes in the 
DCE, resulting in the low attribute importance values found in this study.  
The alignment of patient expectations for healthcare providers and their relative 
preferences for those providers’ technical or interpersonal skills has been previously 
documented. In a study of patient preferences for physicians, the relative importance that 
patients placed on interpersonal communication-related factors and clinical competence-
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related attributes was different for obstetrician-gynecologists (OBGYNs) and family 
physicians than for surgeons.86 Study participants reported that expertise was equally as 
important as or more important than interpersonal communication skills and bedside 
manner for surgeons,86 a finding echoed in two other studies of patient preferences for 
surgeons.87,88 In contrast, communication factors, including ‘listens to me,’ ‘explains things 
clearly,’ ‘respectful,’ ‘easy to talk to,’ and ‘caring,’ were rated more highly than expertise 
when patients were considering OBGYN and family physicians.86  
In conclusion, the low preferences for non-quality attributes in this study may 
provide further evidence that patients perceive the role of a pharmacist as primarily 
focused on accurately performing technical, episodic care (i.e. dispensing) rather than the 
type of ongoing, relationship-centered care they expect of primary care physicians. 
However, ongoing, patient-centered alliances between patients and pharmacists have 
consistently been associated with improved adherence308 and self-efficacy.309,310 Continued 
efforts may therefore be required to promote the role of the pharmacist as a long-term 
partner in the management of chronic conditions. 
 
5.5 Demographic Differences in Community Pharmacy Preferences 
Several demographic differences in community pharmacy preferences were revealed in 
this discrete choice experiment. First, the utility values for five stars on both the overall quality 
and drug-drug interaction-specific quality metrics were higher among women than men. The 
existing literature on gender differences in the relative importance of technical and function 
quality in healthcare is limited.  One study on consumer trust in physician quality information 
reported that men had higher levels of trust in expert sources of information about healthcare 
providers than their female counterparts.73 Another reported that few women prioritize 
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quality metrics when selecting a hospital for labor and delivery.311 The higher importance 
ascribed to quality metrics among the women in this study may reflect their higher degree 
of risk aversion.312 Notably, however, the overall attribute importance value for the quality 
metrics were not significantly different between men and women. Additionally, the utility 
ascribed to a three-star rating was higher among men, though this difference was not 
statistically significant. These findings suggest that both men and women prioritized 
quality during pharmacy selection but that men were more likely than women to perceive 
three stars as adequate. Future research that gathers qualitative information on gender 
differences in the interpretation of the quality metrics and assesses patient preferences for 
gain-framed quality metrics would provide additional insights on the gender differences 
observed in this experiment. 
The utility values obtained in this discrete choice experiment did not vary by age. 
This finding was unexpected given consistent reports that younger patients better 
understand quality data.58,63,64  Past literature also suggests that older patients ascribe 
more value to the communication skills of physicians86 and less value to the convenience of 
grocery stores than their younger counterparts.101 The lack of age differences in the utility 
values obtained in this study may reflect the competing effects of age and education on 
patient preferences for healthcare providers. Higher education is associated with improved 
comprehension of quality information,70 increased trust in institutional sources of 
information,73 and decreased importance ascribed to communication-related attributes 
when selecting a physician.86 The older participants (≥65 years) in this study were highly 
educated; a significantly higher proportion of older adults had at least some graduate 
education (26.7%) than those aged 55-64 years (14.8%), 45-54 years (11.0%), 35-44 years 
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(22.7%), and 18-34 years (15.8%). They were also less likely (18.9%) than those aged 55-
64 (24.9%) and 45-54 (24.1%) to report a high school education or less. These differences 
in educational attainment may have confounded the effect of age on quality metric 
comprehension and preferences during healthcare provider selection. 
 Patient preferences for pharmacy attributes differed by urbanicity. Specifically, the 
utilities of the friendliness/courtesy and patient-pharmacist relationship attributes were 
highest among small town and rural respondents, consistent with past reports patients 
living in rural areas maintain high levels of pharmacy loyalty because of established 
personal relationships with their pharmacists.15 These findings add to the discussion of 
dual relationships with patients and overlapping roles for clinicians as community 
members as notable aspects of healthcare provision in rural settings.313–315  
 The utility values for friendliness/courtesy, pharmacist effort to establish a 
relationship, and communication were higher among survey respondents who had an 
existing relationship with a pharmacist, as indicated by responding “yes” to the statement 
“I know my pharmacist’s name,” than those who did not. The directionality of this 
association cannot be determined from the data. That is, patients who prioritize 
communication and relationships may be more likely to know their pharmacist’s name 
because they either choose a relationship-oriented pharmacy or initiate a relationship with 
the pharmacist. Conversely, patients who know their pharmacist’s name may be satisfied 
with this relationship or feel that it adds to the quality of their care and therefore more 
strongly prefer relationship-oriented attributes when choosing future pharmacies than 
those who have not experienced a personal pharmacist-patient relationship. The latter 
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explanation would suggest that, by making an effort to get to know their patients, 
pharmacists can effectively market the value of ongoing pharmacist-patient relationships.  
 
5.6 Community Pharmacy Market Segmentation  
  The results of the latent class analysis suggested that patient preferences for 
community pharmacy attributes were heterogeneous and that this heterogeneity was best 
represented with a three-class model. Approximately two-thirds of patients belonged to 
the largest segment, the “Quality Class.” Members of the quality class displayed strong 
preferences for quality metrics, with mean attribute importance values (AIV) for the drug-
drug interaction (DDI)-specific quality metric and the overall quality metric of 45.5 and 
33.3, respectively. In that class, no other attribute had a mean attribute importance value 
over five.  The second largest segment, to which 28.3% of patients belonged, was labeled 
the “Relationship Class.” As in Quality Class, the attributes with the highest utility values in 
the Relationship Class were the quality metrics. However, the attribute importance values 
of the friendliness/courtesy, communication, and patient-pharmacist relationship 
attributes (9.0-11.5) were approximately twice as large in the Relationship Class than they 
were in the other classes (3.8-6.2). Finally, members of the Convenience Class, who 
comprised only 4.2% of all respondents, strongly preferred pharmacies with extended 
hours of operation.  
 There were few statistically significant differences in demographic and health 
characteristics between the segments, though the lack of statistical significance may reflect 
the small size of the convenience class. Notably, a significantly higher proportion of 
patients in the Relationship Class reported that they know their pharmacist’s name 
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(42.3%) than members of the convenience (29.0%) and quality classes (32.3%). As 
discussed above, this may suggest that patients with established patient-pharmacist 
relationships ascribe more value to relationship-oriented attributes because of positive 
experiences with personalized pharmacy care. The age distributions of class members also 
differed by segment. Members of the Convenience Class were predominantly members of 
the youngest (18-24 years, 32.3%) and oldest (≥ 55 years, 48.4%) age groups surveyed. 
Members of the middle age groups (25-54 years) were underrepresented in the 
Convenience Class despite the growing time demands on middle-aged adults “sandwiched” 
between caring for both their children and their aging parents.316  
 The overrepresentation of the oldest survey participants in the Convenience Class 
was unexpected given the drop in labor force participation with age.317 However, several 
retired, older adults in the pilot testing for this experiment had referenced prioritizing 
extended pharmacy hours not for everyday accessibility but “in case” something urgent 
comes up. The degree to which older adult membership in the convenience class reflects 
concerns about accessibility in urgent situations could be explored in future research. If 
this concern is widespread, pharmacies with more limited hours may find that offering 
after hours and emergency services for loyal customers, as do many independent 
pharmacies, may prove valuable for recruiting and retaining baby boomers.  
 
 
 
 
 
 
 
 
5.7 Limitations and Future Research 
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5.7.1 Limitations – Methodological Considerations 
 
 The attribute selection process is a critical component of any discrete choice 
analysis, and despite attempts to methodically and transparently select the most 
appropriate attributes for this DCE, certain limitations were introduced by the process. 
First, cost and location were held constant across all pharmacy alternatives. The rationale 
behind this decision is discussed in detail in the methods section and included a desire to 
avoid introducing dominating attributes and a recognition that similar medication costs 
and locations across multiple pharmacies are indeed realistic for a substantial portion of 
the US population. However, preferred pharmacy networks introduce differential pricing 
dependent upon pharmacy selection for many insured adults, particularly those with one of 
the 85% of Medicare Part D plans with preferred pharmacy networks in 2017.318 Because 
cost was held constant in this study, its results cannot be generalized to populations with 
insurance plans that introduce substantial price incentives for patronage at an in-network 
pharmacy. 
The omission of potentially important attributes presents an additional 
methodological limitation. This limitation is intrinsic to the use of DCEs to elicit participant 
preferences, as the number of attributes is necessarily limited by the need to minimize the 
cognitive burden for participants. A number of efforts were made to minimize omitted 
variable bias in this study, including the inclusion of attributes that would be relevant to 
the majority of patients,164 the inclusion of participants who failed the dominant 
scenario,214  and the use of unlabeled alternatives. 214 Still, some participants may have felt 
that the included attributes did not adequately reflect those that would be influential 
during real-life decision-making. For example, several rural participants in focus groups 
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noted that their pharmacy selection processes were largely dependent upon personal or 
community relationships with local pharmacy owners.15 Additionally, feedback received 
during the attribute selection process for this DCE suggested that the presence of a 
pharmacy drive-through and the availability of specialized services like compounding and 
home delivery drive pharmacy patronage decisions in select patients. Future studies 
conducted in targeted patient populations could include different pharmacy attributes that 
are salient to specific populations, though such an approach would considerably limit 
comparability between studies. 
 The instructions for this discrete choice experiment outlined a specific scenario for 
study participants, namely, that they were to consider the scenario in which they had 
recently moved to a new town and needed to find a new pharmacy. This scenario, which 
occurs for the estimated 11.5% of the US population that moves each year,319 was used to 
make clear to participants that a status quo option of remaining at their current pharmacy 
would not be an option in the experiment. The omission of a status quo option allowed this 
experiment to assess patient preferences in the absence of status quo bias and pharmacy 
loyalty, known to be dominating factors in pharmacy selection.15,170 However, this omission 
also constrains the generalizability of this study to those patients who are choosing to 
select a new pharmacy. If pharmacy-related quality metrics were to become publicly 
available, the likelihood that patients would change pharmacies to one more consistent 
with their stated preferences is not known but is likely small given the documented impact 
of status quo bias.  
 The demographic and health characteristics collected at the end of this discrete 
choice experiment were selected based on published literature but were not exhaustive. 
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Participant characteristics that were not collected may have impacted preferences during 
community pharmacy selection in meaningful ways. For example, while limited 
information on caregiving was collected, the specific nature of the caregiving relationship 
was not obtained, and the preferences of caregivers of children, able-bodied spouses, and 
ailing spouses or parents may systematically differ. Employment status, mental health, and 
the use of high-risk or narrow-therapeutic index medications may also influence 
preferences. However, the number of questionnaire items, which exceeded that of most 
health-care related DCEs, was necessarily limited by the cognitive burden of the preceding 
DCE and concerns about participant attrition as that burden was increased. 
Conditional logit (CL), the most commonly used model in the analysis of healthcare-
related DCEs,213  was used in the analysis of the first study aim. CL does not and cannot 
account for systematic preference heterogeneity between respondents, introducing the 
potential for biased estimates. Recognizing the limitation imposed by the assumption of CL 
that preferences are homogenous, a latent class analysis - which models preference 
heterogeneity across a discrete number of groups – was conducted alongside the CL. 
Additionally, the Hierarchical Bayes model used Study Aim 2 accounts for preference 
variation by estimating individual-level utility values.  The results of all three models were 
presented here, consistent with the way in which many published studies that estimate 
both CL and latent class models report the results of both.209,320,321   
Finally, this study design employed a main-effects model only. This design is the 
most commonly used design in healthcare-related DCEs213 and the use of a main-effects 
model minimizes the number of choice tasks per person required for an efficient design. 
However, the main effects model makes the assumption that interactions are statistically 
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significantly different from zero.180 In this study, pilot testing was used to identify 
attributes that were seen as highly correlated, and redundant attributes were removed.  
The final attribute list included two quality metrics, an overall and a specific measure. 
Though participants in the pilot test and published focus groups14,71 and surveys67 tended 
to view overall and specific scores as distinct, with different types of measures appealing to 
different subpopulations, the possibility of bias introduced by interattribute correlation 
cannot be excluded.  
 
 
5.7.2 Limitations – The External Validity of Discrete Choice Experiments 
 
 Stated preference techniques, including discrete choice experiments, have a number 
of inherent limitations in their ability to accurately predict real life decision-making, and   
analyses of the external validity of healthcare-related discrete choice experiments are 
notably limited.322 However, stated preference techniques provide an opportunity to assess 
participant preferences for attributes or attribute levels that do not currently exist, 
allowing decision-makers to gain insights into the possible impact of introducing a new 
attribute – here, publicly available pharmacy-level quality metrics – into the marketplace. 
Should pharmacy-level quality metrics become publicly available, additional research 
should explore the convergence between the results of this and future pharmacy quality-
related discrete choice experiments with real life patient decisions in the community 
pharmacy market.  
 The external validity of this DCE may be limited by the easy accessibility of the 
quality information in the experiment. Studies on patient awareness of healthcare quality 
metrics report very low levels of awareness of publicly available hospital quality 
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metrics,50,51 particularly those available through governmental outlets. 54 If pharmacy 
quality metrics were publicly available, patient awareness of those metrics is likely to be 
similarly low, thus limiting the degree to which the metrics would be used during 
pharmacy selection. Furthermore, this experiment presented the quality information as 
“expert-assessed,” reflecting that the metrics presented were those that have been 
developed by the non-governmental, multi-stakeholder Pharmacy Quality Alliance. If the 
PQA metrics were presented through a .gov website, the metrics may be perceived as less 
trustworthy by patients, who have previously reported moderate to low degrees of trust in 
CAHPS, HEDIS, and Medicare performance data. 74,75  The effect of presenting pharmacy 
quality information through a government-related channel on patient preferences for the 
quality metrics is not known but could be explored in future research.  
Finally, limits on this study’s generalizability are relevant to a discussion of its 
external validity.  The population of respondents yielded from the Qualtrics study panel 
was not nationally representative and therefore are not generalizable to the entire US 
population . The preferences calculated and discussed in this study may best reflect the 
preferences of middle aged Americans with above-average levels of education and income. 
Future research should explore the community pharmacy preferences of populations 
underrepresented in this study population, particularly older adults and those with low 
levels of education and health literacy.  
 
5.7.3 Future Research  
 
 As this was the first quantitative study on patient preferences for community 
pharmacy attributes, its results raise numerous questions and hypotheses to be explored in 
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future research. First, the study results generated a hypothesis that patient preferences for 
the drug-drug interaction metric reflect an underlying risk aversion common among both 
patients and clinicians. Future research is needed to explore the validity of this hypothesis 
and may include additional discrete choice experiments testing the impact of loss- and 
gain-framing on patient preferences for high-quality pharmacies. This hypothesis could 
also be extended to research on quality metrics in other aspects of healthcare, including 
hospitals and physicians. Hospitalcompare.gov currently presents predominantly gain-
framed quality metrics, most often in terms of the proportions of patients who receive 
appropriate care. The impact of loss-framing on increased patient utilization of these 
metrics remains to be studied and would add to the body literature on the optimal 
presentation of quality information. The vast majority of studies on the impact of 
presentation on patient comprehension and use of quality data focus on the presentation of 
the data itself, including the amount and format of data presentation. Few, if any, studies 
have investigated the effect of the wording of the quality measure itself on perceived 
importance and relevance of the measure.  
Secondly, as discussed above, older adults, particularly those above 75 years of age, 
were underrepresented in this study population. The number of older adults and the 
proportion of the population over 65 years is expected to rise considerably in the next 30 
years.323 Polypharmacy is increasingly common in older adults248 and has documented 
associations with numerous adverse health outcomes.324 Community pharmacists are in a 
position to identify and limit polypharmacy and its adverse effects;325 thus, the ways to best 
nudge older adults towards high quality pharmacies that are proactively involved with 
pharmacotherapy management warrant further exploration.  
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Finally, as noted above, the external validity of healthcare-related discrete choice 
experiments has not been extensively studied.322 The pharmacy choices made in this DCE 
cannot currently be compared to those made in real life because pharmacy quality metrics 
are not yet publicly available. Furthermore, “soft” attributes like pharmacist 
communication and friendliness would be difficult to quantify across a large array of 
pharmacies, complicating an analysis of real-life patient decision-making. However, the 
preferences calculated from this DCE could be compared to those estimated from 
alternative preference elicitation methods. For example, the utilities generated from a DCE 
can be compared to those generated from a best-worst scaling exercise. These types of 
empirical comparisons have been encouraged for healthcare-related choice experiments, 
particularly in light of conflicting findings reported by studies comparing the two.326–328    
 
5.8 Conclusion 
 In conclusion, this study explored patient preferences for six community pharmacy 
attributes: two quality metrics, hours of operation, pharmacist friendliness, pharmacist 
communication, and pharmacist effort to establish a pharmacist-patient relationship. The 
participants in this discrete choice experiment exhibited strong preferences for pharmacies 
with high star ratings on a specific quality metric, “Pharmacy ensured there were no 
patients who were dispensed two medications that can cause harm when taken together.” 
This finding may reflect patient expectations of community pharmacists, namely that 
pharmacists ensure that patients are not harmed by the medications filled at their 
pharmacies. Latent class analysis revealed underlying preference heterogeneity and 
identified three classes, including a Quality Class, a Relationship Class, and a Convenience 
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Class. The role of community pharmacists has expanded considerably in past decades and 
will likely continue to change with the changing healthcare environment and efforts to gain 
provider status. Future research on patient expectations of and preferences for community 
pharmacies will be needed to assess the degree to which patients buy-in to expanding 
pharmacist roles and the most effective ways to encourage patients to actively engage with 
their pharmacists to improve health outcomes.    
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